id	sid	tid	token	lemma	pos
cord-353749-2vlc11rx	1	1	key	key	JJ
cord-353749-2vlc11rx	1	2	:	:	:
cord-353749-2vlc11rx	1	3	cord-353749	cord-353749	NNS
cord-353749-2vlc11rx	1	4	-	-	HYPH
cord-353749-2vlc11rx	1	5	2vlc11rx	2vlc11rx	CD
cord-353749-2vlc11rx	1	6	authors	author	NNS
cord-353749-2vlc11rx	1	7	:	:	:
cord-353749-2vlc11rx	1	8	Stricker	Stricker	NNP
cord-353749-2vlc11rx	1	9	,	,	,
cord-353749-2vlc11rx	1	10	Raphael	Raphael	NNP
cord-353749-2vlc11rx	1	11	B	B	NNP
cord-353749-2vlc11rx	1	12	;	;	:
cord-353749-2vlc11rx	1	13	Fesler	Fesler	NNP
cord-353749-2vlc11rx	1	14	,	,	,
cord-353749-2vlc11rx	1	15	Melissa	Melissa	NNP
cord-353749-2vlc11rx	1	16	C	C	NNP
cord-353749-2vlc11rx	1	17	title	title	NN
cord-353749-2vlc11rx	1	18	:	:	:
cord-353749-2vlc11rx	2	1	Flattening	flatten	VBG
cord-353749-2vlc11rx	2	2	the	the	DT
cord-353749-2vlc11rx	2	3	Risk	risk	NN
cord-353749-2vlc11rx	2	4	:	:	:
cord-353749-2vlc11rx	2	5	Pre	pre	JJ
cord-353749-2vlc11rx	2	6	-	-	JJ
cord-353749-2vlc11rx	2	7	Exposure	Exposure	NNP
cord-353749-2vlc11rx	2	8	Prophylaxis	Prophylaxis	NNP
cord-353749-2vlc11rx	2	9	for	for	IN
cord-353749-2vlc11rx	2	10	COVID-19	covid-19	CD
cord-353749-2vlc11rx	2	11	date	date	NN
cord-353749-2vlc11rx	2	12	:	:	:
cord-353749-2vlc11rx	2	13	2020	2020	CD
cord-353749-2vlc11rx	2	14	-	-	SYM
cord-353749-2vlc11rx	2	15	10	10	CD
cord-353749-2vlc11rx	2	16	-	-	SYM
cord-353749-2vlc11rx	2	17	19	19	CD
cord-353749-2vlc11rx	2	18	journal	journal	NN
cord-353749-2vlc11rx	2	19	:	:	:
cord-353749-2vlc11rx	3	1	Infect	infect	VB
cord-353749-2vlc11rx	3	2	Drug	drug	NN
cord-353749-2vlc11rx	3	3	Resist	resist	NN
cord-353749-2vlc11rx	3	4	DOI	doi	NN
cord-353749-2vlc11rx	4	1	:	:	:
cord-353749-2vlc11rx	4	2	10.2147	10.2147	CD
cord-353749-2vlc11rx	4	3	/	/	SYM
cord-353749-2vlc11rx	4	4	idr.s264831	idr.s264831	NN
cord-353749-2vlc11rx	4	5	sha	sha	NN
cord-353749-2vlc11rx	4	6	:	:	:
cord-353749-2vlc11rx	5	1	b331999a09c5f843385f7accaf2e8bfae6577f40	b331999a09c5f843385f7accaf2e8bfae6577f40	NNP
cord-353749-2vlc11rx	5	2	doc_id	doc_id	CD
cord-353749-2vlc11rx	5	3	:	:	:
cord-353749-2vlc11rx	5	4	353749	353749	CD
cord-353749-2vlc11rx	5	5	cord_uid	cord_uid	NNS
cord-353749-2vlc11rx	5	6	:	:	:
cord-353749-2vlc11rx	5	7	2vlc11rx	2vlc11rx	CD
cord-353749-2vlc11rx	6	1	To	to	IN
cord-353749-2vlc11rx	6	2	date	date	NN
cord-353749-2vlc11rx	6	3	,	,	,
cord-353749-2vlc11rx	6	4	more	more	JJR
cord-353749-2vlc11rx	6	5	than	than	IN
cord-353749-2vlc11rx	6	6	35	35	CD
cord-353749-2vlc11rx	6	7	million	million	CD
cord-353749-2vlc11rx	6	8	people	people	NNS
cord-353749-2vlc11rx	6	9	worldwide	worldwide	RB
cord-353749-2vlc11rx	6	10	have	have	VBP
cord-353749-2vlc11rx	6	11	been	be	VBN
cord-353749-2vlc11rx	6	12	infected	infect	VBN
cord-353749-2vlc11rx	6	13	with	with	IN
cord-353749-2vlc11rx	6	14	severe	severe	JJ
cord-353749-2vlc11rx	6	15	acute	acute	JJ
cord-353749-2vlc11rx	6	16	respiratory	respiratory	JJ
cord-353749-2vlc11rx	6	17	syndrome	syndrome	NN
cord-353749-2vlc11rx	6	18	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	6	19	2	2	CD
cord-353749-2vlc11rx	7	1	(	(	-LRB-
cord-353749-2vlc11rx	7	2	SARS	SARS	NNP
cord-353749-2vlc11rx	7	3	-	-	HYPH
cord-353749-2vlc11rx	7	4	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	7	5	)	)	-RRB-
cord-353749-2vlc11rx	7	6	,	,	,
cord-353749-2vlc11rx	7	7	the	the	DT
cord-353749-2vlc11rx	7	8	agent	agent	NN
cord-353749-2vlc11rx	7	9	of	of	IN
cord-353749-2vlc11rx	7	10	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	7	11	disease	disease	NNP
cord-353749-2vlc11rx	7	12	2019	2019	CD
cord-353749-2vlc11rx	7	13	(	(	-LRB-
cord-353749-2vlc11rx	7	14	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	7	15	)	)	-RRB-
cord-353749-2vlc11rx	7	16	,	,	,
cord-353749-2vlc11rx	7	17	and	and	CC
cord-353749-2vlc11rx	7	18	more	more	JJR
cord-353749-2vlc11rx	7	19	than	than	IN
cord-353749-2vlc11rx	7	20	one	one	CD
cord-353749-2vlc11rx	7	21	million	million	CD
cord-353749-2vlc11rx	7	22	have	have	VBP
cord-353749-2vlc11rx	7	23	died	die	VBN
cord-353749-2vlc11rx	7	24	in	in	IN
cord-353749-2vlc11rx	7	25	the	the	DT
cord-353749-2vlc11rx	7	26	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	7	27	pandemic	pandemic	NN
cord-353749-2vlc11rx	7	28	.	.	.
cord-353749-2vlc11rx	8	1	International	international	JJ
cord-353749-2vlc11rx	8	2	economies	economy	NNS
cord-353749-2vlc11rx	8	3	are	be	VBP
cord-353749-2vlc11rx	8	4	stalled	stall	VBN
cord-353749-2vlc11rx	8	5	and	and	CC
cord-353749-2vlc11rx	8	6	social	social	JJ
cord-353749-2vlc11rx	8	7	isolation	isolation	NN
cord-353749-2vlc11rx	8	8	based	base	VBN
cord-353749-2vlc11rx	8	9	on	on	IN
cord-353749-2vlc11rx	8	10	palpable	palpable	JJ
cord-353749-2vlc11rx	8	11	fear	fear	NN
cord-353749-2vlc11rx	8	12	of	of	IN
cord-353749-2vlc11rx	8	13	death	death	NN
cord-353749-2vlc11rx	8	14	remains	remain	VBZ
cord-353749-2vlc11rx	8	15	the	the	DT
cord-353749-2vlc11rx	8	16	order	order	NN
cord-353749-2vlc11rx	8	17	of	of	IN
cord-353749-2vlc11rx	8	18	the	the	DT
cord-353749-2vlc11rx	8	19	day	day	NN
cord-353749-2vlc11rx	8	20	.	.	.
cord-353749-2vlc11rx	9	1	The	the	DT
cord-353749-2vlc11rx	9	2	United	United	NNP
cord-353749-2vlc11rx	9	3	States	States	NNP
cord-353749-2vlc11rx	9	4	and	and	CC
cord-353749-2vlc11rx	9	5	other	other	JJ
cord-353749-2vlc11rx	9	6	countries	country	NNS
cord-353749-2vlc11rx	9	7	are	be	VBP
cord-353749-2vlc11rx	9	8	moving	move	VBG
cord-353749-2vlc11rx	9	9	toward	toward	IN
cord-353749-2vlc11rx	9	10	resuming	resume	VBG
cord-353749-2vlc11rx	9	11	work	work	NN
cord-353749-2vlc11rx	9	12	activities	activity	NNS
cord-353749-2vlc11rx	9	13	and	and	CC
cord-353749-2vlc11rx	9	14	social	social	JJ
cord-353749-2vlc11rx	9	15	interaction	interaction	NN
cord-353749-2vlc11rx	9	16	to	to	TO
cord-353749-2vlc11rx	9	17	boost	boost	VB
cord-353749-2vlc11rx	9	18	economic	economic	JJ
cord-353749-2vlc11rx	9	19	recovery	recovery	NN
cord-353749-2vlc11rx	9	20	.	.	.
cord-353749-2vlc11rx	10	1	While	while	IN
cord-353749-2vlc11rx	10	2	this	this	DT
cord-353749-2vlc11rx	10	3	makes	make	VBZ
cord-353749-2vlc11rx	10	4	financial	financial	JJ
cord-353749-2vlc11rx	10	5	sense	sense	NN
cord-353749-2vlc11rx	10	6	,	,	,
cord-353749-2vlc11rx	10	7	from	from	IN
cord-353749-2vlc11rx	10	8	a	a	DT
cord-353749-2vlc11rx	10	9	medical	medical	JJ
cord-353749-2vlc11rx	10	10	perspective	perspective	NN
cord-353749-2vlc11rx	10	11	our	-PRON-	PRP$
cord-353749-2vlc11rx	10	12	population	population	NN
cord-353749-2vlc11rx	10	13	has	have	VBZ
cord-353749-2vlc11rx	10	14	already	already	RB
cord-353749-2vlc11rx	10	15	suffered	suffer	VBN
cord-353749-2vlc11rx	10	16	and	and	CC
cord-353749-2vlc11rx	10	17	will	will	MD
cord-353749-2vlc11rx	10	18	continue	continue	VB
cord-353749-2vlc11rx	10	19	to	to	TO
cord-353749-2vlc11rx	10	20	suffer	suffer	VB
cord-353749-2vlc11rx	10	21	severe	severe	JJ
cord-353749-2vlc11rx	10	22	losses	loss	NNS
cord-353749-2vlc11rx	10	23	in	in	IN
cord-353749-2vlc11rx	10	24	the	the	DT
cord-353749-2vlc11rx	10	25	absence	absence	NN
cord-353749-2vlc11rx	10	26	of	of	IN
cord-353749-2vlc11rx	10	27	a	a	DT
cord-353749-2vlc11rx	10	28	viable	viable	JJ
cord-353749-2vlc11rx	10	29	aggressive	aggressive	JJ
cord-353749-2vlc11rx	10	30	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	10	31	strategy	strategy	NN
cord-353749-2vlc11rx	10	32	for	for	IN
cord-353749-2vlc11rx	10	33	SARS	SARS	NNP
cord-353749-2vlc11rx	10	34	-	-	HYPH
cord-353749-2vlc11rx	10	35	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	10	36	.	.	.
cord-353749-2vlc11rx	11	1	Herein	herein	RB
cord-353749-2vlc11rx	11	2	,	,	,
cord-353749-2vlc11rx	11	3	we	-PRON-	PRP
cord-353749-2vlc11rx	11	4	present	present	VBP
cord-353749-2vlc11rx	11	5	a	a	DT
cord-353749-2vlc11rx	11	6	plan	plan	NN
cord-353749-2vlc11rx	11	7	to	to	TO
cord-353749-2vlc11rx	11	8	address	address	VB
cord-353749-2vlc11rx	11	9	this	this	DT
cord-353749-2vlc11rx	11	10	problem	problem	NN
cord-353749-2vlc11rx	11	11	.	.	.
cord-353749-2vlc11rx	12	1	The	the	DT
cord-353749-2vlc11rx	12	2	medical	medical	JJ
cord-353749-2vlc11rx	12	3	approach	approach	NN
cord-353749-2vlc11rx	12	4	to	to	IN
cord-353749-2vlc11rx	12	5	SARS	SARS	NNP
cord-353749-2vlc11rx	12	6	-	-	HYPH
cord-353749-2vlc11rx	12	7	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	12	8	is	be	VBZ
cord-353749-2vlc11rx	12	9	based	base	VBN
cord-353749-2vlc11rx	12	10	on	on	IN
cord-353749-2vlc11rx	12	11	three	three	CD
cord-353749-2vlc11rx	12	12	principles	principle	NNS
cord-353749-2vlc11rx	12	13	:	:	:
cord-353749-2vlc11rx	12	14	prevention	prevention	NN
cord-353749-2vlc11rx	12	15	,	,	,
cord-353749-2vlc11rx	12	16	early	early	JJ
cord-353749-2vlc11rx	12	17	treatment	treatment	NN
cord-353749-2vlc11rx	12	18	and	and	CC
cord-353749-2vlc11rx	12	19	late	late	JJ
cord-353749-2vlc11rx	12	20	treatment	treatment	NN
cord-353749-2vlc11rx	12	21	.	.	.
cord-353749-2vlc11rx	13	1	We	-PRON-	PRP
cord-353749-2vlc11rx	13	2	previously	previously	RB
cord-353749-2vlc11rx	13	3	presented	present	VBD
cord-353749-2vlc11rx	13	4	a	a	DT
cord-353749-2vlc11rx	13	5	novel	novel	JJ
cord-353749-2vlc11rx	13	6	plan	plan	NN
cord-353749-2vlc11rx	13	7	to	to	TO
cord-353749-2vlc11rx	13	8	implement	implement	VB
cord-353749-2vlc11rx	13	9	early	early	JJ
cord-353749-2vlc11rx	13	10	treatment	treatment	NN
cord-353749-2vlc11rx	13	11	for	for	IN
cord-353749-2vlc11rx	13	12	COVID-19	covid-19	NN
cord-353749-2vlc11rx	13	13	on	on	IN
cord-353749-2vlc11rx	13	14	a	a	DT
cord-353749-2vlc11rx	13	15	large	large	JJ
cord-353749-2vlc11rx	13	16	scale	scale	NN
cord-353749-2vlc11rx	13	17	as	as	IN
cord-353749-2vlc11rx	13	18	needed	need	VBN
cord-353749-2vlc11rx	13	19	.	.	.
cord-353749-2vlc11rx	13	20	1	1	CD
cord-353749-2vlc11rx	14	1	Although	although	IN
cord-353749-2vlc11rx	14	2	this	this	DT
cord-353749-2vlc11rx	14	3	plan	plan	NN
cord-353749-2vlc11rx	14	4	may	may	MD
cord-353749-2vlc11rx	14	5	salvage	salvage	VB
cord-353749-2vlc11rx	14	6	patients	patient	NNS
cord-353749-2vlc11rx	14	7	with	with	IN
cord-353749-2vlc11rx	14	8	early	early	JJ
cord-353749-2vlc11rx	14	9	disease	disease	NN
cord-353749-2vlc11rx	14	10	,	,	,
cord-353749-2vlc11rx	14	11	it	-PRON-	PRP
cord-353749-2vlc11rx	14	12	is	be	VBZ
cord-353749-2vlc11rx	14	13	less	less	RBR
cord-353749-2vlc11rx	14	14	practical	practical	JJ
cord-353749-2vlc11rx	14	15	than	than	IN
cord-353749-2vlc11rx	14	16	prevention	prevention	NN
cord-353749-2vlc11rx	14	17	for	for	IN
cord-353749-2vlc11rx	14	18	people	people	NNS
cord-353749-2vlc11rx	14	19	who	who	WP
cord-353749-2vlc11rx	14	20	are	be	VBP
cord-353749-2vlc11rx	14	21	resuming	resume	VBG
cord-353749-2vlc11rx	14	22	work	work	NN
cord-353749-2vlc11rx	14	23	activities	activity	NNS
cord-353749-2vlc11rx	14	24	and	and	CC
cord-353749-2vlc11rx	14	25	who	who	WP
cord-353749-2vlc11rx	14	26	may	may	MD
cord-353749-2vlc11rx	14	27	be	be	VB
cord-353749-2vlc11rx	14	28	exposed	expose	VBN
cord-353749-2vlc11rx	14	29	to	to	IN
cord-353749-2vlc11rx	14	30	SARS	SARS	NNP
cord-353749-2vlc11rx	14	31	-	-	HYPH
cord-353749-2vlc11rx	14	32	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	14	33	via	via	IN
cord-353749-2vlc11rx	14	34	contact	contact	NN
cord-353749-2vlc11rx	14	35	,	,	,
cord-353749-2vlc11rx	14	36	aerosol	aerosol	NN
cord-353749-2vlc11rx	14	37	and/or	and/or	CC
cord-353749-2vlc11rx	14	38	droplet	droplet	NN
cord-353749-2vlc11rx	14	39	transmission	transmission	NN
cord-353749-2vlc11rx	14	40	.	.	.
cord-353749-2vlc11rx	15	1	2	2	LS
cord-353749-2vlc11rx	16	1	As	as	IN
cord-353749-2vlc11rx	16	2	for	for	IN
cord-353749-2vlc11rx	16	3	late	late	JJ
cord-353749-2vlc11rx	16	4	treatment	treatment	NN
cord-353749-2vlc11rx	16	5	,	,	,
cord-353749-2vlc11rx	16	6	the	the	DT
cord-353749-2vlc11rx	16	7	high	high	JJ
cord-353749-2vlc11rx	16	8	mortality	mortality	NN
cord-353749-2vlc11rx	16	9	rate	rate	NN
cord-353749-2vlc11rx	16	10	of	of	IN
cord-353749-2vlc11rx	16	11	50	50	CD
cord-353749-2vlc11rx	16	12	%	%	NN
cord-353749-2vlc11rx	16	13	or	or	CC
cord-353749-2vlc11rx	16	14	more	more	JJR
cord-353749-2vlc11rx	16	15	for	for	IN
cord-353749-2vlc11rx	16	16	patients	patient	NNS
cord-353749-2vlc11rx	16	17	on	on	IN
cord-353749-2vlc11rx	16	18	respiratory	respiratory	JJ
cord-353749-2vlc11rx	16	19	support	support	NN
cord-353749-2vlc11rx	16	20	makes	make	VBZ
cord-353749-2vlc11rx	16	21	implementation	implementation	NN
cord-353749-2vlc11rx	16	22	of	of	IN
cord-353749-2vlc11rx	16	23	prevention	prevention	NN
cord-353749-2vlc11rx	16	24	and	and	CC
cord-353749-2vlc11rx	16	25	early	early	JJ
cord-353749-2vlc11rx	16	26	treatment	treatment	NN
cord-353749-2vlc11rx	16	27	an	an	DT
cord-353749-2vlc11rx	16	28	urgent	urgent	JJ
cord-353749-2vlc11rx	16	29	priority	priority	NN
cord-353749-2vlc11rx	16	30	.	.	.
cord-353749-2vlc11rx	17	1	3	3	LS
cord-353749-2vlc11rx	18	1	Furthermore	furthermore	RB
cord-353749-2vlc11rx	18	2	,	,	,
cord-353749-2vlc11rx	18	3	the	the	DT
cord-353749-2vlc11rx	18	4	emergence	emergence	NN
cord-353749-2vlc11rx	18	5	of	of	IN
cord-353749-2vlc11rx	18	6	persistent	persistent	JJ
cord-353749-2vlc11rx	18	7	debilitating	debilitating	JJ
cord-353749-2vlc11rx	18	8	symptoms	symptom	NNS
cord-353749-2vlc11rx	18	9	in	in	IN
cord-353749-2vlc11rx	18	10	survivors	survivor	NNS
cord-353749-2vlc11rx	18	11	indicates	indicate	VBZ
cord-353749-2vlc11rx	18	12	that	that	IN
cord-353749-2vlc11rx	18	13	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	18	14	is	be	VBZ
cord-353749-2vlc11rx	18	15	a	a	DT
cord-353749-2vlc11rx	18	16	complex	complex	JJ
cord-353749-2vlc11rx	18	17	illness	illness	NN
cord-353749-2vlc11rx	18	18	that	that	WDT
cord-353749-2vlc11rx	18	19	is	be	VBZ
cord-353749-2vlc11rx	18	20	best	well	RBS
cord-353749-2vlc11rx	18	21	avoided	avoid	VBN
cord-353749-2vlc11rx	18	22	.	.	.
cord-353749-2vlc11rx	19	1	4	4	LS
cord-353749-2vlc11rx	19	2	Residual	residual	JJ
cord-353749-2vlc11rx	19	3	risk	risk	NN
cord-353749-2vlc11rx	19	4	of	of	IN
cord-353749-2vlc11rx	19	5	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	19	6	will	will	MD
cord-353749-2vlc11rx	19	7	likely	likely	RB
cord-353749-2vlc11rx	19	8	persist	persist	VB
cord-353749-2vlc11rx	19	9	in	in	IN
cord-353749-2vlc11rx	19	10	the	the	DT
cord-353749-2vlc11rx	19	11	future	future	NN
cord-353749-2vlc11rx	19	12	,	,	,
cord-353749-2vlc11rx	19	13	and	and	CC
cord-353749-2vlc11rx	19	14	this	this	DT
cord-353749-2vlc11rx	19	15	risk	risk	NN
cord-353749-2vlc11rx	19	16	is	be	VBZ
cord-353749-2vlc11rx	19	17	associated	associate	VBN
cord-353749-2vlc11rx	19	18	with	with	IN
cord-353749-2vlc11rx	19	19	additional	additional	JJ
cord-353749-2vlc11rx	19	20	global	global	JJ
cord-353749-2vlc11rx	19	21	mental	mental	JJ
cord-353749-2vlc11rx	19	22	health	health	NN
cord-353749-2vlc11rx	19	23	problems	problem	NNS
cord-353749-2vlc11rx	19	24	such	such	JJ
cord-353749-2vlc11rx	19	25	as	as	IN
cord-353749-2vlc11rx	19	26	stress	stress	NN
cord-353749-2vlc11rx	19	27	,	,	,
cord-353749-2vlc11rx	19	28	anxiety	anxiety	NN
cord-353749-2vlc11rx	19	29	,	,	,
cord-353749-2vlc11rx	19	30	depressive	depressive	JJ
cord-353749-2vlc11rx	19	31	symptoms	symptom	NNS
cord-353749-2vlc11rx	19	32	,	,	,
cord-353749-2vlc11rx	19	33	insomnia	insomnia	NN
cord-353749-2vlc11rx	19	34	,	,	,
cord-353749-2vlc11rx	19	35	denial	denial	NN
cord-353749-2vlc11rx	19	36	,	,	,
cord-353749-2vlc11rx	19	37	anger	anger	NN
cord-353749-2vlc11rx	19	38	and	and	CC
cord-353749-2vlc11rx	19	39	fear	fear	NN
cord-353749-2vlc11rx	19	40	.	.	.
cord-353749-2vlc11rx	20	1	5	5	CD
cord-353749-2vlc11rx	20	2	,	,	,
cord-353749-2vlc11rx	20	3	6	6	CD
cord-353749-2vlc11rx	21	1	The	the	DT
cord-353749-2vlc11rx	21	2	medical	medical	JJ
cord-353749-2vlc11rx	21	3	costs	cost	NNS
cord-353749-2vlc11rx	21	4	of	of	IN
cord-353749-2vlc11rx	21	5	a	a	DT
cord-353749-2vlc11rx	21	6	poorly	poorly	RB
cord-353749-2vlc11rx	21	7	controlled	control	VBN
cord-353749-2vlc11rx	21	8	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	21	9	pandemic	pandemic	NN
cord-353749-2vlc11rx	21	10	are	be	VBP
cord-353749-2vlc11rx	21	11	projected	project	VBN
cord-353749-2vlc11rx	21	12	to	to	TO
cord-353749-2vlc11rx	21	13	reach	reach	VB
cord-353749-2vlc11rx	21	14	hundreds	hundred	NNS
cord-353749-2vlc11rx	21	15	of	of	IN
cord-353749-2vlc11rx	21	16	billions	billion	NNS
cord-353749-2vlc11rx	21	17	of	of	IN
cord-353749-2vlc11rx	21	18	dollars	dollar	NNS
cord-353749-2vlc11rx	21	19	in	in	IN
cord-353749-2vlc11rx	21	20	the	the	DT
cord-353749-2vlc11rx	21	21	United	United	NNP
cord-353749-2vlc11rx	21	22	States	States	NNP
cord-353749-2vlc11rx	21	23	.	.	.
cord-353749-2vlc11rx	22	1	7	7	LS
cord-353749-2vlc11rx	22	2	Prophylaxis	Prophylaxis	NNP
cord-353749-2vlc11rx	22	3	for	for	IN
cord-353749-2vlc11rx	22	4	viral	viral	JJ
cord-353749-2vlc11rx	22	5	infections	infection	NNS
cord-353749-2vlc11rx	22	6	traditionally	traditionally	RB
cord-353749-2vlc11rx	22	7	relies	rely	VBZ
cord-353749-2vlc11rx	22	8	on	on	IN
cord-353749-2vlc11rx	22	9	vaccines	vaccine	NNS
cord-353749-2vlc11rx	22	10	.	.	.
cord-353749-2vlc11rx	23	1	Although	although	IN
cord-353749-2vlc11rx	23	2	a	a	DT
cord-353749-2vlc11rx	23	3	vaccine	vaccine	NN
cord-353749-2vlc11rx	23	4	for	for	IN
cord-353749-2vlc11rx	23	5	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	23	6	would	would	MD
cord-353749-2vlc11rx	23	7	be	be	VB
cord-353749-2vlc11rx	23	8	an	an	DT
cord-353749-2vlc11rx	23	9	optimal	optimal	JJ
cord-353749-2vlc11rx	23	10	solution	solution	NN
cord-353749-2vlc11rx	23	11	,	,	,
cord-353749-2vlc11rx	23	12	the	the	DT
cord-353749-2vlc11rx	23	13	prospects	prospect	NNS
cord-353749-2vlc11rx	23	14	for	for	IN
cord-353749-2vlc11rx	23	15	a	a	DT
cord-353749-2vlc11rx	23	16	safe	safe	JJ
cord-353749-2vlc11rx	23	17	and	and	CC
cord-353749-2vlc11rx	23	18	effective	effective	JJ
cord-353749-2vlc11rx	23	19	vaccine	vaccine	NN
cord-353749-2vlc11rx	23	20	are	be	VBP
cord-353749-2vlc11rx	23	21	murky	murky	JJ
cord-353749-2vlc11rx	23	22	at	at	IN
cord-353749-2vlc11rx	23	23	best	good	JJS
cord-353749-2vlc11rx	23	24	and	and	CC
cord-353749-2vlc11rx	23	25	probably	probably	RB
cord-353749-2vlc11rx	23	26	not	not	RB
cord-353749-2vlc11rx	23	27	a	a	DT
cord-353749-2vlc11rx	23	28	viable	viable	JJ
cord-353749-2vlc11rx	23	29	option	option	NN
cord-353749-2vlc11rx	23	30	in	in	IN
cord-353749-2vlc11rx	23	31	the	the	DT
cord-353749-2vlc11rx	23	32	next	next	JJ
cord-353749-2vlc11rx	23	33	two	two	CD
cord-353749-2vlc11rx	23	34	years	year	NNS
cord-353749-2vlc11rx	23	35	due	due	JJ
cord-353749-2vlc11rx	23	36	to	to	IN
cord-353749-2vlc11rx	23	37	mutational	mutational	JJ
cord-353749-2vlc11rx	23	38	variation	variation	NN
cord-353749-2vlc11rx	23	39	of	of	IN
cord-353749-2vlc11rx	23	40	the	the	DT
cord-353749-2vlc11rx	23	41	virus	virus	NN
cord-353749-2vlc11rx	23	42	and	and	CC
cord-353749-2vlc11rx	23	43	potential	potential	JJ
cord-353749-2vlc11rx	23	44	vaccine	vaccine	NN
cord-353749-2vlc11rx	23	45	enhancement	enhancement	NN
cord-353749-2vlc11rx	23	46	of	of	IN
cord-353749-2vlc11rx	23	47	viral	viral	JJ
cord-353749-2vlc11rx	23	48	infection	infection	NN
cord-353749-2vlc11rx	23	49	.	.	.
cord-353749-2vlc11rx	24	1	8	8	CD
cord-353749-2vlc11rx	24	2	,	,	,
cord-353749-2vlc11rx	24	3	9	9	CD
cord-353749-2vlc11rx	24	4	Herd	herd	NN
cord-353749-2vlc11rx	24	5	immunity	immunity	NN
cord-353749-2vlc11rx	24	6	to	to	IN
cord-353749-2vlc11rx	24	7	SARS	SARS	NNP
cord-353749-2vlc11rx	24	8	-	-	:
cord-353749-2vlc11rx	24	9	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	24	10	also	also	RB
cord-353749-2vlc11rx	24	11	may	may	MD
cord-353749-2vlc11rx	24	12	be	be	VB
cord-353749-2vlc11rx	24	13	difficult	difficult	JJ
cord-353749-2vlc11rx	24	14	to	to	TO
cord-353749-2vlc11rx	24	15	achieve	achieve	VB
cord-353749-2vlc11rx	24	16	because	because	IN
cord-353749-2vlc11rx	24	17	the	the	DT
cord-353749-2vlc11rx	24	18	infection	infection	NN
cord-353749-2vlc11rx	24	19	rate	rate	NN
cord-353749-2vlc11rx	24	20	is	be	VBZ
cord-353749-2vlc11rx	24	21	too	too	RB
cord-353749-2vlc11rx	24	22	low	low	JJ
cord-353749-2vlc11rx	24	23	.	.	.
cord-353749-2vlc11rx	25	1	10	10	CD
cord-353749-2vlc11rx	25	2	,	,	,
cord-353749-2vlc11rx	25	3	11	11	CD
cord-353749-2vlc11rx	26	1	Therefore	therefore	RB
cord-353749-2vlc11rx	26	2	,	,	,
cord-353749-2vlc11rx	26	3	an	an	DT
cord-353749-2vlc11rx	26	4	alternate	alternate	JJ
cord-353749-2vlc11rx	26	5	prevention	prevention	NN
cord-353749-2vlc11rx	26	6	strategy	strategy	NN
cord-353749-2vlc11rx	26	7	is	be	VBZ
cord-353749-2vlc11rx	26	8	needed	need	VBN
cord-353749-2vlc11rx	26	9	when	when	WRB
cord-353749-2vlc11rx	26	10	social	social	JJ
cord-353749-2vlc11rx	26	11	distancing	distancing	NN
cord-353749-2vlc11rx	26	12	is	be	VBZ
cord-353749-2vlc11rx	26	13	phased	phase	VBN
cord-353749-2vlc11rx	26	14	out	out	RP
cord-353749-2vlc11rx	26	15	during	during	IN
cord-353749-2vlc11rx	26	16	economic	economic	JJ
cord-353749-2vlc11rx	26	17	recovery	recovery	NN
cord-353749-2vlc11rx	26	18	.	.	.
cord-353749-2vlc11rx	27	1	Drawing	draw	VBG
cord-353749-2vlc11rx	27	2	on	on	IN
cord-353749-2vlc11rx	27	3	lessons	lesson	NNS
cord-353749-2vlc11rx	27	4	from	from	IN
cord-353749-2vlc11rx	27	5	the	the	DT
cord-353749-2vlc11rx	27	6	HIV	HIV	NNP
cord-353749-2vlc11rx	27	7	/	/	SYM
cord-353749-2vlc11rx	27	8	AIDS	AIDS	NNP
cord-353749-2vlc11rx	27	9	pandemic	pandemic	NN
cord-353749-2vlc11rx	27	10	,	,	,
cord-353749-2vlc11rx	27	11	we	-PRON-	PRP
cord-353749-2vlc11rx	27	12	know	know	VBP
cord-353749-2vlc11rx	27	13	that	that	IN
cord-353749-2vlc11rx	27	14	pre	pre	JJ
cord-353749-2vlc11rx	27	15	-	-	JJ
cord-353749-2vlc11rx	27	16	exposure	exposure	JJ
cord-353749-2vlc11rx	27	17	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	27	18	(	(	-LRB-
cord-353749-2vlc11rx	27	19	PrEP	prep	NN
cord-353749-2vlc11rx	27	20	)	)	-RRB-
cord-353749-2vlc11rx	27	21	with	with	IN
cord-353749-2vlc11rx	27	22	antiviral	antiviral	JJ
cord-353749-2vlc11rx	27	23	agents	agent	NNS
cord-353749-2vlc11rx	27	24	is	be	VBZ
cord-353749-2vlc11rx	27	25	a	a	DT
cord-353749-2vlc11rx	27	26	viable	viable	JJ
cord-353749-2vlc11rx	27	27	strategy	strategy	NN
cord-353749-2vlc11rx	27	28	to	to	TO
cord-353749-2vlc11rx	27	29	prevent	prevent	VB
cord-353749-2vlc11rx	27	30	infection	infection	NN
cord-353749-2vlc11rx	27	31	.	.	.
cord-353749-2vlc11rx	28	1	12	12	CD
cord-353749-2vlc11rx	29	1	In	in	IN
cord-353749-2vlc11rx	29	2	the	the	DT
cord-353749-2vlc11rx	29	3	case	case	NN
cord-353749-2vlc11rx	29	4	of	of	IN
cord-353749-2vlc11rx	29	5	HIV	HIV	NNP
cord-353749-2vlc11rx	29	6	/	/	SYM
cord-353749-2vlc11rx	29	7	AIDS	AIDS	NNP
cord-353749-2vlc11rx	29	8	,	,	,
cord-353749-2vlc11rx	29	9	however	however	RB
cord-353749-2vlc11rx	29	10	,	,	,
cord-353749-2vlc11rx	29	11	this	this	DT
cord-353749-2vlc11rx	29	12	treatment	treatment	NN
cord-353749-2vlc11rx	29	13	-	-	HYPH
cord-353749-2vlc11rx	29	14	intensive	intensive	JJ
cord-353749-2vlc11rx	29	15	and	and	CC
cord-353749-2vlc11rx	29	16	expensive	expensive	JJ
cord-353749-2vlc11rx	29	17	strategy	strategy	NN
cord-353749-2vlc11rx	29	18	only	only	RB
cord-353749-2vlc11rx	29	19	works	work	VBZ
cord-353749-2vlc11rx	29	20	because	because	IN
cord-353749-2vlc11rx	29	21	of	of	IN
cord-353749-2vlc11rx	29	22	the	the	DT
cord-353749-2vlc11rx	29	23	relatively	relatively	RB
cord-353749-2vlc11rx	29	24	small	small	JJ
cord-353749-2vlc11rx	29	25	number	number	NN
cord-353749-2vlc11rx	29	26	of	of	IN
cord-353749-2vlc11rx	29	27	subjects	subject	NNS
cord-353749-2vlc11rx	29	28	at	at	IN
cord-353749-2vlc11rx	29	29	risk	risk	NN
cord-353749-2vlc11rx	29	30	.	.	.
cord-353749-2vlc11rx	30	1	For	for	IN
cord-353749-2vlc11rx	30	2	the	the	DT
cord-353749-2vlc11rx	30	3	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	30	4	pandemic	pandemic	NN
cord-353749-2vlc11rx	30	5	,	,	,
cord-353749-2vlc11rx	30	6	we	-PRON-	PRP
cord-353749-2vlc11rx	30	7	need	need	VBP
cord-353749-2vlc11rx	30	8	a	a	DT
cord-353749-2vlc11rx	30	9	more	more	RBR
cord-353749-2vlc11rx	30	10	practical	practical	JJ
cord-353749-2vlc11rx	30	11	approach	approach	NN
cord-353749-2vlc11rx	30	12	to	to	IN
cord-353749-2vlc11rx	30	13	prevention	prevention	NN
cord-353749-2vlc11rx	30	14	.	.	.
cord-353749-2vlc11rx	31	1	Based	base	VBN
cord-353749-2vlc11rx	31	2	on	on	IN
cord-353749-2vlc11rx	31	3	worldwide	worldwide	JJ
cord-353749-2vlc11rx	31	4	experience	experience	NN
cord-353749-2vlc11rx	31	5	with	with	IN
cord-353749-2vlc11rx	31	6	SARS	SARS	NNP
cord-353749-2vlc11rx	31	7	-	-	HYPH
cord-353749-2vlc11rx	31	8	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	31	9	,	,	,
cord-353749-2vlc11rx	31	10	we	-PRON-	PRP
cord-353749-2vlc11rx	31	11	now	now	RB
cord-353749-2vlc11rx	31	12	know	know	VBP
cord-353749-2vlc11rx	31	13	that	that	IN
cord-353749-2vlc11rx	31	14	certain	certain	JJ
cord-353749-2vlc11rx	31	15	groups	group	NNS
cord-353749-2vlc11rx	31	16	carry	carry	VBP
cord-353749-2vlc11rx	31	17	a	a	DT
cord-353749-2vlc11rx	31	18	higher	high	JJR
cord-353749-2vlc11rx	31	19	risk	risk	NN
cord-353749-2vlc11rx	31	20	of	of	IN
cord-353749-2vlc11rx	31	21	developing	develop	VBG
cord-353749-2vlc11rx	31	22	severe	severe	JJ
cord-353749-2vlc11rx	31	23	complications	complication	NNS
cord-353749-2vlc11rx	31	24	of	of	IN
cord-353749-2vlc11rx	31	25	COVID-19	covid-19	NN
cord-353749-2vlc11rx	31	26	.	.	.
cord-353749-2vlc11rx	31	27	3	3	CD
cord-353749-2vlc11rx	32	1	In	in	IN
cord-353749-2vlc11rx	32	2	addition	addition	NN
cord-353749-2vlc11rx	32	3	,	,	,
cord-353749-2vlc11rx	32	4	medical	medical	JJ
cord-353749-2vlc11rx	32	5	personnel	personnel	NNS
cord-353749-2vlc11rx	32	6	have	have	VBP
cord-353749-2vlc11rx	32	7	more	more	JJR
cord-353749-2vlc11rx	32	8	than	than	IN
cord-353749-2vlc11rx	32	9	three	three	CD
cord-353749-2vlc11rx	32	10	times	time	NNS
cord-353749-2vlc11rx	32	11	the	the	DT
cord-353749-2vlc11rx	32	12	risk	risk	NN
cord-353749-2vlc11rx	32	13	of	of	IN
cord-353749-2vlc11rx	32	14	acquiring	acquire	VBG
cord-353749-2vlc11rx	32	15	the	the	DT
cord-353749-2vlc11rx	32	16	disease	disease	NN
cord-353749-2vlc11rx	32	17	from	from	IN
cord-353749-2vlc11rx	32	18	repeated	repeat	VBN
cord-353749-2vlc11rx	32	19	exposure	exposure	NN
cord-353749-2vlc11rx	32	20	to	to	IN
cord-353749-2vlc11rx	32	21	infected	infected	JJ
cord-353749-2vlc11rx	32	22	patients	patient	NNS
cord-353749-2vlc11rx	32	23	and	and	CC
cord-353749-2vlc11rx	32	24	household	household	NN
cord-353749-2vlc11rx	32	25	contacts	contact	NNS
cord-353749-2vlc11rx	32	26	.	.	.
cord-353749-2vlc11rx	33	1	15	15	CD
cord-353749-2vlc11rx	33	2	,	,	,
cord-353749-2vlc11rx	33	3	16	16	CD
cord-353749-2vlc11rx	33	4	As	as	IN
cord-353749-2vlc11rx	33	5	schools	school	NNS
cord-353749-2vlc11rx	33	6	reopen	reopen	VBP
cord-353749-2vlc11rx	33	7	and	and	CC
cord-353749-2vlc11rx	33	8	asymptomatic	asymptomatic	JJ
cord-353749-2vlc11rx	33	9	children	child	NNS
cord-353749-2vlc11rx	33	10	increase	increase	VBP
cord-353749-2vlc11rx	33	11	the	the	DT
cord-353749-2vlc11rx	33	12	risk	risk	NN
cord-353749-2vlc11rx	33	13	of	of	IN
cord-353749-2vlc11rx	33	14	viral	viral	JJ
cord-353749-2vlc11rx	33	15	transmission	transmission	NN
cord-353749-2vlc11rx	33	16	,	,	,
cord-353749-2vlc11rx	33	17	more	more	JJR
cord-353749-2vlc11rx	33	18	teachers	teacher	NNS
cord-353749-2vlc11rx	33	19	and	and	CC
cord-353749-2vlc11rx	33	20	parents	parent	NNS
cord-353749-2vlc11rx	33	21	will	will	MD
cord-353749-2vlc11rx	33	22	need	need	VB
cord-353749-2vlc11rx	33	23	protection	protection	NN
cord-353749-2vlc11rx	33	24	against	against	IN
cord-353749-2vlc11rx	33	25	viral	viral	JJ
cord-353749-2vlc11rx	33	26	infection	infection	NN
cord-353749-2vlc11rx	33	27	.	.	.
cord-353749-2vlc11rx	34	1	17	17	CD
cord-353749-2vlc11rx	34	2	Other	other	JJ
cord-353749-2vlc11rx	34	3	high	high	JJ
cord-353749-2vlc11rx	34	4	-	-	HYPH
cord-353749-2vlc11rx	34	5	risk	risk	NN
cord-353749-2vlc11rx	34	6	groups	group	NNS
cord-353749-2vlc11rx	34	7	include	include	VBP
cord-353749-2vlc11rx	34	8	first	first	JJ
cord-353749-2vlc11rx	34	9	responders	responder	NNS
cord-353749-2vlc11rx	34	10	,	,	,
cord-353749-2vlc11rx	34	11	factory	factory	NN
cord-353749-2vlc11rx	34	12	workers	worker	NNS
cord-353749-2vlc11rx	34	13	and	and	CC
cord-353749-2vlc11rx	34	14	sailors	sailor	NNS
cord-353749-2vlc11rx	34	15	confined	confine	VBN
cord-353749-2vlc11rx	34	16	to	to	IN
cord-353749-2vlc11rx	34	17	close	close	JJ
cord-353749-2vlc11rx	34	18	quarters	quarter	NNS
cord-353749-2vlc11rx	34	19	,	,	,
cord-353749-2vlc11rx	34	20	and	and	CC
cord-353749-2vlc11rx	34	21	prisoners	prisoner	NNS
cord-353749-2vlc11rx	34	22	.	.	.
cord-353749-2vlc11rx	35	1	18	18	CD
cord-353749-2vlc11rx	35	2	Individuals	individual	NNS
cord-353749-2vlc11rx	35	3	with	with	IN
cord-353749-2vlc11rx	35	4	certain	certain	JJ
cord-353749-2vlc11rx	35	5	genotypes	genotype	NNS
cord-353749-2vlc11rx	35	6	may	may	MD
cord-353749-2vlc11rx	35	7	also	also	RB
cord-353749-2vlc11rx	35	8	have	have	VB
cord-353749-2vlc11rx	35	9	increased	increase	VBN
cord-353749-2vlc11rx	35	10	susceptibility	susceptibility	NN
cord-353749-2vlc11rx	35	11	to	to	IN
cord-353749-2vlc11rx	35	12	severe	severe	JJ
cord-353749-2vlc11rx	35	13	COVID-19	covid-19	NN
cord-353749-2vlc11rx	35	14	.	.	.
cord-353749-2vlc11rx	36	1	19	19	CD
cord-353749-2vlc11rx	37	1	These	these	DT
cord-353749-2vlc11rx	37	2	subjects	subject	NNS
cord-353749-2vlc11rx	37	3	would	would	MD
cord-353749-2vlc11rx	37	4	benefit	benefit	VB
cord-353749-2vlc11rx	37	5	from	from	IN
cord-353749-2vlc11rx	37	6	a	a	DT
cord-353749-2vlc11rx	37	7	simple	simple	JJ
cord-353749-2vlc11rx	37	8	PrEP	prep	NN
cord-353749-2vlc11rx	37	9	-	-	HYPH
cord-353749-2vlc11rx	37	10	type	type	NN
cord-353749-2vlc11rx	37	11	treatment	treatment	NN
cord-353749-2vlc11rx	37	12	for	for	IN
cord-353749-2vlc11rx	37	13	SARS	SARS	NNP
cord-353749-2vlc11rx	37	14	-	-	HYPH
cord-353749-2vlc11rx	37	15	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	37	16	.	.	.
cord-353749-2vlc11rx	38	1	Where	where	WRB
cord-353749-2vlc11rx	38	2	can	can	MD
cord-353749-2vlc11rx	38	3	we	-PRON-	PRP
cord-353749-2vlc11rx	38	4	find	find	VB
cord-353749-2vlc11rx	38	5	a	a	DT
cord-353749-2vlc11rx	38	6	prophylactic	prophylactic	JJ
cord-353749-2vlc11rx	38	7	treatment	treatment	NN
cord-353749-2vlc11rx	38	8	that	that	WDT
cord-353749-2vlc11rx	38	9	is	be	VBZ
cord-353749-2vlc11rx	38	10	easy	easy	JJ
cord-353749-2vlc11rx	38	11	to	to	TO
cord-353749-2vlc11rx	38	12	use	use	VB
cord-353749-2vlc11rx	38	13	,	,	,
cord-353749-2vlc11rx	38	14	inexpensive	inexpensive	JJ
cord-353749-2vlc11rx	38	15	and	and	CC
cord-353749-2vlc11rx	38	16	already	already	RB
cord-353749-2vlc11rx	38	17	available	available	JJ
cord-353749-2vlc11rx	38	18	?	?	.
cord-353749-2vlc11rx	39	1	One	one	CD
cord-353749-2vlc11rx	39	2	answer	answer	NN
cord-353749-2vlc11rx	39	3	lies	lie	VBZ
cord-353749-2vlc11rx	39	4	in	in	IN
cord-353749-2vlc11rx	39	5	a	a	DT
cord-353749-2vlc11rx	39	6	medication	medication	NN
cord-353749-2vlc11rx	39	7	that	that	WDT
cord-353749-2vlc11rx	39	8	has	have	VBZ
cord-353749-2vlc11rx	39	9	generated	generate	VBN
cord-353749-2vlc11rx	39	10	significant	significant	JJ
cord-353749-2vlc11rx	39	11	controversy	controversy	NN
cord-353749-2vlc11rx	39	12	so	so	RB
cord-353749-2vlc11rx	39	13	far	far	RB
cord-353749-2vlc11rx	39	14	in	in	IN
cord-353749-2vlc11rx	39	15	the	the	DT
cord-353749-2vlc11rx	39	16	pandemic	pandemic	NN
cord-353749-2vlc11rx	39	17	:	:	:
cord-353749-2vlc11rx	39	18	hydroxychloroquine	hydroxychloroquine	NNP
cord-353749-2vlc11rx	39	19	(	(	-LRB-
cord-353749-2vlc11rx	39	20	HCQ	HCQ	NNP
cord-353749-2vlc11rx	39	21	)	)	-RRB-
cord-353749-2vlc11rx	39	22	.	.	.
cord-353749-2vlc11rx	40	1	This	this	DT
cord-353749-2vlc11rx	40	2	medication	medication	NN
cord-353749-2vlc11rx	40	3	has	have	VBZ
cord-353749-2vlc11rx	40	4	been	be	VBN
cord-353749-2vlc11rx	40	5	used	use	VBN
cord-353749-2vlc11rx	40	6	in	in	IN
cord-353749-2vlc11rx	40	7	combination	combination	NN
cord-353749-2vlc11rx	40	8	with	with	IN
cord-353749-2vlc11rx	40	9	azithromycin	azithromycin	NN
cord-353749-2vlc11rx	40	10	for	for	IN
cord-353749-2vlc11rx	40	11	treatment	treatment	NN
cord-353749-2vlc11rx	40	12	of	of	IN
cord-353749-2vlc11rx	40	13	established	establish	VBN
cord-353749-2vlc11rx	40	14	SARS	SARS	NNP
cord-353749-2vlc11rx	40	15	-	-	HYPH
cord-353749-2vlc11rx	40	16	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	40	17	infection	infection	NN
cord-353749-2vlc11rx	40	18	,	,	,
cord-353749-2vlc11rx	40	19	with	with	IN
cord-353749-2vlc11rx	40	20	variable	variable	JJ
cord-353749-2vlc11rx	40	21	results	result	NNS
cord-353749-2vlc11rx	40	22	.	.	.
cord-353749-2vlc11rx	41	1	20	20	CD
cord-353749-2vlc11rx	41	2	,	,	,
cord-353749-2vlc11rx	41	3	21	21	CD
cord-353749-2vlc11rx	41	4	There	there	EX
cord-353749-2vlc11rx	41	5	has	have	VBZ
cord-353749-2vlc11rx	41	6	been	be	VBN
cord-353749-2vlc11rx	41	7	concern	concern	NN
cord-353749-2vlc11rx	41	8	about	about	IN
cord-353749-2vlc11rx	41	9	cardiac	cardiac	JJ
cord-353749-2vlc11rx	41	10	and	and	CC
cord-353749-2vlc11rx	41	11	retinal	retinal	JJ
cord-353749-2vlc11rx	41	12	toxicity	toxicity	NN
cord-353749-2vlc11rx	41	13	with	with	IN
cord-353749-2vlc11rx	41	14	high	high	JJ
cord-353749-2vlc11rx	41	15	-	-	HYPH
cord-353749-2vlc11rx	41	16	dose	dose	NN
cord-353749-2vlc11rx	41	17	HCQ	HCQ	NNP
cord-353749-2vlc11rx	41	18	,	,	,
cord-353749-2vlc11rx	41	19	especially	especially	RB
cord-353749-2vlc11rx	41	20	because	because	IN
cord-353749-2vlc11rx	41	21	azithromycin	azithromycin	NN
cord-353749-2vlc11rx	41	22	increases	increase	VBZ
cord-353749-2vlc11rx	41	23	blood	blood	NN
cord-353749-2vlc11rx	41	24	levels	level	NNS
cord-353749-2vlc11rx	41	25	of	of	IN
cord-353749-2vlc11rx	41	26	the	the	DT
cord-353749-2vlc11rx	41	27	medication	medication	NN
cord-353749-2vlc11rx	41	28	.	.	.
cord-353749-2vlc11rx	42	1	22,23	22,23	CD
cord-353749-2vlc11rx	43	1	Furthermore	furthermore	RB
cord-353749-2vlc11rx	43	2	,	,	,
cord-353749-2vlc11rx	43	3	shortages	shortage	NNS
cord-353749-2vlc11rx	43	4	of	of	IN
cord-353749-2vlc11rx	43	5	the	the	DT
cord-353749-2vlc11rx	43	6	two	two	CD
cord-353749-2vlc11rx	43	7	antimicrobials	antimicrobial	NNS
cord-353749-2vlc11rx	43	8	have	have	VBP
cord-353749-2vlc11rx	43	9	occurred	occur	VBN
cord-353749-2vlc11rx	43	10	due	due	IN
cord-353749-2vlc11rx	43	11	to	to	IN
cord-353749-2vlc11rx	43	12	overprescribing	overprescribe	VBG
cord-353749-2vlc11rx	43	13	in	in	IN
cord-353749-2vlc11rx	43	14	the	the	DT
cord-353749-2vlc11rx	43	15	face	face	NN
cord-353749-2vlc11rx	43	16	of	of	IN
cord-353749-2vlc11rx	43	17	the	the	DT
cord-353749-2vlc11rx	43	18	pandemic	pandemic	NN
cord-353749-2vlc11rx	43	19	.	.	.
cord-353749-2vlc11rx	44	1	Nevertheless	nevertheless	RB
cord-353749-2vlc11rx	44	2	,	,	,
cord-353749-2vlc11rx	44	3	the	the	DT
cord-353749-2vlc11rx	44	4	combination	combination	NN
cord-353749-2vlc11rx	44	5	appears	appear	VBZ
cord-353749-2vlc11rx	44	6	to	to	TO
cord-353749-2vlc11rx	44	7	be	be	VB
cord-353749-2vlc11rx	44	8	effective	effective	JJ
cord-353749-2vlc11rx	44	9	in	in	IN
cord-353749-2vlc11rx	44	10	patients	patient	NNS
cord-353749-2vlc11rx	44	11	with	with	IN
cord-353749-2vlc11rx	44	12	early	early	JJ
cord-353749-2vlc11rx	44	13	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	44	14	,	,	,
cord-353749-2vlc11rx	44	15	although	although	IN
cord-353749-2vlc11rx	44	16	it	-PRON-	PRP
cord-353749-2vlc11rx	44	17	appears	appear	VBZ
cord-353749-2vlc11rx	44	18	to	to	TO
cord-353749-2vlc11rx	44	19	be	be	VB
cord-353749-2vlc11rx	44	20	less	less	RBR
cord-353749-2vlc11rx	44	21	effective	effective	JJ
cord-353749-2vlc11rx	44	22	in	in	IN
cord-353749-2vlc11rx	44	23	hospitalized	hospitalize	VBN
cord-353749-2vlc11rx	44	24	patients	patient	NNS
cord-353749-2vlc11rx	44	25	with	with	IN
cord-353749-2vlc11rx	44	26	advanced	advanced	JJ
cord-353749-2vlc11rx	44	27	disease	disease	NN
cord-353749-2vlc11rx	44	28	.	.	.
cord-353749-2vlc11rx	45	1	20,21	20,21	CD
cord-353749-2vlc11rx	45	2	HCQ	HCQ	NNP
cord-353749-2vlc11rx	45	3	treatment	treatment	NN
cord-353749-2vlc11rx	45	4	was	be	VBD
cord-353749-2vlc11rx	45	5	shown	show	VBN
cord-353749-2vlc11rx	45	6	to	to	TO
cord-353749-2vlc11rx	45	7	protect	protect	VB
cord-353749-2vlc11rx	45	8	multiple	multiple	JJ
cord-353749-2vlc11rx	45	9	organs	organ	NNS
cord-353749-2vlc11rx	45	10	from	from	IN
cord-353749-2vlc11rx	45	11	inflammation	inflammation	NN
cord-353749-2vlc11rx	45	12	in	in	IN
cord-353749-2vlc11rx	45	13	hospitalized	hospitalize	VBN
cord-353749-2vlc11rx	45	14	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	45	15	patients	patient	NNS
cord-353749-2vlc11rx	45	16	.	.	.
cord-353749-2vlc11rx	46	1	24	24	CD
cord-353749-2vlc11rx	47	1	In	in	IN
cord-353749-2vlc11rx	47	2	one	one	CD
cord-353749-2vlc11rx	47	3	uncontrolled	uncontrolled	JJ
cord-353749-2vlc11rx	47	4	study	study	NN
cord-353749-2vlc11rx	47	5	,	,	,
cord-353749-2vlc11rx	47	6	HCQ	HCQ	NNP
cord-353749-2vlc11rx	47	7	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	47	8	in	in	IN
cord-353749-2vlc11rx	47	9	a	a	DT
cord-353749-2vlc11rx	47	10	hospital	hospital	NN
cord-353749-2vlc11rx	47	11	setting	set	VBG
cord-353749-2vlc11rx	47	12	with	with	IN
cord-353749-2vlc11rx	47	13	a	a	DT
cord-353749-2vlc11rx	47	14	known	know	VBN
cord-353749-2vlc11rx	47	15	SARS	SARS	NNP
cord-353749-2vlc11rx	47	16	-	-	HYPH
cord-353749-2vlc11rx	47	17	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	47	18	exposure	exposure	NN
cord-353749-2vlc11rx	47	19	prevented	prevent	VBD
cord-353749-2vlc11rx	47	20	dissemination	dissemination	NN
cord-353749-2vlc11rx	47	21	of	of	IN
cord-353749-2vlc11rx	47	22	viral	viral	JJ
cord-353749-2vlc11rx	47	23	infection	infection	NN
cord-353749-2vlc11rx	47	24	.	.	.
cord-353749-2vlc11rx	48	1	25	25	CD
cord-353749-2vlc11rx	49	1	An	an	DT
cord-353749-2vlc11rx	49	2	overlooked	overlooked	JJ
cord-353749-2vlc11rx	49	3	property	property	NN
cord-353749-2vlc11rx	49	4	of	of	IN
cord-353749-2vlc11rx	49	5	HCQ	HCQ	NNP
cord-353749-2vlc11rx	49	6	is	be	VBZ
cord-353749-2vlc11rx	49	7	its	-PRON-	PRP$
cord-353749-2vlc11rx	49	8	extremely	extremely	RB
cord-353749-2vlc11rx	49	9	long	long	JJ
cord-353749-2vlc11rx	49	10	half	half	JJ
cord-353749-2vlc11rx	49	11	-	-	HYPH
cord-353749-2vlc11rx	49	12	life	life	NN
cord-353749-2vlc11rx	49	13	,	,	,
cord-353749-2vlc11rx	49	14	estimated	estimate	VBN
cord-353749-2vlc11rx	49	15	at	at	IN
cord-353749-2vlc11rx	49	16	up	up	IN
cord-353749-2vlc11rx	49	17	to	to	TO
cord-353749-2vlc11rx	49	18	40	40	CD
cord-353749-2vlc11rx	49	19	days	day	NNS
cord-353749-2vlc11rx	49	20	with	with	IN
cord-353749-2vlc11rx	49	21	oral	oral	JJ
cord-353749-2vlc11rx	49	22	dosing	dosing	NN
cord-353749-2vlc11rx	49	23	.	.	.
cord-353749-2vlc11rx	50	1	26	26	CD
cord-353749-2vlc11rx	50	2	,	,	,
cord-353749-2vlc11rx	50	3	27	27	CD
cord-353749-2vlc11rx	50	4	This	this	DT
cord-353749-2vlc11rx	50	5	extraordinary	extraordinary	JJ
cord-353749-2vlc11rx	50	6	property	property	NN
cord-353749-2vlc11rx	50	7	has	have	VBZ
cord-353749-2vlc11rx	50	8	allowed	allow	VBN
cord-353749-2vlc11rx	50	9	the	the	DT
cord-353749-2vlc11rx	50	10	medication	medication	NN
cord-353749-2vlc11rx	50	11	to	to	TO
cord-353749-2vlc11rx	50	12	be	be	VB
cord-353749-2vlc11rx	50	13	used	use	VBN
cord-353749-2vlc11rx	50	14	for	for	IN
cord-353749-2vlc11rx	50	15	decades	decade	NNS
cord-353749-2vlc11rx	50	16	as	as	IN
cord-353749-2vlc11rx	50	17	weekly	weekly	JJ
cord-353749-2vlc11rx	50	18	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	50	19	for	for	IN
cord-353749-2vlc11rx	50	20	malaria	malaria	NN
cord-353749-2vlc11rx	50	21	.	.	.
cord-353749-2vlc11rx	51	1	28	28	CD
cord-353749-2vlc11rx	51	2	,	,	,
cord-353749-2vlc11rx	51	3	29	29	CD
cord-353749-2vlc11rx	52	1	Although	although	IN
cord-353749-2vlc11rx	52	2	HCQ	hcq	NN
cord-353749-2vlc11rx	52	3	-	-	HYPH
cord-353749-2vlc11rx	52	4	resistant	resistant	JJ
cord-353749-2vlc11rx	52	5	malaria	malaria	NN
cord-353749-2vlc11rx	52	6	has	have	VBZ
cord-353749-2vlc11rx	52	7	eventually	eventually	RB
cord-353749-2vlc11rx	52	8	developed	develop	VBN
cord-353749-2vlc11rx	52	9	in	in	IN
cord-353749-2vlc11rx	52	10	parts	part	NNS
cord-353749-2vlc11rx	52	11	of	of	IN
cord-353749-2vlc11rx	52	12	the	the	DT
cord-353749-2vlc11rx	52	13	world	world	NN
cord-353749-2vlc11rx	52	14	,	,	,
cord-353749-2vlc11rx	52	15	the	the	DT
cord-353749-2vlc11rx	52	16	benefit	benefit	NN
cord-353749-2vlc11rx	52	17	of	of	IN
cord-353749-2vlc11rx	52	18	the	the	DT
cord-353749-2vlc11rx	52	19	medication	medication	NN
cord-353749-2vlc11rx	52	20	is	be	VBZ
cord-353749-2vlc11rx	52	21	still	still	RB
cord-353749-2vlc11rx	52	22	recognized	recognize	VBN
cord-353749-2vlc11rx	52	23	in	in	IN
cord-353749-2vlc11rx	52	24	terms	term	NNS
cord-353749-2vlc11rx	52	25	of	of	IN
cord-353749-2vlc11rx	52	26	low	low	JJ
cord-353749-2vlc11rx	52	27	cost	cost	NN
cord-353749-2vlc11rx	52	28	,	,	,
cord-353749-2vlc11rx	52	29	ease	ease	NN
cord-353749-2vlc11rx	52	30	of	of	IN
cord-353749-2vlc11rx	52	31	use	use	NN
cord-353749-2vlc11rx	52	32	and	and	CC
cord-353749-2vlc11rx	52	33	limited	limited	JJ
cord-353749-2vlc11rx	52	34	side	side	NN
cord-353749-2vlc11rx	52	35	effects	effect	NNS
cord-353749-2vlc11rx	52	36	in	in	IN
cord-353749-2vlc11rx	52	37	areas	area	NNS
cord-353749-2vlc11rx	52	38	with	with	IN
cord-353749-2vlc11rx	52	39	susceptible	susceptible	JJ
cord-353749-2vlc11rx	52	40	disease	disease	NN
cord-353749-2vlc11rx	52	41	.	.	.
cord-353749-2vlc11rx	53	1	[	[	-LRB-
cord-353749-2vlc11rx	53	2	29	29	CD
cord-353749-2vlc11rx	53	3	]	]	-RRB-
cord-353749-2vlc11rx	53	4	[	[	-LRB-
cord-353749-2vlc11rx	53	5	30	30	CD
cord-353749-2vlc11rx	53	6	]	]	-RRB-
cord-353749-2vlc11rx	54	1	[	[	-LRB-
cord-353749-2vlc11rx	54	2	31	31	CD
cord-353749-2vlc11rx	54	3	]	]	-RRB-
cord-353749-2vlc11rx	55	1	Malaria	malaria	NN
cord-353749-2vlc11rx	55	2	prophylaxis	prophylaxis	JJ
cord-353749-2vlc11rx	55	3	with	with	IN
cord-353749-2vlc11rx	55	4	HCQ	HCQ	NNP
cord-353749-2vlc11rx	55	5	may	may	MD
cord-353749-2vlc11rx	55	6	contribute	contribute	VB
cord-353749-2vlc11rx	55	7	in	in	IN
cord-353749-2vlc11rx	55	8	part	part	NN
cord-353749-2vlc11rx	55	9	to	to	IN
cord-353749-2vlc11rx	55	10	the	the	DT
cord-353749-2vlc11rx	55	11	reportedly	reportedly	RB
cord-353749-2vlc11rx	55	12	low	low	JJ
cord-353749-2vlc11rx	55	13	rate	rate	NN
cord-353749-2vlc11rx	55	14	of	of	IN
cord-353749-2vlc11rx	55	15	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	55	16	infection	infection	NN
cord-353749-2vlc11rx	55	17	seen	see	VBN
cord-353749-2vlc11rx	55	18	so	so	RB
cord-353749-2vlc11rx	55	19	far	far	RB
cord-353749-2vlc11rx	55	20	in	in	IN
cord-353749-2vlc11rx	55	21	sub	sub	JJ
cord-353749-2vlc11rx	55	22	-	-	JJ
cord-353749-2vlc11rx	55	23	Saharan	saharan	JJ
cord-353749-2vlc11rx	55	24	Africa	Africa	NNP
cord-353749-2vlc11rx	55	25	.	.	.
cord-353749-2vlc11rx	56	1	32	32	CD
cord-353749-2vlc11rx	56	2	,	,	,
cord-353749-2vlc11rx	56	3	33	33	CD
cord-353749-2vlc11rx	56	4	Data	datum	NNS
cord-353749-2vlc11rx	56	5	from	from	IN
cord-353749-2vlc11rx	56	6	three	three	CD
cord-353749-2vlc11rx	56	7	randomized	randomized	JJ
cord-353749-2vlc11rx	56	8	clinical	clinical	JJ
cord-353749-2vlc11rx	56	9	trials	trial	NNS
cord-353749-2vlc11rx	56	10	using	use	VBG
cord-353749-2vlc11rx	56	11	HCQ	HCQ	NNP
cord-353749-2vlc11rx	56	12	for	for	IN
cord-353749-2vlc11rx	56	13	the	the	DT
cord-353749-2vlc11rx	56	14	prevention	prevention	NN
cord-353749-2vlc11rx	56	15	and	and	CC
cord-353749-2vlc11rx	56	16	treatment	treatment	NN
cord-353749-2vlc11rx	56	17	of	of	IN
cord-353749-2vlc11rx	56	18	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	56	19	did	do	VBD
cord-353749-2vlc11rx	56	20	not	not	RB
cord-353749-2vlc11rx	56	21	suggest	suggest	VB
cord-353749-2vlc11rx	56	22	significant	significant	JJ
cord-353749-2vlc11rx	56	23	safety	safety	NN
cord-353749-2vlc11rx	56	24	concerns	concern	NNS
cord-353749-2vlc11rx	56	25	,	,	,
cord-353749-2vlc11rx	56	26	and	and	CC
cord-353749-2vlc11rx	56	27	there	there	EX
cord-353749-2vlc11rx	56	28	were	be	VBD
cord-353749-2vlc11rx	56	29	no	no	DT
cord-353749-2vlc11rx	56	30	sudden	sudden	JJ
cord-353749-2vlc11rx	56	31	deaths	death	NNS
cord-353749-2vlc11rx	56	32	in	in	IN
cord-353749-2vlc11rx	56	33	any	any	DT
cord-353749-2vlc11rx	56	34	trial	trial	NN
cord-353749-2vlc11rx	56	35	.	.	.
cord-353749-2vlc11rx	57	1	34	34	CD
cord-353749-2vlc11rx	57	2	HCQ	HCQ	NNP
cord-353749-2vlc11rx	57	3	treatment	treatment	NN
cord-353749-2vlc11rx	57	4	is	be	VBZ
cord-353749-2vlc11rx	57	5	also	also	RB
cord-353749-2vlc11rx	57	6	considered	consider	VBN
cord-353749-2vlc11rx	57	7	safe	safe	JJ
cord-353749-2vlc11rx	57	8	for	for	IN
cord-353749-2vlc11rx	57	9	use	use	NN
cord-353749-2vlc11rx	57	10	in	in	IN
cord-353749-2vlc11rx	57	11	pregnancy	pregnancy	NN
cord-353749-2vlc11rx	57	12	and	and	CC
cord-353749-2vlc11rx	57	13	childhood	childhood	NN
cord-353749-2vlc11rx	57	14	diseases	disease	NNS
cord-353749-2vlc11rx	57	15	.	.	.
cord-353749-2vlc11rx	58	1	35	35	CD
cord-353749-2vlc11rx	58	2	,	,	,
cord-353749-2vlc11rx	58	3	36	36	CD
cord-353749-2vlc11rx	59	1	Unfortunately	unfortunately	RB
cord-353749-2vlc11rx	59	2	,	,	,
cord-353749-2vlc11rx	59	3	extrapolation	extrapolation	NN
cord-353749-2vlc11rx	59	4	of	of	IN
cord-353749-2vlc11rx	59	5	inpatient	inpatient	JJ
cord-353749-2vlc11rx	59	6	HCQ	HCQ	NNP
cord-353749-2vlc11rx	59	7	use	use	NN
cord-353749-2vlc11rx	59	8	to	to	IN
cord-353749-2vlc11rx	59	9	outpatient	outpatient	NN
cord-353749-2vlc11rx	59	10	settings	setting	NNS
cord-353749-2vlc11rx	59	11	has	have	VBZ
cord-353749-2vlc11rx	59	12	muddied	muddy	VBN
cord-353749-2vlc11rx	59	13	both	both	PDT
cord-353749-2vlc11rx	59	14	the	the	DT
cord-353749-2vlc11rx	59	15	risks	risk	NNS
cord-353749-2vlc11rx	59	16	and	and	CC
cord-353749-2vlc11rx	59	17	benefits	benefit	NNS
cord-353749-2vlc11rx	59	18	of	of	IN
cord-353749-2vlc11rx	59	19	this	this	DT
cord-353749-2vlc11rx	59	20	readily	readily	RB
cord-353749-2vlc11rx	59	21	available	available	JJ
cord-353749-2vlc11rx	59	22	preventive	preventive	JJ
cord-353749-2vlc11rx	59	23	treatment	treatment	NN
cord-353749-2vlc11rx	59	24	for	for	IN
cord-353749-2vlc11rx	59	25	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	59	26	.	.	.
cord-353749-2vlc11rx	60	1	37	37	CD
cord-353749-2vlc11rx	61	1	Based	base	VBN
cord-353749-2vlc11rx	61	2	on	on	IN
cord-353749-2vlc11rx	61	3	these	these	DT
cord-353749-2vlc11rx	61	4	observations	observation	NNS
cord-353749-2vlc11rx	61	5	,	,	,
cord-353749-2vlc11rx	61	6	we	-PRON-	PRP
cord-353749-2vlc11rx	61	7	propose	propose	VBP
cord-353749-2vlc11rx	61	8	instituting	institute	VBG
cord-353749-2vlc11rx	61	9	a	a	DT
cord-353749-2vlc11rx	61	10	prophylactic	prophylactic	JJ
cord-353749-2vlc11rx	61	11	regimen	regimen	NN
cord-353749-2vlc11rx	61	12	for	for	IN
cord-353749-2vlc11rx	61	13	SARS	SARS	NNP
cord-353749-2vlc11rx	61	14	-	-	HYPH
cord-353749-2vlc11rx	61	15	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	61	16	in	in	IN
cord-353749-2vlc11rx	61	17	the	the	DT
cord-353749-2vlc11rx	61	18	high	high	JJ
cord-353749-2vlc11rx	61	19	-	-	HYPH
cord-353749-2vlc11rx	61	20	risk	risk	NN
cord-353749-2vlc11rx	61	21	patients	patient	NNS
cord-353749-2vlc11rx	61	22	listed	list	VBN
cord-353749-2vlc11rx	61	23	above	above	RB
cord-353749-2vlc11rx	61	24	.	.	.
cord-353749-2vlc11rx	62	1	The	the	DT
cord-353749-2vlc11rx	62	2	dose	dose	JJ
cord-353749-2vlc11rx	62	3	limit	limit	NN
cord-353749-2vlc11rx	62	4	should	should	MD
cord-353749-2vlc11rx	62	5	be	be	VB
cord-353749-2vlc11rx	62	6	400	400	CD
cord-353749-2vlc11rx	62	7	mg	mg	NNP
cord-353749-2vlc11rx	62	8	weekly	weekly	NN
cord-353749-2vlc11rx	62	9	based	base	VBN
cord-353749-2vlc11rx	62	10	on	on	IN
cord-353749-2vlc11rx	62	11	malaria	malaria	NN
cord-353749-2vlc11rx	62	12	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	62	13	recommendations	recommendation	NNS
cord-353749-2vlc11rx	62	14	and	and	CC
cord-353749-2vlc11rx	62	15	continuing	continue	VBG
cord-353749-2vlc11rx	62	16	for	for	IN
cord-353749-2vlc11rx	62	17	one	one	CD
cord-353749-2vlc11rx	62	18	month	month	NN
cord-353749-2vlc11rx	62	19	or	or	CC
cord-353749-2vlc11rx	62	20	longer	long	RBR
cord-353749-2vlc11rx	62	21	depending	depend	VBG
cord-353749-2vlc11rx	62	22	on	on	IN
cord-353749-2vlc11rx	62	23	the	the	DT
cord-353749-2vlc11rx	62	24	degree	degree	NN
cord-353749-2vlc11rx	62	25	of	of	IN
cord-353749-2vlc11rx	62	26	social	social	JJ
cord-353749-2vlc11rx	62	27	interaction	interaction	NN
cord-353749-2vlc11rx	62	28	and	and	CC
cord-353749-2vlc11rx	62	29	risk	risk	NN
cord-353749-2vlc11rx	62	30	of	of	IN
cord-353749-2vlc11rx	62	31	viral	viral	JJ
cord-353749-2vlc11rx	62	32	exposure	exposure	NN
cord-353749-2vlc11rx	62	33	.	.	.
cord-353749-2vlc11rx	63	1	The	the	DT
cord-353749-2vlc11rx	63	2	use	use	NN
cord-353749-2vlc11rx	63	3	of	of	IN
cord-353749-2vlc11rx	63	4	this	this	DT
cord-353749-2vlc11rx	63	5	prophylactic	prophylactic	JJ
cord-353749-2vlc11rx	63	6	regimen	regimen	NN
cord-353749-2vlc11rx	63	7	will	will	MD
cord-353749-2vlc11rx	63	8	allow	allow	VB
cord-353749-2vlc11rx	63	9	individuals	individual	NNS
cord-353749-2vlc11rx	63	10	to	to	TO
cord-353749-2vlc11rx	63	11	resume	resume	VB
cord-353749-2vlc11rx	63	12	work	work	NN
cord-353749-2vlc11rx	63	13	with	with	IN
cord-353749-2vlc11rx	63	14	some	some	DT
cord-353749-2vlc11rx	63	15	modicum	modicum	NN
cord-353749-2vlc11rx	63	16	of	of	IN
cord-353749-2vlc11rx	63	17	protection	protection	NN
cord-353749-2vlc11rx	63	18	against	against	IN
cord-353749-2vlc11rx	63	19	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	63	20	.	.	.
cord-353749-2vlc11rx	64	1	PrEP	prep	NN
cord-353749-2vlc11rx	64	2	would	would	MD
cord-353749-2vlc11rx	64	3	also	also	RB
cord-353749-2vlc11rx	64	4	prevent	prevent	VB
cord-353749-2vlc11rx	64	5	high	high	JJ
cord-353749-2vlc11rx	64	6	-	-	HYPH
cord-353749-2vlc11rx	64	7	risk	risk	NN
cord-353749-2vlc11rx	64	8	individuals	individual	NNS
cord-353749-2vlc11rx	64	9	from	from	IN
cord-353749-2vlc11rx	64	10	acquiring	acquire	VBG
cord-353749-2vlc11rx	64	11	infection	infection	NN
cord-353749-2vlc11rx	64	12	from	from	IN
cord-353749-2vlc11rx	64	13	close	close	JJ
cord-353749-2vlc11rx	64	14	contacts	contact	NNS
cord-353749-2vlc11rx	64	15	infected	infect	VBN
cord-353749-2vlc11rx	64	16	with	with	IN
cord-353749-2vlc11rx	64	17	the	the	DT
cord-353749-2vlc11rx	64	18	virus	virus	NN
cord-353749-2vlc11rx	64	19	,	,	,
cord-353749-2vlc11rx	64	20	and	and	CC
cord-353749-2vlc11rx	64	21	it	-PRON-	PRP
cord-353749-2vlc11rx	64	22	would	would	MD
cord-353749-2vlc11rx	64	23	hopefully	hopefully	RB
cord-353749-2vlc11rx	64	24	attenuate	attenuate	VB
cord-353749-2vlc11rx	64	25	SARS	SARS	NNP
cord-353749-2vlc11rx	64	26	-	-	HYPH
cord-353749-2vlc11rx	64	27	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	64	28	infection	infection	NN
cord-353749-2vlc11rx	64	29	if	if	IN
cord-353749-2vlc11rx	64	30	it	-PRON-	PRP
cord-353749-2vlc11rx	64	31	did	do	VBD
cord-353749-2vlc11rx	64	32	occur	occur	VB
cord-353749-2vlc11rx	64	33	.	.	.
cord-353749-2vlc11rx	65	1	13	13	CD
cord-353749-2vlc11rx	66	1	Although	although	IN
cord-353749-2vlc11rx	66	2	a	a	DT
cord-353749-2vlc11rx	66	3	higher	high	JJR
cord-353749-2vlc11rx	66	4	-	-	HYPH
cord-353749-2vlc11rx	66	5	dose	dose	NN
cord-353749-2vlc11rx	66	6	regimen	regimen	NN
cord-353749-2vlc11rx	66	7	might	may	MD
cord-353749-2vlc11rx	66	8	be	be	VB
cord-353749-2vlc11rx	66	9	more	more	RBR
cord-353749-2vlc11rx	66	10	effective	effective	JJ
cord-353749-2vlc11rx	66	11	,	,	,
cord-353749-2vlc11rx	66	12	higher	high	JJR
cord-353749-2vlc11rx	66	13	dosing	dosing	NN
cord-353749-2vlc11rx	66	14	would	would	MD
cord-353749-2vlc11rx	66	15	also	also	RB
cord-353749-2vlc11rx	66	16	increase	increase	VB
cord-353749-2vlc11rx	66	17	the	the	DT
cord-353749-2vlc11rx	66	18	risk	risk	NN
cord-353749-2vlc11rx	66	19	of	of	IN
cord-353749-2vlc11rx	66	20	adverse	adverse	JJ
cord-353749-2vlc11rx	66	21	events	event	NNS
cord-353749-2vlc11rx	66	22	without	without	IN
cord-353749-2vlc11rx	66	23	clear	clear	JJ
cord-353749-2vlc11rx	66	24	benefit	benefit	NN
cord-353749-2vlc11rx	66	25	at	at	IN
cord-353749-2vlc11rx	66	26	this	this	DT
cord-353749-2vlc11rx	66	27	point	point	NN
cord-353749-2vlc11rx	66	28	in	in	IN
cord-353749-2vlc11rx	66	29	the	the	DT
cord-353749-2vlc11rx	66	30	pandemic	pandemic	NN
cord-353749-2vlc11rx	66	31	.	.	.
cord-353749-2vlc11rx	67	1	38	38	CD
cord-353749-2vlc11rx	67	2	,	,	,
cord-353749-2vlc11rx	67	3	39	39	CD
cord-353749-2vlc11rx	68	1	If	if	IN
cord-353749-2vlc11rx	68	2	symptoms	symptom	NNS
cord-353749-2vlc11rx	68	3	of	of	IN
cord-353749-2vlc11rx	68	4	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	68	5	develop	develop	VBP
cord-353749-2vlc11rx	68	6	despite	despite	IN
cord-353749-2vlc11rx	68	7	the	the	DT
cord-353749-2vlc11rx	68	8	use	use	NN
cord-353749-2vlc11rx	68	9	of	of	IN
cord-353749-2vlc11rx	68	10	PrEP	prep	NN
cord-353749-2vlc11rx	68	11	,	,	,
cord-353749-2vlc11rx	68	12	further	further	JJ
cord-353749-2vlc11rx	68	13	treatment	treatment	NN
cord-353749-2vlc11rx	68	14	should	should	MD
cord-353749-2vlc11rx	68	15	be	be	VB
cord-353749-2vlc11rx	68	16	instituted	institute	VBN
cord-353749-2vlc11rx	68	17	immediately	immediately	RB
cord-353749-2vlc11rx	68	18	,	,	,
cord-353749-2vlc11rx	68	19	as	as	IN
cord-353749-2vlc11rx	68	20	outlined	outline	VBN
cord-353749-2vlc11rx	68	21	in	in	IN
cord-353749-2vlc11rx	68	22	our	-PRON-	PRP$
cord-353749-2vlc11rx	68	23	previous	previous	JJ
cord-353749-2vlc11rx	68	24	publication	publication	NN
cord-353749-2vlc11rx	68	25	.	.	.
cord-353749-2vlc11rx	69	1	1	1	LS
cord-353749-2vlc11rx	70	1	Recently	recently	RB
cord-353749-2vlc11rx	70	2	three	three	CD
cord-353749-2vlc11rx	70	3	studies	study	NNS
cord-353749-2vlc11rx	70	4	of	of	IN
cord-353749-2vlc11rx	70	5	HCQ	HCQ	NNP
cord-353749-2vlc11rx	70	6	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	70	7	in	in	IN
cord-353749-2vlc11rx	70	8	healthcare	healthcare	NN
cord-353749-2vlc11rx	70	9	workers	worker	NNS
cord-353749-2vlc11rx	70	10	(	(	-LRB-
cord-353749-2vlc11rx	70	11	HCWs	HCWs	NNPS
cord-353749-2vlc11rx	70	12	)	)	-RRB-
cord-353749-2vlc11rx	70	13	from	from	IN
cord-353749-2vlc11rx	70	14	India	India	NNP
cord-353749-2vlc11rx	70	15	reported	report	VBD
cord-353749-2vlc11rx	70	16	encouraging	encouraging	JJ
cord-353749-2vlc11rx	70	17	results	result	NNS
cord-353749-2vlc11rx	70	18	.	.	.
cord-353749-2vlc11rx	71	1	One	one	CD
cord-353749-2vlc11rx	71	2	cohort	cohort	NN
cord-353749-2vlc11rx	71	3	study	study	NN
cord-353749-2vlc11rx	71	4	found	find	VBD
cord-353749-2vlc11rx	71	5	that	that	IN
cord-353749-2vlc11rx	71	6	38	38	CD
cord-353749-2vlc11rx	71	7	%	%	NN
cord-353749-2vlc11rx	71	8	of	of	IN
cord-353749-2vlc11rx	71	9	untreated	untreated	JJ
cord-353749-2vlc11rx	71	10	HCWs	HCWs	NNPS
cord-353749-2vlc11rx	71	11	developed	develop	VBD
cord-353749-2vlc11rx	71	12	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	71	13	infection	infection	NN
cord-353749-2vlc11rx	71	14	compared	compare	VBN
cord-353749-2vlc11rx	71	15	to	to	IN
cord-353749-2vlc11rx	71	16	7	7	CD
cord-353749-2vlc11rx	71	17	%	%	NN
cord-353749-2vlc11rx	71	18	of	of	IN
cord-353749-2vlc11rx	71	19	HCWs	hcw	NNS
cord-353749-2vlc11rx	71	20	treated	treat	VBN
cord-353749-2vlc11rx	71	21	with	with	IN
cord-353749-2vlc11rx	71	22	weekly	weekly	JJ
cord-353749-2vlc11rx	71	23	HCQ	HCQ	NNP
cord-353749-2vlc11rx	71	24	PrEP	prep	NN
cord-353749-2vlc11rx	71	25	(	(	-LRB-
cord-353749-2vlc11rx	71	26	p<0.001	p<0.001	JJ
cord-353749-2vlc11rx	71	27	)	)	-RRB-
cord-353749-2vlc11rx	71	28	.	.	.
cord-353749-2vlc11rx	72	1	40	40	CD
cord-353749-2vlc11rx	73	1	The	the	DT
cord-353749-2vlc11rx	73	2	second	second	JJ
cord-353749-2vlc11rx	73	3	case	case	NN
cord-353749-2vlc11rx	73	4	-	-	HYPH
cord-353749-2vlc11rx	73	5	control	control	NN
cord-353749-2vlc11rx	73	6	study	study	NN
cord-353749-2vlc11rx	73	7	of	of	IN
cord-353749-2vlc11rx	73	8	HCWs	HCWs	NNPS
cord-353749-2vlc11rx	73	9	found	find	VBD
cord-353749-2vlc11rx	73	10	that	that	IN
cord-353749-2vlc11rx	73	11	four	four	CD
cord-353749-2vlc11rx	73	12	or	or	CC
cord-353749-2vlc11rx	73	13	more	more	JJR
cord-353749-2vlc11rx	73	14	weekly	weekly	JJ
cord-353749-2vlc11rx	73	15	doses	dose	NNS
cord-353749-2vlc11rx	73	16	of	of	IN
cord-353749-2vlc11rx	73	17	HCQ	HCQ	NNP
cord-353749-2vlc11rx	73	18	resulted	result	VBD
cord-353749-2vlc11rx	73	19	in	in	IN
cord-353749-2vlc11rx	73	20	significantly	significantly	RB
cord-353749-2vlc11rx	73	21	less	less	JJR
cord-353749-2vlc11rx	73	22	infection	infection	NN
cord-353749-2vlc11rx	73	23	with	with	IN
cord-353749-2vlc11rx	73	24	SARS	SARS	NNP
cord-353749-2vlc11rx	73	25	-	-	HYPH
cord-353749-2vlc11rx	73	26	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	73	27	(	(	-LRB-
cord-353749-2vlc11rx	73	28	adjusted	adjust	VBN
cord-353749-2vlc11rx	73	29	odds	odd	NNS
cord-353749-2vlc11rx	73	30	ratio	ratio	NN
cord-353749-2vlc11rx	73	31	0.44	0.44	CD
cord-353749-2vlc11rx	73	32	,	,	,
cord-353749-2vlc11rx	73	33	p<0.001	p<0.001	CD
cord-353749-2vlc11rx	73	34	)	)	-RRB-
cord-353749-2vlc11rx	73	35	.	.	.
cord-353749-2vlc11rx	74	1	41	41	CD
cord-353749-2vlc11rx	75	1	The	the	DT
cord-353749-2vlc11rx	75	2	third	third	JJ
cord-353749-2vlc11rx	75	3	study	study	NN
cord-353749-2vlc11rx	75	4	was	be	VBD
cord-353749-2vlc11rx	75	5	a	a	DT
cord-353749-2vlc11rx	75	6	questionnaire	questionnaire	NN
cord-353749-2vlc11rx	75	7	-	-	HYPH
cord-353749-2vlc11rx	75	8	based	base	VBN
cord-353749-2vlc11rx	75	9	analysis	analysis	NN
cord-353749-2vlc11rx	75	10	showing	show	VBG
cord-353749-2vlc11rx	75	11	that	that	IN
cord-353749-2vlc11rx	75	12	HCWs	HCWs	NNPS
cord-353749-2vlc11rx	75	13	who	who	WP
cord-353749-2vlc11rx	75	14	had	have	VBD
cord-353749-2vlc11rx	75	15	taken	take	VBN
cord-353749-2vlc11rx	75	16	a	a	DT
cord-353749-2vlc11rx	75	17	full	full	JJ
cord-353749-2vlc11rx	75	18	course	course	NN
cord-353749-2vlc11rx	75	19	of	of	IN
cord-353749-2vlc11rx	75	20	HCQ	hcq	NN
cord-353749-2vlc11rx	75	21	PrEP	prep	NN
cord-353749-2vlc11rx	75	22	(	(	-LRB-
cord-353749-2vlc11rx	75	23	seven	seven	CD
cord-353749-2vlc11rx	75	24	or	or	CC
cord-353749-2vlc11rx	75	25	more	more	JJR
cord-353749-2vlc11rx	75	26	weekly	weekly	JJ
cord-353749-2vlc11rx	75	27	doses	dose	NNS
cord-353749-2vlc11rx	75	28	)	)	-RRB-
cord-353749-2vlc11rx	75	29	had	have	VBD
cord-353749-2vlc11rx	75	30	significantly	significantly	RB
cord-353749-2vlc11rx	75	31	less	less	JJR
cord-353749-2vlc11rx	75	32	infection	infection	NN
cord-353749-2vlc11rx	75	33	with	with	IN
cord-353749-2vlc11rx	75	34	SARS	SARS	NNP
cord-353749-2vlc11rx	75	35	-	-	HYPH
cord-353749-2vlc11rx	75	36	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	75	37	compared	compare	VBN
cord-353749-2vlc11rx	75	38	to	to	IN
cord-353749-2vlc11rx	75	39	those	those	DT
cord-353749-2vlc11rx	75	40	who	who	WP
cord-353749-2vlc11rx	75	41	had	have	VBD
cord-353749-2vlc11rx	75	42	taken	take	VBN
cord-353749-2vlc11rx	75	43	either	either	CC
cord-353749-2vlc11rx	75	44	an	an	DT
cord-353749-2vlc11rx	75	45	incomplete	incomplete	JJ
cord-353749-2vlc11rx	75	46	course	course	NN
cord-353749-2vlc11rx	75	47	or	or	CC
cord-353749-2vlc11rx	75	48	no	no	DT
cord-353749-2vlc11rx	75	49	HCQ	hcq	NN
cord-353749-2vlc11rx	75	50	at	at	RB
cord-353749-2vlc11rx	75	51	all	all	DT
cord-353749-2vlc11rx	75	52	(	(	-LRB-
cord-353749-2vlc11rx	75	53	p	p	NN
cord-353749-2vlc11rx	75	54	=	=	SYM
cord-353749-2vlc11rx	75	55	0.021	0.021	CD
cord-353749-2vlc11rx	75	56	)	)	-RRB-
cord-353749-2vlc11rx	75	57	.	.	.
cord-353749-2vlc11rx	76	1	42	42	CD
cord-353749-2vlc11rx	76	2	Additional	additional	JJ
cord-353749-2vlc11rx	76	3	clinical	clinical	JJ
cord-353749-2vlc11rx	76	4	observations	observation	NNS
cord-353749-2vlc11rx	76	5	suggest	suggest	VBP
cord-353749-2vlc11rx	76	6	that	that	IN
cord-353749-2vlc11rx	76	7	HCQ	HCQ	NNP
cord-353749-2vlc11rx	76	8	PrEP	prep	NN
cord-353749-2vlc11rx	76	9	may	may	MD
cord-353749-2vlc11rx	76	10	be	be	VB
cord-353749-2vlc11rx	76	11	effective	effective	JJ
cord-353749-2vlc11rx	76	12	for	for	IN
cord-353749-2vlc11rx	76	13	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	76	14	.	.	.
cord-353749-2vlc11rx	77	1	In	in	IN
cord-353749-2vlc11rx	77	2	a	a	DT
cord-353749-2vlc11rx	77	3	multicenter	multicenter	JJ
cord-353749-2vlc11rx	77	4	retrospective	retrospective	JJ
cord-353749-2vlc11rx	77	5	study	study	NN
cord-353749-2vlc11rx	77	6	of	of	IN
cord-353749-2vlc11rx	77	7	6,228	6,228	CD
cord-353749-2vlc11rx	77	8	rheumatic	rheumatic	JJ
cord-353749-2vlc11rx	77	9	disease	disease	NN
cord-353749-2vlc11rx	77	10	patients	patient	NNS
cord-353749-2vlc11rx	77	11	from	from	IN
cord-353749-2vlc11rx	77	12	China	China	NNP
cord-353749-2vlc11rx	77	13	,	,	,
cord-353749-2vlc11rx	77	14	patients	patient	NNS
cord-353749-2vlc11rx	77	15	who	who	WP
cord-353749-2vlc11rx	77	16	were	be	VBD
cord-353749-2vlc11rx	77	17	taking	take	VBG
cord-353749-2vlc11rx	77	18	HCQ	HCQ	NNP
cord-353749-2vlc11rx	77	19	had	have	VBD
cord-353749-2vlc11rx	77	20	a	a	DT
cord-353749-2vlc11rx	77	21	lower	low	JJR
cord-353749-2vlc11rx	77	22	risk	risk	NN
cord-353749-2vlc11rx	77	23	of	of	IN
cord-353749-2vlc11rx	77	24	SARS	SARS	NNP
cord-353749-2vlc11rx	77	25	-	-	HYPH
cord-353749-2vlc11rx	77	26	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	77	27	infection	infection	NN
cord-353749-2vlc11rx	77	28	compared	compare	VBN
cord-353749-2vlc11rx	77	29	to	to	IN
cord-353749-2vlc11rx	77	30	patients	patient	NNS
cord-353749-2vlc11rx	77	31	taking	take	VBG
cord-353749-2vlc11rx	77	32	other	other	JJ
cord-353749-2vlc11rx	77	33	disease	disease	NN
cord-353749-2vlc11rx	77	34	-	-	HYPH
cord-353749-2vlc11rx	77	35	modifying	modify	VBG
cord-353749-2vlc11rx	77	36	anti	anti	JJ
cord-353749-2vlc11rx	77	37	-	-	JJ
cord-353749-2vlc11rx	77	38	rheumatic	rheumatic	JJ
cord-353749-2vlc11rx	77	39	drugs	drug	NNS
cord-353749-2vlc11rx	77	40	(	(	-LRB-
cord-353749-2vlc11rx	77	41	odds	odd	NNS
cord-353749-2vlc11rx	77	42	ratio	ratio	NN
cord-353749-2vlc11rx	77	43	0.09	0.09	CD
cord-353749-2vlc11rx	77	44	,	,	,
cord-353749-2vlc11rx	77	45	p=0.044	p=0.044	NNP
cord-353749-2vlc11rx	77	46	)	)	-RRB-
cord-353749-2vlc11rx	77	47	.	.	.
cord-353749-2vlc11rx	78	1	43	43	CD
cord-353749-2vlc11rx	79	1	Another	another	DT
cord-353749-2vlc11rx	79	2	population	population	NN
cord-353749-2vlc11rx	79	3	-	-	HYPH
cord-353749-2vlc11rx	79	4	based	base	VBN
cord-353749-2vlc11rx	79	5	analysis	analysis	NN
cord-353749-2vlc11rx	79	6	of	of	IN
cord-353749-2vlc11rx	79	7	over	over	IN
cord-353749-2vlc11rx	79	8	360,000	360,000	CD
cord-353749-2vlc11rx	79	9	subjects	subject	NNS
cord-353749-2vlc11rx	79	10	from	from	IN
cord-353749-2vlc11rx	79	11	Portugal	Portugal	NNP
cord-353749-2vlc11rx	79	12	found	find	VBD
cord-353749-2vlc11rx	79	13	that	that	IN
cord-353749-2vlc11rx	79	14	chronic	chronic	JJ
cord-353749-2vlc11rx	79	15	HCQ	HCQ	NNP
cord-353749-2vlc11rx	79	16	treatment	treatment	NN
cord-353749-2vlc11rx	79	17	was	be	VBD
cord-353749-2vlc11rx	79	18	associated	associate	VBN
cord-353749-2vlc11rx	79	19	with	with	IN
cord-353749-2vlc11rx	79	20	a	a	DT
cord-353749-2vlc11rx	79	21	significant	significant	JJ
cord-353749-2vlc11rx	79	22	decrease	decrease	NN
cord-353749-2vlc11rx	79	23	in	in	IN
cord-353749-2vlc11rx	79	24	SARS	SARS	NNP
cord-353749-2vlc11rx	79	25	-	-	HYPH
cord-353749-2vlc11rx	79	26	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	79	27	infection	infection	NN
cord-353749-2vlc11rx	79	28	(	(	-LRB-
cord-353749-2vlc11rx	79	29	adjusted	adjust	VBN
cord-353749-2vlc11rx	79	30	odds	odd	NNS
cord-353749-2vlc11rx	79	31	ratio	ratio	NN
cord-353749-2vlc11rx	79	32	0.51	0.51	CD
cord-353749-2vlc11rx	79	33	,	,	,
cord-353749-2vlc11rx	79	34	p=0.04	p=0.04	NNP
cord-353749-2vlc11rx	79	35	)	)	-RRB-
cord-353749-2vlc11rx	79	36	.	.	.
cord-353749-2vlc11rx	80	1	44	44	CD
cord-353749-2vlc11rx	81	1	An	an	DT
cord-353749-2vlc11rx	81	2	observational	observational	JJ
cord-353749-2vlc11rx	81	3	study	study	NN
cord-353749-2vlc11rx	81	4	of	of	IN
cord-353749-2vlc11rx	81	5	1,274	1,274	CD
cord-353749-2vlc11rx	81	6	early	early	JJ
cord-353749-2vlc11rx	81	7	outpatient	outpatient	NN
cord-353749-2vlc11rx	81	8	COVID-19	covid-19	CD
cord-353749-2vlc11rx	81	9	cases	case	NNS
cord-353749-2vlc11rx	81	10	in	in	IN
cord-353749-2vlc11rx	81	11	New	New	NNP
cord-353749-2vlc11rx	81	12	Jersey	Jersey	NNP
cord-353749-2vlc11rx	81	13	found	find	VBD
cord-353749-2vlc11rx	81	14	that	that	IN
cord-353749-2vlc11rx	81	15	a	a	DT
cord-353749-2vlc11rx	81	16	prescription	prescription	NN
cord-353749-2vlc11rx	81	17	of	of	IN
cord-353749-2vlc11rx	81	18	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	81	19	reduced	reduce	VBD
cord-353749-2vlc11rx	81	20	the	the	DT
cord-353749-2vlc11rx	81	21	risk	risk	NN
cord-353749-2vlc11rx	81	22	of	of	IN
cord-353749-2vlc11rx	81	23	hospitalization	hospitalization	NN
cord-353749-2vlc11rx	81	24	by	by	IN
cord-353749-2vlc11rx	81	25	47	47	CD
cord-353749-2vlc11rx	81	26	%	%	NN
cord-353749-2vlc11rx	81	27	(	(	-LRB-
cord-353749-2vlc11rx	81	28	odds	odd	NNS
cord-353749-2vlc11rx	81	29	ratio	ratio	NN
cord-353749-2vlc11rx	81	30	0.53	0.53	CD
cord-353749-2vlc11rx	81	31	)	)	-RRB-
cord-353749-2vlc11rx	81	32	.	.	.
cord-353749-2vlc11rx	82	1	The	the	DT
cord-353749-2vlc11rx	82	2	benefit	benefit	NN
cord-353749-2vlc11rx	82	3	appeared	appear	VBD
cord-353749-2vlc11rx	82	4	to	to	TO
cord-353749-2vlc11rx	82	5	be	be	VB
cord-353749-2vlc11rx	82	6	lost	lose	VBN
cord-353749-2vlc11rx	82	7	if	if	IN
cord-353749-2vlc11rx	82	8	treatment	treatment	NN
cord-353749-2vlc11rx	82	9	was	be	VBD
cord-353749-2vlc11rx	82	10	delayed	delay	VBN
cord-353749-2vlc11rx	82	11	more	more	JJR
cord-353749-2vlc11rx	82	12	than	than	IN
cord-353749-2vlc11rx	82	13	two	two	CD
cord-353749-2vlc11rx	82	14	days	day	NNS
cord-353749-2vlc11rx	82	15	after	after	IN
cord-353749-2vlc11rx	82	16	the	the	DT
cord-353749-2vlc11rx	82	17	onset	onset	NN
cord-353749-2vlc11rx	82	18	of	of	IN
cord-353749-2vlc11rx	82	19	symptoms	symptom	NNS
cord-353749-2vlc11rx	82	20	.	.	.
cord-353749-2vlc11rx	83	1	45	45	CD
cord-353749-2vlc11rx	84	1	In	in	IN
cord-353749-2vlc11rx	84	2	a	a	DT
cord-353749-2vlc11rx	84	3	retrospective	retrospective	JJ
cord-353749-2vlc11rx	84	4	cohort	cohort	NN
cord-353749-2vlc11rx	84	5	study	study	NN
cord-353749-2vlc11rx	84	6	of	of	IN
cord-353749-2vlc11rx	84	7	32,109	32,109	CD
cord-353749-2vlc11rx	84	8	rheumatic	rheumatic	JJ
cord-353749-2vlc11rx	84	9	disease	disease	NN
cord-353749-2vlc11rx	84	10	patients	patient	NNS
cord-353749-2vlc11rx	84	11	from	from	IN
cord-353749-2vlc11rx	84	12	the	the	DT
cord-353749-2vlc11rx	84	13	US	US	NNP
cord-353749-2vlc11rx	84	14	Veterans	Veterans	NNPS
cord-353749-2vlc11rx	84	15	Health	Health	NNP
cord-353749-2vlc11rx	84	16	Administration	Administration	NNP
cord-353749-2vlc11rx	84	17	,	,	,
cord-353749-2vlc11rx	84	18	the	the	DT
cord-353749-2vlc11rx	84	19	incidence	incidence	NN
cord-353749-2vlc11rx	84	20	of	of	IN
cord-353749-2vlc11rx	84	21	SARS	SARS	NNP
cord-353749-2vlc11rx	84	22	-	-	HYPH
cord-353749-2vlc11rx	84	23	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	84	24	infection	infection	NN
cord-353749-2vlc11rx	84	25	was	be	VBD
cord-353749-2vlc11rx	84	26	equivalent	equivalent	JJ
cord-353749-2vlc11rx	84	27	regardless	regardless	RB
cord-353749-2vlc11rx	84	28	of	of	IN
cord-353749-2vlc11rx	84	29	chronic	chronic	JJ
cord-353749-2vlc11rx	84	30	HCQ	HCQ	NNP
cord-353749-2vlc11rx	84	31	use	use	NN
cord-353749-2vlc11rx	84	32	(	(	-LRB-
cord-353749-2vlc11rx	84	33	0.3	0.3	CD
cord-353749-2vlc11rx	84	34	%	%	NN
cord-353749-2vlc11rx	84	35	in	in	IN
cord-353749-2vlc11rx	84	36	users	user	NNS
cord-353749-2vlc11rx	84	37	versus	versus	IN
cord-353749-2vlc11rx	84	38	0.4	0.4	CD
cord-353749-2vlc11rx	84	39	%	%	NN
cord-353749-2vlc11rx	84	40	in	in	IN
cord-353749-2vlc11rx	84	41	non	non	NNS
cord-353749-2vlc11rx	84	42	-	-	NNS
cord-353749-2vlc11rx	84	43	users	user	NNS
cord-353749-2vlc11rx	84	44	)	)	-RRB-
cord-353749-2vlc11rx	84	45	,	,	,
cord-353749-2vlc11rx	84	46	but	but	CC
cord-353749-2vlc11rx	84	47	mortality	mortality	NN
cord-353749-2vlc11rx	84	48	was	be	VBD
cord-353749-2vlc11rx	84	49	significantly	significantly	RB
cord-353749-2vlc11rx	84	50	decreased	decrease	VBN
cord-353749-2vlc11rx	84	51	in	in	IN
cord-353749-2vlc11rx	84	52	patients	patient	NNS
cord-353749-2vlc11rx	84	53	taking	take	VBG
cord-353749-2vlc11rx	84	54	HCQ	HCQ	NNP
cord-353749-2vlc11rx	84	55	(	(	-LRB-
cord-353749-2vlc11rx	84	56	odds	odd	NNS
cord-353749-2vlc11rx	84	57	ratio	ratio	NN
cord-353749-2vlc11rx	84	58	0.70	0.70	CD
cord-353749-2vlc11rx	84	59	,	,	,
cord-353749-2vlc11rx	84	60	p=0.0031	p=0.0031	NNP
cord-353749-2vlc11rx	84	61	)	)	-RRB-
cord-353749-2vlc11rx	84	62	.	.	.
cord-353749-2vlc11rx	85	1	46	46	CD
cord-353749-2vlc11rx	85	2	HCQ	HCQ	NNP
cord-353749-2vlc11rx	85	3	PrEP	prep	NN
cord-353749-2vlc11rx	85	4	failed	fail	VBD
cord-353749-2vlc11rx	85	5	to	to	TO
cord-353749-2vlc11rx	85	6	prevent	prevent	VB
cord-353749-2vlc11rx	85	7	experimental	experimental	JJ
cord-353749-2vlc11rx	85	8	viral	viral	JJ
cord-353749-2vlc11rx	85	9	infection	infection	NN
cord-353749-2vlc11rx	85	10	in	in	IN
cord-353749-2vlc11rx	85	11	Syrian	syrian	JJ
cord-353749-2vlc11rx	85	12	hamsters	hamster	NNS
cord-353749-2vlc11rx	85	13	and	and	CC
cord-353749-2vlc11rx	85	14	macaque	macaque	NN
cord-353749-2vlc11rx	85	15	monkeys	monkey	NNS
cord-353749-2vlc11rx	85	16	,	,	,
cord-353749-2vlc11rx	85	17	but	but	CC
cord-353749-2vlc11rx	85	18	all	all	DT
cord-353749-2vlc11rx	85	19	of	of	IN
cord-353749-2vlc11rx	85	20	the	the	DT
cord-353749-2vlc11rx	85	21	animals	animal	NNS
cord-353749-2vlc11rx	85	22	cleared	clear	VBD
cord-353749-2vlc11rx	85	23	their	-PRON-	PRP$
cord-353749-2vlc11rx	85	24	infections	infection	NNS
cord-353749-2vlc11rx	85	25	and	and	CC
cord-353749-2vlc11rx	85	26	none	none	NN
cord-353749-2vlc11rx	85	27	died	die	VBD
cord-353749-2vlc11rx	85	28	.	.	.
cord-353749-2vlc11rx	86	1	Thus	thus	RB
cord-353749-2vlc11rx	86	2	,	,	,
cord-353749-2vlc11rx	86	3	the	the	DT
cord-353749-2vlc11rx	86	4	hamster	hamster	NN
cord-353749-2vlc11rx	86	5	and	and	CC
cord-353749-2vlc11rx	86	6	monkey	monkey	NN
cord-353749-2vlc11rx	86	7	PrEP	prep	NN
cord-353749-2vlc11rx	86	8	models	model	NNS
cord-353749-2vlc11rx	86	9	have	have	VBP
cord-353749-2vlc11rx	86	10	questionable	questionable	JJ
cord-353749-2vlc11rx	86	11	significance	significance	NN
cord-353749-2vlc11rx	86	12	for	for	IN
cord-353749-2vlc11rx	86	13	humans	human	NNS
cord-353749-2vlc11rx	86	14	.	.	.
cord-353749-2vlc11rx	87	1	47	47	CD
cord-353749-2vlc11rx	87	2	,	,	,
cord-353749-2vlc11rx	87	3	48	48	CD
cord-353749-2vlc11rx	87	4	Larger	large	JJR
cord-353749-2vlc11rx	87	5	randomized	randomized	JJ
cord-353749-2vlc11rx	87	6	controlled	control	VBN
cord-353749-2vlc11rx	87	7	trials	trial	NNS
cord-353749-2vlc11rx	87	8	(	(	-LRB-
cord-353749-2vlc11rx	87	9	RCTs	RCTs	NNP
cord-353749-2vlc11rx	87	10	)	)	-RRB-
cord-353749-2vlc11rx	87	11	of	of	IN
cord-353749-2vlc11rx	87	12	HCQ	HCQ	NNP
cord-353749-2vlc11rx	87	13	PrEP	prep	NN
cord-353749-2vlc11rx	87	14	are	be	VBP
cord-353749-2vlc11rx	87	15	ongoing	ongoing	JJ
cord-353749-2vlc11rx	87	16	in	in	IN
cord-353749-2vlc11rx	87	17	the	the	DT
cord-353749-2vlc11rx	87	18	United	United	NNP
cord-353749-2vlc11rx	87	19	States	States	NNP
cord-353749-2vlc11rx	87	20	and	and	CC
cord-353749-2vlc11rx	87	21	elsewhere	elsewhere	RB
cord-353749-2vlc11rx	87	22	.	.	.
cord-353749-2vlc11rx	88	1	[	[	-LRB-
cord-353749-2vlc11rx	88	2	49	49	CD
cord-353749-2vlc11rx	88	3	]	]	-RRB-
cord-353749-2vlc11rx	88	4	[	[	-LRB-
cord-353749-2vlc11rx	88	5	50	50	CD
cord-353749-2vlc11rx	88	6	]	]	-RRB-
cord-353749-2vlc11rx	88	7	[	[	-LRB-
cord-353749-2vlc11rx	88	8	51	51	CD
cord-353749-2vlc11rx	88	9	]	]	-RRB-
cord-353749-2vlc11rx	89	1	[	[	-LRB-
cord-353749-2vlc11rx	89	2	52	52	CD
cord-353749-2vlc11rx	89	3	]	]	-RRB-
cord-353749-2vlc11rx	90	1	The	the	DT
cord-353749-2vlc11rx	90	2	results	result	NNS
cord-353749-2vlc11rx	90	3	of	of	IN
cord-353749-2vlc11rx	90	4	two	two	CD
cord-353749-2vlc11rx	90	5	RCTs	rct	NNS
cord-353749-2vlc11rx	90	6	that	that	WDT
cord-353749-2vlc11rx	90	7	enrolled	enrol	VBD
cord-353749-2vlc11rx	90	8	1,615	1,615	CD
cord-353749-2vlc11rx	90	9	HCWs	HCWs	NNPS
cord-353749-2vlc11rx	90	10	were	be	VBD
cord-353749-2vlc11rx	90	11	recently	recently	RB
cord-353749-2vlc11rx	90	12	released	release	VBN
cord-353749-2vlc11rx	90	13	,	,	,
cord-353749-2vlc11rx	90	14	and	and	CC
cord-353749-2vlc11rx	90	15	among	among	IN
cord-353749-2vlc11rx	90	16	1,053	1,053	CD
cord-353749-2vlc11rx	90	17	subjects	subject	NNS
cord-353749-2vlc11rx	90	18	who	who	WP
cord-353749-2vlc11rx	90	19	received	receive	VBD
cord-353749-2vlc11rx	90	20	HCQ	HCQ	NNP
cord-353749-2vlc11rx	90	21	PrEP	prep	NN
cord-353749-2vlc11rx	90	22	there	there	EX
cord-353749-2vlc11rx	90	23	were	be	VBD
cord-353749-2vlc11rx	90	24	no	no	DT
cord-353749-2vlc11rx	90	25	hospitalizations	hospitalization	NNS
cord-353749-2vlc11rx	90	26	,	,	,
cord-353749-2vlc11rx	90	27	no	no	DT
cord-353749-2vlc11rx	90	28	deaths	death	NNS
cord-353749-2vlc11rx	90	29	and	and	CC
cord-353749-2vlc11rx	90	30	no	no	DT
cord-353749-2vlc11rx	90	31	cardiac	cardiac	JJ
cord-353749-2vlc11rx	90	32	complications	complication	NNS
cord-353749-2vlc11rx	90	33	.	.	.
cord-353749-2vlc11rx	91	1	In	in	IN
cord-353749-2vlc11rx	91	2	addition	addition	NN
cord-353749-2vlc11rx	91	3	,	,	,
cord-353749-2vlc11rx	91	4	once	once	RB
cord-353749-2vlc11rx	91	5	-	-	HYPH
cord-353749-2vlc11rx	91	6	weekly	weekly	NN
cord-353749-2vlc11rx	91	7	dosing	dosing	NN
cord-353749-2vlc11rx	91	8	appeared	appear	VBD
cord-353749-2vlc11rx	91	9	to	to	TO
cord-353749-2vlc11rx	91	10	be	be	VB
cord-353749-2vlc11rx	91	11	as	as	RB
cord-353749-2vlc11rx	91	12	effective	effective	JJ
cord-353749-2vlc11rx	91	13	as	as	IN
cord-353749-2vlc11rx	91	14	twice	twice	RB
cord-353749-2vlc11rx	91	15	-	-	HYPH
cord-353749-2vlc11rx	91	16	weekly	weekly	NN
cord-353749-2vlc11rx	91	17	or	or	CC
cord-353749-2vlc11rx	91	18	daily	daily	JJ
cord-353749-2vlc11rx	91	19	dosing	dose	VBG
cord-353749-2vlc11rx	91	20	for	for	IN
cord-353749-2vlc11rx	91	21	HCQ	HCQ	NNP
cord-353749-2vlc11rx	91	22	PrEP	prep	NN
cord-353749-2vlc11rx	91	23	.	.	.
cord-353749-2vlc11rx	92	1	Because	because	IN
cord-353749-2vlc11rx	92	2	the	the	DT
cord-353749-2vlc11rx	92	3	studies	study	NNS
cord-353749-2vlc11rx	92	4	were	be	VBD
cord-353749-2vlc11rx	92	5	terminated	terminate	VBN
cord-353749-2vlc11rx	92	6	prematurely	prematurely	RB
cord-353749-2vlc11rx	92	7	they	-PRON-	PRP
cord-353749-2vlc11rx	92	8	were	be	VBD
cord-353749-2vlc11rx	92	9	underpowered	underpowere	VBN
cord-353749-2vlc11rx	92	10	to	to	TO
cord-353749-2vlc11rx	92	11	show	show	VB
cord-353749-2vlc11rx	92	12	a	a	DT
cord-353749-2vlc11rx	92	13	treatment	treatment	NN
cord-353749-2vlc11rx	92	14	benefit	benefit	NN
cord-353749-2vlc11rx	92	15	,	,	,
cord-353749-2vlc11rx	92	16	however	however	RB
cord-353749-2vlc11rx	92	17	.	.	.
cord-353749-2vlc11rx	93	1	53	53	CD
cord-353749-2vlc11rx	93	2	,	,	,
cord-353749-2vlc11rx	93	3	54	54	CD
cord-353749-2vlc11rx	94	1	Since	since	IN
cord-353749-2vlc11rx	94	2	RCTs	rct	NNS
cord-353749-2vlc11rx	94	3	require	require	VBP
cord-353749-2vlc11rx	94	4	an	an	DT
cord-353749-2vlc11rx	94	5	average	average	NN
cord-353749-2vlc11rx	94	6	of	of	IN
cord-353749-2vlc11rx	94	7	5.5	5.5	CD
cord-353749-2vlc11rx	94	8	years	year	NNS
cord-353749-2vlc11rx	94	9	for	for	IN
cord-353749-2vlc11rx	94	10	completion	completion	NN
cord-353749-2vlc11rx	94	11	at	at	IN
cord-353749-2vlc11rx	94	12	an	an	DT
cord-353749-2vlc11rx	94	13	average	average	JJ
cord-353749-2vlc11rx	94	14	cost	cost	NN
cord-353749-2vlc11rx	94	15	of	of	IN
cord-353749-2vlc11rx	94	16	over	over	IN
cord-353749-2vlc11rx	94	17	a	a	DT
cord-353749-2vlc11rx	94	18	million	million	CD
cord-353749-2vlc11rx	94	19	dollars	dollar	NNS
cord-353749-2vlc11rx	94	20	,	,	,
cord-353749-2vlc11rx	94	21	it	-PRON-	PRP
cord-353749-2vlc11rx	94	22	may	may	MD
cord-353749-2vlc11rx	94	23	take	take	VB
cord-353749-2vlc11rx	94	24	a	a	DT
cord-353749-2vlc11rx	94	25	long	long	JJ
cord-353749-2vlc11rx	94	26	time	time	NN
cord-353749-2vlc11rx	94	27	to	to	TO
cord-353749-2vlc11rx	94	28	obtain	obtain	VB
cord-353749-2vlc11rx	94	29	conclusive	conclusive	JJ
cord-353749-2vlc11rx	94	30	results	result	NNS
cord-353749-2vlc11rx	94	31	from	from	IN
cord-353749-2vlc11rx	94	32	these	these	DT
cord-353749-2vlc11rx	94	33	studies	study	NNS
cord-353749-2vlc11rx	94	34	.	.	.
cord-353749-2vlc11rx	95	1	[	[	-LRB-
cord-353749-2vlc11rx	95	2	55	55	CD
cord-353749-2vlc11rx	95	3	]	]	-RRB-
cord-353749-2vlc11rx	95	4	[	[	-LRB-
cord-353749-2vlc11rx	95	5	56	56	CD
cord-353749-2vlc11rx	95	6	]	]	-RRB-
cord-353749-2vlc11rx	95	7	[	[	-LRB-
cord-353749-2vlc11rx	95	8	57	57	CD
cord-353749-2vlc11rx	95	9	]	]	-RRB-
cord-353749-2vlc11rx	96	1	In	in	IN
cord-353749-2vlc11rx	96	2	the	the	DT
cord-353749-2vlc11rx	96	3	face	face	NN
cord-353749-2vlc11rx	96	4	of	of	IN
cord-353749-2vlc11rx	96	5	a	a	DT
cord-353749-2vlc11rx	96	6	public	public	JJ
cord-353749-2vlc11rx	96	7	health	health	NN
cord-353749-2vlc11rx	96	8	crisis	crisis	NN
cord-353749-2vlc11rx	96	9	,	,	,
cord-353749-2vlc11rx	96	10	it	-PRON-	PRP
cord-353749-2vlc11rx	96	11	is	be	VBZ
cord-353749-2vlc11rx	96	12	important	important	JJ
cord-353749-2vlc11rx	96	13	to	to	TO
cord-353749-2vlc11rx	96	14	consider	consider	VB
cord-353749-2vlc11rx	96	15	life	life	NN
cord-353749-2vlc11rx	96	16	-	-	HYPH
cord-353749-2vlc11rx	96	17	saving	save	VBG
cord-353749-2vlc11rx	96	18	approaches	approach	NNS
cord-353749-2vlc11rx	96	19	based	base	VBN
cord-353749-2vlc11rx	96	20	on	on	IN
cord-353749-2vlc11rx	96	21	scientific	scientific	JJ
cord-353749-2vlc11rx	96	22	logic	logic	NN
cord-353749-2vlc11rx	96	23	and	and	CC
cord-353749-2vlc11rx	96	24	clinical	clinical	JJ
cord-353749-2vlc11rx	96	25	availability	availability	NN
cord-353749-2vlc11rx	96	26	even	even	RB
cord-353749-2vlc11rx	96	27	if	if	IN
cord-353749-2vlc11rx	96	28	definitive	definitive	JJ
cord-353749-2vlc11rx	96	29	results	result	NNS
cord-353749-2vlc11rx	96	30	are	be	VBP
cord-353749-2vlc11rx	96	31	pending	pende	VBG
cord-353749-2vlc11rx	96	32	.	.	.
cord-353749-2vlc11rx	97	1	21,58	21,58	CD
cord-353749-2vlc11rx	98	1	Unfortunately	unfortunately	RB
cord-353749-2vlc11rx	98	2	,	,	,
cord-353749-2vlc11rx	98	3	HCQ	HCQ	NNP
cord-353749-2vlc11rx	98	4	has	have	VBZ
cord-353749-2vlc11rx	98	5	generated	generate	VBN
cord-353749-2vlc11rx	98	6	significant	significant	JJ
cord-353749-2vlc11rx	98	7	controversy	controversy	NN
cord-353749-2vlc11rx	98	8	resulting	result	VBG
cord-353749-2vlc11rx	98	9	in	in	IN
cord-353749-2vlc11rx	98	10	the	the	DT
cord-353749-2vlc11rx	98	11	public	public	JJ
cord-353749-2vlc11rx	98	12	perception	perception	NN
cord-353749-2vlc11rx	98	13	that	that	IN
cord-353749-2vlc11rx	98	14	the	the	DT
cord-353749-2vlc11rx	98	15	medication	medication	NN
cord-353749-2vlc11rx	98	16	is	be	VBZ
cord-353749-2vlc11rx	98	17	dangerous	dangerous	JJ
cord-353749-2vlc11rx	98	18	and	and	CC
cord-353749-2vlc11rx	98	19	ineffective	ineffective	JJ
cord-353749-2vlc11rx	98	20	.	.	.
cord-353749-2vlc11rx	99	1	In	in	IN
cord-353749-2vlc11rx	99	2	light	light	NN
cord-353749-2vlc11rx	99	3	of	of	IN
cord-353749-2vlc11rx	99	4	this	this	DT
cord-353749-2vlc11rx	99	5	problem	problem	NN
cord-353749-2vlc11rx	99	6	,	,	,
cord-353749-2vlc11rx	99	7	weekly	weekly	JJ
cord-353749-2vlc11rx	99	8	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	99	9	with	with	IN
cord-353749-2vlc11rx	99	10	mefloquine	mefloquine	NNP
cord-353749-2vlc11rx	100	1	250	250	CD
cord-353749-2vlc11rx	100	2	mg	mg	PRP
cord-353749-2vlc11rx	100	3	could	could	MD
cord-353749-2vlc11rx	100	4	be	be	VB
cord-353749-2vlc11rx	100	5	used	use	VBN
cord-353749-2vlc11rx	100	6	instead	instead	RB
cord-353749-2vlc11rx	100	7	.	.	.
cord-353749-2vlc11rx	101	1	This	this	DT
cord-353749-2vlc11rx	101	2	oral	oral	JJ
cord-353749-2vlc11rx	101	3	medication	medication	NN
cord-353749-2vlc11rx	101	4	has	have	VBZ
cord-353749-2vlc11rx	101	5	a	a	DT
cord-353749-2vlc11rx	101	6	half	half	JJ
cord-353749-2vlc11rx	101	7	-	-	HYPH
cord-353749-2vlc11rx	101	8	life	life	NN
cord-353749-2vlc11rx	101	9	of	of	IN
cord-353749-2vlc11rx	101	10	about	about	RB
cord-353749-2vlc11rx	101	11	three	three	CD
cord-353749-2vlc11rx	101	12	weeks	week	NNS
cord-353749-2vlc11rx	101	13	and	and	CC
cord-353749-2vlc11rx	101	14	appears	appear	VBZ
cord-353749-2vlc11rx	101	15	to	to	TO
cord-353749-2vlc11rx	101	16	be	be	VB
cord-353749-2vlc11rx	101	17	active	active	JJ
cord-353749-2vlc11rx	101	18	against	against	IN
cord-353749-2vlc11rx	101	19	SARS	SARS	NNP
cord-353749-2vlc11rx	101	20	-	-	HYPH
cord-353749-2vlc11rx	101	21	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	101	22	in	in	IN
cord-353749-2vlc11rx	101	23	vitro	vitro	FW
cord-353749-2vlc11rx	101	24	,	,	,
cord-353749-2vlc11rx	101	25	which	which	WDT
cord-353749-2vlc11rx	101	26	makes	make	VBZ
cord-353749-2vlc11rx	101	27	it	-PRON-	PRP
cord-353749-2vlc11rx	101	28	suitable	suitable	JJ
cord-353749-2vlc11rx	101	29	for	for	IN
cord-353749-2vlc11rx	101	30	weekly	weekly	JJ
cord-353749-2vlc11rx	101	31	antiviral	antiviral	JJ
cord-353749-2vlc11rx	101	32	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	101	33	.	.	.
cord-353749-2vlc11rx	102	1	59	59	CD
cord-353749-2vlc11rx	102	2	,	,	,
cord-353749-2vlc11rx	102	3	60	60	CD
cord-353749-2vlc11rx	103	1	The	the	DT
cord-353749-2vlc11rx	103	2	troubling	troubling	JJ
cord-353749-2vlc11rx	103	3	neuropsychiatric	neuropsychiatric	JJ
cord-353749-2vlc11rx	103	4	side	side	NN
cord-353749-2vlc11rx	103	5	effects	effect	NNS
cord-353749-2vlc11rx	103	6	of	of	IN
cord-353749-2vlc11rx	103	7	mefloquine	mefloquine	NN
cord-353749-2vlc11rx	103	8	make	make	VBP
cord-353749-2vlc11rx	103	9	the	the	DT
cord-353749-2vlc11rx	103	10	drug	drug	NN
cord-353749-2vlc11rx	103	11	a	a	DT
cord-353749-2vlc11rx	103	12	less	less	RBR
cord-353749-2vlc11rx	103	13	attractive	attractive	JJ
cord-353749-2vlc11rx	103	14	option	option	NN
cord-353749-2vlc11rx	103	15	for	for	IN
cord-353749-2vlc11rx	103	16	PrEP	prep	NN
cord-353749-2vlc11rx	103	17	.	.	.
cord-353749-2vlc11rx	104	1	Another	another	DT
cord-353749-2vlc11rx	104	2	option	option	NN
cord-353749-2vlc11rx	104	3	is	be	VBZ
cord-353749-2vlc11rx	104	4	the	the	DT
cord-353749-2vlc11rx	104	5	antiparasitic	antiparasitic	JJ
cord-353749-2vlc11rx	104	6	drug	drug	NN
cord-353749-2vlc11rx	104	7	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	104	8	.	.	.
cord-353749-2vlc11rx	105	1	This	this	DT
cord-353749-2vlc11rx	105	2	antimicrobial	antimicrobial	JJ
cord-353749-2vlc11rx	105	3	agent	agent	NN
cord-353749-2vlc11rx	105	4	with	with	IN
cord-353749-2vlc11rx	105	5	antiviral	antiviral	JJ
cord-353749-2vlc11rx	105	6	properties	property	NNS
cord-353749-2vlc11rx	105	7	appears	appear	VBZ
cord-353749-2vlc11rx	105	8	to	to	TO
cord-353749-2vlc11rx	105	9	be	be	VB
cord-353749-2vlc11rx	105	10	effective	effective	JJ
cord-353749-2vlc11rx	105	11	against	against	IN
cord-353749-2vlc11rx	105	12	SARS	SARS	NNP
cord-353749-2vlc11rx	105	13	-	-	HYPH
cord-353749-2vlc11rx	105	14	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	105	15	in	in	IN
cord-353749-2vlc11rx	105	16	vitro	vitro	FW
cord-353749-2vlc11rx	105	17	and	and	CC
cord-353749-2vlc11rx	105	18	in	in	IN
cord-353749-2vlc11rx	105	19	vivo	vivo	NNP
cord-353749-2vlc11rx	105	20	.	.	.
cord-353749-2vlc11rx	106	1	[	[	-LRB-
cord-353749-2vlc11rx	106	2	61	61	CD
cord-353749-2vlc11rx	106	3	]	]	-RRB-
cord-353749-2vlc11rx	106	4	[	[	-LRB-
cord-353749-2vlc11rx	106	5	62	62	CD
cord-353749-2vlc11rx	106	6	]	]	-RRB-
cord-353749-2vlc11rx	106	7	[	[	-LRB-
cord-353749-2vlc11rx	106	8	63	63	CD
cord-353749-2vlc11rx	106	9	]	]	-RRB-
cord-353749-2vlc11rx	107	1	[	[	-LRB-
cord-353749-2vlc11rx	107	2	64	64	CD
cord-353749-2vlc11rx	107	3	]	]	-RRB-
cord-353749-2vlc11rx	108	1	The	the	DT
cord-353749-2vlc11rx	108	2	half	half	JJ
cord-353749-2vlc11rx	108	3	-	-	HYPH
cord-353749-2vlc11rx	108	4	life	life	NN
cord-353749-2vlc11rx	108	5	of	of	IN
cord-353749-2vlc11rx	108	6	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	108	7	is	be	VBZ
cord-353749-2vlc11rx	108	8	12	12	CD
cord-353749-2vlc11rx	108	9	-	-	SYM
cord-353749-2vlc11rx	108	10	36	36	CD
cord-353749-2vlc11rx	108	11	hours	hour	NNS
cord-353749-2vlc11rx	108	12	in	in	IN
cord-353749-2vlc11rx	108	13	humans	human	NNS
cord-353749-2vlc11rx	108	14	,	,	,
cord-353749-2vlc11rx	108	15	and	and	CC
cord-353749-2vlc11rx	108	16	its	-PRON-	PRP$
cord-353749-2vlc11rx	108	17	metabolites	metabolite	NNS
cord-353749-2vlc11rx	108	18	may	may	MD
cord-353749-2vlc11rx	108	19	persist	persist	VB
cord-353749-2vlc11rx	108	20	for	for	IN
cord-353749-2vlc11rx	108	21	up	up	IN
cord-353749-2vlc11rx	108	22	to	to	TO
cord-353749-2vlc11rx	108	23	12	12	CD
cord-353749-2vlc11rx	108	24	days	day	NNS
cord-353749-2vlc11rx	108	25	due	due	JJ
cord-353749-2vlc11rx	108	26	to	to	IN
cord-353749-2vlc11rx	108	27	high	high	JJ
cord-353749-2vlc11rx	108	28	liposolubility	liposolubility	NN
cord-353749-2vlc11rx	108	29	.	.	.
cord-353749-2vlc11rx	109	1	It	-PRON-	PRP
cord-353749-2vlc11rx	109	2	can	can	MD
cord-353749-2vlc11rx	109	3	be	be	VB
cord-353749-2vlc11rx	109	4	dosed	dose	VBN
cord-353749-2vlc11rx	109	5	daily	daily	RB
cord-353749-2vlc11rx	109	6	or	or	CC
cord-353749-2vlc11rx	109	7	weekly	weekly	RB
cord-353749-2vlc11rx	109	8	at	at	IN
cord-353749-2vlc11rx	109	9	0.15	0.15	CD
cord-353749-2vlc11rx	109	10	-	-	SYM
cord-353749-2vlc11rx	109	11	0.2	0.2	CD
cord-353749-2vlc11rx	109	12	mg	mg	NN
cord-353749-2vlc11rx	110	1	/kg	/kg	NFP
cord-353749-2vlc11rx	110	2	with	with	IN
cord-353749-2vlc11rx	110	3	minimal	minimal	JJ
cord-353749-2vlc11rx	110	4	side	side	NN
cord-353749-2vlc11rx	110	5	effects	effect	NNS
cord-353749-2vlc11rx	110	6	,	,	,
cord-353749-2vlc11rx	110	7	but	but	CC
cord-353749-2vlc11rx	110	8	clinical	clinical	JJ
cord-353749-2vlc11rx	110	9	PrEP	prep	NN
cord-353749-2vlc11rx	110	10	trials	trial	NNS
cord-353749-2vlc11rx	110	11	for	for	IN
cord-353749-2vlc11rx	110	12	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	110	13	using	use	VBG
cord-353749-2vlc11rx	110	14	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	110	15	have	have	VBP
cord-353749-2vlc11rx	110	16	not	not	RB
cord-353749-2vlc11rx	110	17	been	be	VBN
cord-353749-2vlc11rx	110	18	organized	organize	VBN
cord-353749-2vlc11rx	110	19	to	to	IN
cord-353749-2vlc11rx	110	20	date	date	NN
cord-353749-2vlc11rx	110	21	,	,	,
cord-353749-2vlc11rx	110	22	and	and	CC
cord-353749-2vlc11rx	110	23	appropriate	appropriate	JJ
cord-353749-2vlc11rx	110	24	antiviral	antiviral	JJ
cord-353749-2vlc11rx	110	25	dosing	dosing	NN
cord-353749-2vlc11rx	110	26	remains	remain	VBZ
cord-353749-2vlc11rx	110	27	questionable	questionable	JJ
cord-353749-2vlc11rx	110	28	.	.	.
cord-353749-2vlc11rx	111	1	65	65	CD
cord-353749-2vlc11rx	111	2	Individuals	individual	NNS
cord-353749-2vlc11rx	111	3	with	with	IN
cord-353749-2vlc11rx	111	4	specific	specific	JJ
cord-353749-2vlc11rx	111	5	gene	gene	NN
cord-353749-2vlc11rx	111	6	mutations	mutation	NNS
cord-353749-2vlc11rx	111	7	may	may	MD
cord-353749-2vlc11rx	111	8	have	have	VB
cord-353749-2vlc11rx	111	9	adverse	adverse	JJ
cord-353749-2vlc11rx	111	10	reactions	reaction	NNS
cord-353749-2vlc11rx	111	11	to	to	IN
cord-353749-2vlc11rx	111	12	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	111	13	.	.	.
cord-353749-2vlc11rx	112	1	66	66	CD
cord-353749-2vlc11rx	113	1	Tafenoquine	Tafenoquine	NNP
cord-353749-2vlc11rx	113	2	,	,	,
cord-353749-2vlc11rx	113	3	a	a	DT
cord-353749-2vlc11rx	113	4	newer	new	JJR
cord-353749-2vlc11rx	113	5	antimalarial	antimalarial	JJ
cord-353749-2vlc11rx	113	6	agent	agent	NN
cord-353749-2vlc11rx	113	7	that	that	WDT
cord-353749-2vlc11rx	113	8	can	can	MD
cord-353749-2vlc11rx	113	9	be	be	VB
cord-353749-2vlc11rx	113	10	dosed	dose	VBN
cord-353749-2vlc11rx	113	11	weekly	weekly	RB
cord-353749-2vlc11rx	113	12	with	with	IN
cord-353749-2vlc11rx	113	13	a	a	DT
cord-353749-2vlc11rx	113	14	half	half	JJ
cord-353749-2vlc11rx	113	15	-	-	HYPH
cord-353749-2vlc11rx	113	16	life	life	NN
cord-353749-2vlc11rx	113	17	of	of	IN
cord-353749-2vlc11rx	113	18	2	2	CD
cord-353749-2vlc11rx	113	19	-	-	SYM
cord-353749-2vlc11rx	113	20	3	3	CD
cord-353749-2vlc11rx	113	21	weeks	week	NNS
cord-353749-2vlc11rx	113	22	,	,	,
cord-353749-2vlc11rx	113	23	has	have	VBZ
cord-353749-2vlc11rx	113	24	been	be	VBN
cord-353749-2vlc11rx	113	25	suggested	suggest	VBN
cord-353749-2vlc11rx	113	26	for	for	IN
cord-353749-2vlc11rx	113	27	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	113	28	PrEP	prep	NN
cord-353749-2vlc11rx	113	29	,	,	,
cord-353749-2vlc11rx	113	30	but	but	CC
cord-353749-2vlc11rx	113	31	the	the	DT
cord-353749-2vlc11rx	113	32	side	side	NN
cord-353749-2vlc11rx	113	33	effects	effect	NNS
cord-353749-2vlc11rx	113	34	and	and	CC
cord-353749-2vlc11rx	113	35	cost	cost	NN
cord-353749-2vlc11rx	113	36	of	of	IN
cord-353749-2vlc11rx	113	37	this	this	DT
cord-353749-2vlc11rx	113	38	medication	medication	NN
cord-353749-2vlc11rx	113	39	make	make	VB
cord-353749-2vlc11rx	113	40	it	-PRON-	PRP
cord-353749-2vlc11rx	113	41	a	a	DT
cord-353749-2vlc11rx	113	42	less	less	RBR
cord-353749-2vlc11rx	113	43	attractive	attractive	JJ
cord-353749-2vlc11rx	113	44	candidate	candidate	NN
cord-353749-2vlc11rx	113	45	for	for	IN
cord-353749-2vlc11rx	113	46	widespread	widespread	JJ
cord-353749-2vlc11rx	113	47	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	113	48	.	.	.
cord-353749-2vlc11rx	114	1	67	67	CD
cord-353749-2vlc11rx	114	2	,	,	,
cord-353749-2vlc11rx	114	3	68	68	CD
cord-353749-2vlc11rx	114	4	 	 	_SP
cord-353749-2vlc11rx	115	1	In	in	IN
cord-353749-2vlc11rx	115	2	patients	patient	NNS
cord-353749-2vlc11rx	115	3	with	with	IN
cord-353749-2vlc11rx	115	4	HIV	HIV	NNP
cord-353749-2vlc11rx	115	5	/	/	SYM
cord-353749-2vlc11rx	115	6	AIDS	AIDS	NNP
cord-353749-2vlc11rx	115	7	,	,	,
cord-353749-2vlc11rx	115	8	treatment	treatment	NN
cord-353749-2vlc11rx	115	9	with	with	IN
cord-353749-2vlc11rx	115	10	tenofovir	tenofovir	NNP
cord-353749-2vlc11rx	115	11	disoproxil	disoproxil	NNP
cord-353749-2vlc11rx	115	12	fumarate	fumarate	NNP
cord-353749-2vlc11rx	115	13	(	(	-LRB-
cord-353749-2vlc11rx	115	14	TDF)/emtricitabine	TDF)/emtricitabine	NNP
cord-353749-2vlc11rx	115	15	(	(	-LRB-
cord-353749-2vlc11rx	115	16	FTC	FTC	NNP
cord-353749-2vlc11rx	115	17	)	)	-RRB-
cord-353749-2vlc11rx	115	18	lowered	lower	VBD
cord-353749-2vlc11rx	115	19	the	the	DT
cord-353749-2vlc11rx	115	20	risk	risk	NN
cord-353749-2vlc11rx	115	21	of	of	IN
cord-353749-2vlc11rx	115	22	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	115	23	,	,	,
cord-353749-2vlc11rx	115	24	but	but	CC
cord-353749-2vlc11rx	115	25	these	these	DT
cord-353749-2vlc11rx	115	26	medications	medication	NNS
cord-353749-2vlc11rx	115	27	are	be	VBP
cord-353749-2vlc11rx	115	28	expensive	expensive	JJ
cord-353749-2vlc11rx	115	29	and	and	CC
cord-353749-2vlc11rx	115	30	must	must	MD
cord-353749-2vlc11rx	115	31	be	be	VB
cord-353749-2vlc11rx	115	32	dosed	dose	VBN
cord-353749-2vlc11rx	115	33	daily	daily	RB
cord-353749-2vlc11rx	115	34	.	.	.
cord-353749-2vlc11rx	116	1	69	69	CD
cord-353749-2vlc11rx	116	2	Therapy	therapy	NN
cord-353749-2vlc11rx	116	3	with	with	IN
cord-353749-2vlc11rx	116	4	convalescent	convalescent	JJ
cord-353749-2vlc11rx	116	5	plasma	plasma	NN
cord-353749-2vlc11rx	116	6	has	have	VBZ
cord-353749-2vlc11rx	116	7	been	be	VBN
cord-353749-2vlc11rx	116	8	administered	administer	VBN
cord-353749-2vlc11rx	116	9	to	to	IN
cord-353749-2vlc11rx	116	10	severely	severely	RB
cord-353749-2vlc11rx	116	11	ill	ill	VB
cord-353749-2vlc11rx	116	12	COVID-19	covid-19	CD
cord-353749-2vlc11rx	116	13	patients	patient	NNS
cord-353749-2vlc11rx	116	14	and	and	CC
cord-353749-2vlc11rx	116	15	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	116	16	with	with	IN
cord-353749-2vlc11rx	116	17	plasma	plasma	NN
cord-353749-2vlc11rx	116	18	or	or	CC
cord-353749-2vlc11rx	116	19	neutralizing	neutralize	VBG
cord-353749-2vlc11rx	116	20	monoclonal	monoclonal	JJ
cord-353749-2vlc11rx	116	21	antibodies	antibody	NNS
cord-353749-2vlc11rx	116	22	has	have	VBZ
cord-353749-2vlc11rx	116	23	been	be	VBN
cord-353749-2vlc11rx	116	24	suggested	suggest	VBN
cord-353749-2vlc11rx	116	25	,	,	,
cord-353749-2vlc11rx	116	26	but	but	CC
cord-353749-2vlc11rx	116	27	use	use	NN
cord-353749-2vlc11rx	116	28	of	of	IN
cord-353749-2vlc11rx	116	29	these	these	DT
cord-353749-2vlc11rx	116	30	nascent	nascent	JJ
cord-353749-2vlc11rx	116	31	non	non	JJ
cord-353749-2vlc11rx	116	32	-	-	JJ
cord-353749-2vlc11rx	116	33	standardized	standardized	JJ
cord-353749-2vlc11rx	116	34	treatments	treatment	NNS
cord-353749-2vlc11rx	116	35	for	for	IN
cord-353749-2vlc11rx	116	36	PrEP	prep	NN
cord-353749-2vlc11rx	116	37	has	have	VBZ
cord-353749-2vlc11rx	116	38	not	not	RB
cord-353749-2vlc11rx	116	39	been	be	VBN
cord-353749-2vlc11rx	116	40	evaluated	evaluate	VBN
cord-353749-2vlc11rx	116	41	.	.	.
cord-353749-2vlc11rx	117	1	[	[	-LRB-
cord-353749-2vlc11rx	117	2	70	70	CD
cord-353749-2vlc11rx	117	3	]	]	-RRB-
cord-353749-2vlc11rx	117	4	[	[	-LRB-
cord-353749-2vlc11rx	117	5	71	71	CD
cord-353749-2vlc11rx	117	6	]	]	-RRB-
cord-353749-2vlc11rx	118	1	[	[	-LRB-
cord-353749-2vlc11rx	118	2	72	72	CD
cord-353749-2vlc11rx	118	3	]	]	-RRB-
cord-353749-2vlc11rx	119	1	[	[	-LRB-
cord-353749-2vlc11rx	119	2	73	73	CD
cord-353749-2vlc11rx	119	3	]	]	-RRB-
cord-353749-2vlc11rx	120	1	[	[	-LRB-
cord-353749-2vlc11rx	120	2	74	74	CD
cord-353749-2vlc11rx	120	3	]	]	-RRB-
cord-353749-2vlc11rx	120	4	 	 	_SP
cord-353749-2vlc11rx	121	1	The	the	DT
cord-353749-2vlc11rx	121	2	efficacy	efficacy	NN
cord-353749-2vlc11rx	121	3	and	and	CC
cord-353749-2vlc11rx	121	4	safety	safety	NN
cord-353749-2vlc11rx	121	5	of	of	IN
cord-353749-2vlc11rx	121	6	barrier	barrier	NN
cord-353749-2vlc11rx	121	7	protection	protection	NN
cord-353749-2vlc11rx	121	8	(	(	-LRB-
cord-353749-2vlc11rx	121	9	primarily	primarily	RB
cord-353749-2vlc11rx	121	10	facemasks	facemask	NNS
cord-353749-2vlc11rx	121	11	)	)	-RRB-
cord-353749-2vlc11rx	121	12	in	in	IN
cord-353749-2vlc11rx	121	13	the	the	DT
cord-353749-2vlc11rx	121	14	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	121	15	pandemic	pandemic	NN
cord-353749-2vlc11rx	121	16	continues	continue	VBZ
cord-353749-2vlc11rx	121	17	to	to	TO
cord-353749-2vlc11rx	121	18	be	be	VB
cord-353749-2vlc11rx	121	19	debated	debate	VBN
cord-353749-2vlc11rx	121	20	,	,	,
cord-353749-2vlc11rx	121	21	and	and	CC
cord-353749-2vlc11rx	121	22	formal	formal	JJ
cord-353749-2vlc11rx	121	23	studies	study	NNS
cord-353749-2vlc11rx	121	24	in	in	IN
cord-353749-2vlc11rx	121	25	various	various	JJ
cord-353749-2vlc11rx	121	26	settings	setting	NNS
cord-353749-2vlc11rx	121	27	have	have	VBP
cord-353749-2vlc11rx	121	28	been	be	VBN
cord-353749-2vlc11rx	121	29	recommended	recommend	VBN
cord-353749-2vlc11rx	121	30	.	.	.
cord-353749-2vlc11rx	122	1	75	75	CD
cord-353749-2vlc11rx	122	2	,	,	,
cord-353749-2vlc11rx	122	3	76	76	CD
cord-353749-2vlc11rx	123	1	For	for	IN
cord-353749-2vlc11rx	123	2	HCWs	hcw	NNS
cord-353749-2vlc11rx	123	3	with	with	IN
cord-353749-2vlc11rx	123	4	high	high	JJ
cord-353749-2vlc11rx	123	5	-	-	HYPH
cord-353749-2vlc11rx	123	6	risk	risk	NN
cord-353749-2vlc11rx	123	7	patient	patient	NN
cord-353749-2vlc11rx	123	8	42	42	CD
cord-353749-2vlc11rx	124	1	For	for	IN
cord-353749-2vlc11rx	124	2	the	the	DT
cord-353749-2vlc11rx	124	3	general	general	JJ
cord-353749-2vlc11rx	124	4	population	population	NN
cord-353749-2vlc11rx	124	5	,	,	,
cord-353749-2vlc11rx	124	6	facemasks	facemask	NNS
cord-353749-2vlc11rx	124	7	appear	appear	VBP
cord-353749-2vlc11rx	124	8	to	to	TO
cord-353749-2vlc11rx	124	9	be	be	VB
cord-353749-2vlc11rx	124	10	less	less	RBR
cord-353749-2vlc11rx	124	11	effective	effective	JJ
cord-353749-2vlc11rx	124	12	due	due	IN
cord-353749-2vlc11rx	124	13	to	to	IN
cord-353749-2vlc11rx	124	14	technical	technical	JJ
cord-353749-2vlc11rx	124	15	limitations	limitation	NNS
cord-353749-2vlc11rx	124	16	,	,	,
cord-353749-2vlc11rx	124	17	compliance	compliance	NN
cord-353749-2vlc11rx	124	18	issues	issue	NNS
cord-353749-2vlc11rx	124	19	and	and	CC
cord-353749-2vlc11rx	124	20	variable	variable	JJ
cord-353749-2vlc11rx	124	21	transmission	transmission	NN
cord-353749-2vlc11rx	124	22	risks	risk	NNS
cord-353749-2vlc11rx	124	23	.	.	.
cord-353749-2vlc11rx	125	1	75	75	CD
cord-353749-2vlc11rx	125	2	,	,	,
cord-353749-2vlc11rx	125	3	76	76	CD
cord-353749-2vlc11rx	126	1	The	the	DT
cord-353749-2vlc11rx	126	2	theory	theory	NN
cord-353749-2vlc11rx	126	3	of	of	IN
cord-353749-2vlc11rx	126	4	"	"	``
cord-353749-2vlc11rx	126	5	variolation	variolation	NN
cord-353749-2vlc11rx	126	6	"	"	''
cord-353749-2vlc11rx	126	7	,	,	,
cord-353749-2vlc11rx	126	8	which	which	WDT
cord-353749-2vlc11rx	126	9	states	state	VBZ
cord-353749-2vlc11rx	126	10	that	that	IN
cord-353749-2vlc11rx	126	11	population	population	NN
cord-353749-2vlc11rx	126	12	-	-	HYPH
cord-353749-2vlc11rx	126	13	wide	wide	JJ
cord-353749-2vlc11rx	126	14	masking	masking	NN
cord-353749-2vlc11rx	126	15	may	may	MD
cord-353749-2vlc11rx	126	16	limit	limit	VB
cord-353749-2vlc11rx	126	17	viral	viral	JJ
cord-353749-2vlc11rx	126	18	load	load	NN
cord-353749-2vlc11rx	126	19	exposure	exposure	NN
cord-353749-2vlc11rx	126	20	and	and	CC
cord-353749-2vlc11rx	126	21	thereby	thereby	RB
cord-353749-2vlc11rx	126	22	attenuate	attenuate	VB
cord-353749-2vlc11rx	126	23	the	the	DT
cord-353749-2vlc11rx	126	24	severity	severity	NN
cord-353749-2vlc11rx	126	25	of	of	IN
cord-353749-2vlc11rx	126	26	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	126	27	,	,	,
cord-353749-2vlc11rx	126	28	remains	remain	VBZ
cord-353749-2vlc11rx	126	29	to	to	TO
cord-353749-2vlc11rx	126	30	be	be	VB
cord-353749-2vlc11rx	126	31	proven	prove	VBN
cord-353749-2vlc11rx	126	32	.	.	.
cord-353749-2vlc11rx	127	1	77	77	CD
cord-353749-2vlc11rx	128	1	Although	although	IN
cord-353749-2vlc11rx	128	2	not	not	RB
cord-353749-2vlc11rx	128	3	a	a	DT
cord-353749-2vlc11rx	128	4	perfect	perfect	JJ
cord-353749-2vlc11rx	128	5	solution	solution	NN
cord-353749-2vlc11rx	128	6	,	,	,
cord-353749-2vlc11rx	128	7	medication	medication	NN
cord-353749-2vlc11rx	128	8	-	-	HYPH
cord-353749-2vlc11rx	128	9	based	base	VBN
cord-353749-2vlc11rx	128	10	PrEP	prep	NN
cord-353749-2vlc11rx	128	11	should	should	MD
cord-353749-2vlc11rx	128	12	largely	largely	RB
cord-353749-2vlc11rx	128	13	eliminate	eliminate	VB
cord-353749-2vlc11rx	128	14	the	the	DT
cord-353749-2vlc11rx	128	15	drawbacks	drawback	NNS
cord-353749-2vlc11rx	128	16	of	of	IN
cord-353749-2vlc11rx	128	17	barrier	barrier	NN
cord-353749-2vlc11rx	128	18	protection	protection	NN
cord-353749-2vlc11rx	128	19	by	by	IN
cord-353749-2vlc11rx	128	20	providing	provide	VBG
cord-353749-2vlc11rx	128	21	consistent	consistent	JJ
cord-353749-2vlc11rx	128	22	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	128	23	against	against	IN
cord-353749-2vlc11rx	128	24	viral	viral	JJ
cord-353749-2vlc11rx	128	25	infection	infection	NN
cord-353749-2vlc11rx	128	26	for	for	IN
cord-353749-2vlc11rx	128	27	as	as	RB
cord-353749-2vlc11rx	128	28	long	long	RB
cord-353749-2vlc11rx	128	29	as	as	IN
cord-353749-2vlc11rx	128	30	the	the	DT
cord-353749-2vlc11rx	128	31	medication	medication	NN
cord-353749-2vlc11rx	128	32	is	be	VBZ
cord-353749-2vlc11rx	128	33	used	use	VBN
cord-353749-2vlc11rx	128	34	and	and	CC
cord-353749-2vlc11rx	128	35	the	the	DT
cord-353749-2vlc11rx	128	36	virus	virus	NN
cord-353749-2vlc11rx	128	37	remains	remain	VBZ
cord-353749-2vlc11rx	128	38	clinically	clinically	RB
cord-353749-2vlc11rx	128	39	susceptible	susceptible	JJ
cord-353749-2vlc11rx	128	40	.	.	.
cord-353749-2vlc11rx	129	1	As	as	IN
cord-353749-2vlc11rx	129	2	economies	economy	NNS
cord-353749-2vlc11rx	129	3	reopen	reopen	VBP
cord-353749-2vlc11rx	129	4	,	,	,
cord-353749-2vlc11rx	129	5	schools	school	NNS
cord-353749-2vlc11rx	129	6	resume	resume	VBP
cord-353749-2vlc11rx	129	7	and	and	CC
cord-353749-2vlc11rx	129	8	passive	passive	JJ
cord-353749-2vlc11rx	129	9	social	social	JJ
cord-353749-2vlc11rx	129	10	distancing	distancing	NN
cord-353749-2vlc11rx	129	11	becomes	become	VBZ
cord-353749-2vlc11rx	129	12	more	more	RBR
cord-353749-2vlc11rx	129	13	difficult	difficult	JJ
cord-353749-2vlc11rx	129	14	,	,	,
cord-353749-2vlc11rx	129	15	there	there	EX
cord-353749-2vlc11rx	129	16	is	be	VBZ
cord-353749-2vlc11rx	129	17	an	an	DT
cord-353749-2vlc11rx	129	18	urgent	urgent	JJ
cord-353749-2vlc11rx	129	19	need	need	NN
cord-353749-2vlc11rx	129	20	for	for	IN
cord-353749-2vlc11rx	129	21	active	active	JJ
cord-353749-2vlc11rx	129	22	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	129	23	against	against	IN
cord-353749-2vlc11rx	129	24	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	129	25	.	.	.
cord-353749-2vlc11rx	130	1	PrEP	prep	NN
cord-353749-2vlc11rx	130	2	modeled	model	VBN
cord-353749-2vlc11rx	130	3	on	on	IN
cord-353749-2vlc11rx	130	4	malaria	malaria	NN
cord-353749-2vlc11rx	130	5	and	and	CC
cord-353749-2vlc11rx	130	6	HIV	HIV	NNP
cord-353749-2vlc11rx	130	7	/	/	SYM
cord-353749-2vlc11rx	130	8	AIDS	AIDS	NNP
cord-353749-2vlc11rx	130	9	prevention	prevention	NN
cord-353749-2vlc11rx	130	10	using	use	VBG
cord-353749-2vlc11rx	130	11	readily	readily	RB
cord-353749-2vlc11rx	130	12	available	available	JJ
cord-353749-2vlc11rx	130	13	and	and	CC
cord-353749-2vlc11rx	130	14	clinically	clinically	RB
cord-353749-2vlc11rx	130	15	appropriate	appropriate	JJ
cord-353749-2vlc11rx	130	16	medication	medication	NN
cord-353749-2vlc11rx	130	17	provides	provide	VBZ
cord-353749-2vlc11rx	130	18	the	the	DT
cord-353749-2vlc11rx	130	19	means	mean	NNS
cord-353749-2vlc11rx	130	20	to	to	TO
cord-353749-2vlc11rx	130	21	fulfill	fulfill	VB
cord-353749-2vlc11rx	130	22	this	this	DT
cord-353749-2vlc11rx	130	23	need	need	NN
cord-353749-2vlc11rx	130	24	in	in	IN
cord-353749-2vlc11rx	130	25	large	large	JJ
cord-353749-2vlc11rx	130	26	populations	population	NNS
cord-353749-2vlc11rx	130	27	at	at	IN
cord-353749-2vlc11rx	130	28	risk	risk	NN
cord-353749-2vlc11rx	130	29	for	for	IN
cord-353749-2vlc11rx	130	30	viral	viral	JJ
cord-353749-2vlc11rx	130	31	infection	infection	NN
cord-353749-2vlc11rx	130	32	.	.	.
cord-353749-2vlc11rx	131	1	Until	until	IN
cord-353749-2vlc11rx	131	2	a	a	DT
cord-353749-2vlc11rx	131	3	vaccine	vaccine	NN
cord-353749-2vlc11rx	131	4	can	can	MD
cord-353749-2vlc11rx	131	5	be	be	VB
cord-353749-2vlc11rx	131	6	found	find	VBN
cord-353749-2vlc11rx	131	7	,	,	,
cord-353749-2vlc11rx	131	8	PrEP	prep	NN
cord-353749-2vlc11rx	131	9	for	for	IN
cord-353749-2vlc11rx	131	10	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	131	11	seems	seem	VBZ
cord-353749-2vlc11rx	131	12	a	a	DT
cord-353749-2vlc11rx	131	13	logical	logical	JJ
cord-353749-2vlc11rx	131	14	and	and	CC
cord-353749-2vlc11rx	131	15	feasible	feasible	JJ
cord-353749-2vlc11rx	131	16	choice	choice	NN
cord-353749-2vlc11rx	131	17	for	for	IN
cord-353749-2vlc11rx	131	18	resumption	resumption	NN
cord-353749-2vlc11rx	131	19	of	of	IN
cord-353749-2vlc11rx	131	20	work	work	NN
cord-353749-2vlc11rx	131	21	activities	activity	NNS
cord-353749-2vlc11rx	131	22	and	and	CC
cord-353749-2vlc11rx	131	23	social	social	JJ
cord-353749-2vlc11rx	131	24	interaction	interaction	NN
cord-353749-2vlc11rx	131	25	on	on	IN
cord-353749-2vlc11rx	131	26	a	a	DT
cord-353749-2vlc11rx	131	27	worldwide	worldwide	JJ
cord-353749-2vlc11rx	131	28	scale	scale	NN
cord-353749-2vlc11rx	131	29	.	.	.
cord-353749-2vlc11rx	132	1	There	there	EX
cord-353749-2vlc11rx	132	2	is	be	VBZ
cord-353749-2vlc11rx	132	3	no	no	DT
cord-353749-2vlc11rx	132	4	funding	funding	NN
cord-353749-2vlc11rx	132	5	to	to	TO
cord-353749-2vlc11rx	132	6	report	report	VB
cord-353749-2vlc11rx	132	7	.	.	.
cord-353749-2vlc11rx	133	1	The	the	DT
cord-353749-2vlc11rx	133	2	authors	author	NNS
cord-353749-2vlc11rx	133	3	report	report	VBP
cord-353749-2vlc11rx	133	4	no	no	DT
cord-353749-2vlc11rx	133	5	conflicts	conflict	NNS
cord-353749-2vlc11rx	133	6	of	of	IN
cord-353749-2vlc11rx	133	7	interest	interest	NN
cord-353749-2vlc11rx	133	8	in	in	IN
cord-353749-2vlc11rx	133	9	this	this	DT
cord-353749-2vlc11rx	133	10	work	work	NN
cord-353749-2vlc11rx	133	11	.	.	.
cord-353749-2vlc11rx	134	1	patients	patient	NNS
cord-353749-2vlc11rx	134	2	with	with	IN
cord-353749-2vlc11rx	134	3	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	134	4	and	and	CC
cord-353749-2vlc11rx	134	5	azithromycin	azithromycin	NNP
cord-353749-2vlc11rx	134	6	:	:	:
cord-353749-2vlc11rx	134	7	a	a	DT
cord-353749-2vlc11rx	134	8	retrospective	retrospective	JJ
cord-353749-2vlc11rx	134	9	analysis	analysis	NN
cord-353749-2vlc11rx	134	10	of	of	IN
cord-353749-2vlc11rx	134	11	1061	1061	CD
cord-353749-2vlc11rx	134	12	cases	case	NNS
cord-353749-2vlc11rx	134	13	in	in	IN
cord-353749-2vlc11rx	134	14	Marseille	Marseille	NNP
cord-353749-2vlc11rx	134	15	,	,	,
cord-353749-2vlc11rx	134	16	France	France	NNP
cord-353749-2vlc11rx	134	17	.	.	.
cord-353749-2vlc11rx	134	18	 	 	_SP
cord-353749-2vlc11rx	135	1	A	a	DT
cord-353749-2vlc11rx	135	2	novel	novel	JJ
cord-353749-2vlc11rx	135	3	plan	plan	NN
cord-353749-2vlc11rx	135	4	to	to	TO
cord-353749-2vlc11rx	135	5	deal	deal	VB
cord-353749-2vlc11rx	135	6	with	with	IN
cord-353749-2vlc11rx	135	7	SARS	SARS	NNP
cord-353749-2vlc11rx	135	8	-	-	HYPH
cord-353749-2vlc11rx	135	9	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	135	10	and	and	CC
cord-353749-2vlc11rx	135	11	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	135	12	disease	disease	NN
cord-353749-2vlc11rx	136	1	The	the	DT
cord-353749-2vlc11rx	136	2	infectious	infectious	JJ
cord-353749-2vlc11rx	136	3	nature	nature	NN
cord-353749-2vlc11rx	136	4	of	of	IN
cord-353749-2vlc11rx	136	5	patient	patient	NN
cord-353749-2vlc11rx	136	6	-	-	HYPH
cord-353749-2vlc11rx	136	7	generated	generate	VBN
cord-353749-2vlc11rx	136	8	SARS	SARS	NNP
cord-353749-2vlc11rx	136	9	-	-	HYPH
cord-353749-2vlc11rx	136	10	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	136	11	aerosol	aerosol	NN
cord-353749-2vlc11rx	136	12	Characteristics	characteristic	NNS
cord-353749-2vlc11rx	136	13	of	of	IN
cord-353749-2vlc11rx	136	14	hospitalized	hospitalize	VBN
cord-353749-2vlc11rx	136	15	adults	adult	NNS
cord-353749-2vlc11rx	136	16	with	with	IN
cord-353749-2vlc11rx	136	17	COVID-19	covid-19	CD
cord-353749-2vlc11rx	136	18	in	in	IN
cord-353749-2vlc11rx	136	19	an	an	DT
cord-353749-2vlc11rx	136	20	integrated	integrated	JJ
cord-353749-2vlc11rx	136	21	health	health	NN
cord-353749-2vlc11rx	136	22	care	care	NN
cord-353749-2vlc11rx	136	23	system	system	NN
cord-353749-2vlc11rx	136	24	in	in	IN
cord-353749-2vlc11rx	136	25	California	California	NNP
cord-353749-2vlc11rx	136	26	Symptom	symptom	NN
cord-353749-2vlc11rx	136	27	duration	duration	NN
cord-353749-2vlc11rx	136	28	and	and	CC
cord-353749-2vlc11rx	136	29	risk	risk	NN
cord-353749-2vlc11rx	136	30	factors	factor	NNS
cord-353749-2vlc11rx	136	31	for	for	IN
cord-353749-2vlc11rx	136	32	delayed	delay	VBN
cord-353749-2vlc11rx	136	33	return	return	NN
cord-353749-2vlc11rx	136	34	to	to	IN
cord-353749-2vlc11rx	136	35	usual	usual	JJ
cord-353749-2vlc11rx	136	36	health	health	NN
cord-353749-2vlc11rx	136	37	among	among	IN
cord-353749-2vlc11rx	136	38	outpatients	outpatient	NNS
cord-353749-2vlc11rx	136	39	with	with	IN
cord-353749-2vlc11rx	136	40	COVID-19	covid-19	CD
cord-353749-2vlc11rx	136	41	in	in	IN
cord-353749-2vlc11rx	136	42	a	a	DT
cord-353749-2vlc11rx	136	43	multistate	multistate	JJ
cord-353749-2vlc11rx	136	44	health	health	NN
cord-353749-2vlc11rx	136	45	care	care	NN
cord-353749-2vlc11rx	136	46	systems	system	NNS
cord-353749-2vlc11rx	136	47	network	network	NN
cord-353749-2vlc11rx	137	1	-United	-unite	VBN
cord-353749-2vlc11rx	137	2	States	state	NNS
cord-353749-2vlc11rx	138	1	Thinking	think	VBG
cord-353749-2vlc11rx	138	2	of	of	IN
cord-353749-2vlc11rx	138	3	risk	risk	NN
cord-353749-2vlc11rx	138	4	in	in	IN
cord-353749-2vlc11rx	138	5	the	the	DT
cord-353749-2vlc11rx	138	6	era	era	NN
cord-353749-2vlc11rx	138	7	of	of	IN
cord-353749-2vlc11rx	138	8	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	138	9	The	the	DT
cord-353749-2vlc11rx	138	10	outbreak	outbreak	NN
cord-353749-2vlc11rx	138	11	of	of	IN
cord-353749-2vlc11rx	138	12	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	138	13	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	138	14	and	and	CC
cord-353749-2vlc11rx	138	15	its	-PRON-	PRP$
cord-353749-2vlc11rx	138	16	impact	impact	NN
cord-353749-2vlc11rx	138	17	on	on	IN
cord-353749-2vlc11rx	138	18	global	global	JJ
cord-353749-2vlc11rx	138	19	mental	mental	JJ
cord-353749-2vlc11rx	138	20	health	health	NN
cord-353749-2vlc11rx	138	21	Coronavirus	Coronavirus	NNP
cord-353749-2vlc11rx	138	22	medical	medical	JJ
cord-353749-2vlc11rx	138	23	costs	cost	NNS
cord-353749-2vlc11rx	138	24	could	could	MD
cord-353749-2vlc11rx	138	25	soar	soar	VB
cord-353749-2vlc11rx	138	26	into	into	IN
cord-353749-2vlc11rx	138	27	hundreds	hundred	NNS
cord-353749-2vlc11rx	138	28	of	of	IN
cord-353749-2vlc11rx	138	29	billions	billion	NNS
cord-353749-2vlc11rx	138	30	as	as	IN
cord-353749-2vlc11rx	138	31	more	more	JJR
cord-353749-2vlc11rx	138	32	Americans	Americans	NNPS
cord-353749-2vlc11rx	138	33	become	become	VBP
cord-353749-2vlc11rx	138	34	infected	infected	JJ
cord-353749-2vlc11rx	138	35	.	.	.
cord-353749-2vlc11rx	139	1	The	the	DT
cord-353749-2vlc11rx	139	2	Conversation	Conversation	NNP
cord-353749-2vlc11rx	139	3	SARS	SARS	NNP
cord-353749-2vlc11rx	139	4	-	-	HYPH
cord-353749-2vlc11rx	139	5	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	139	6	vaccines	vaccine	NNS
cord-353749-2vlc11rx	139	7	in	in	IN
cord-353749-2vlc11rx	139	8	development	development	NN
cord-353749-2vlc11rx	139	9	Insights	insight	NNS
cord-353749-2vlc11rx	139	10	on	on	IN
cord-353749-2vlc11rx	139	11	early	early	JJ
cord-353749-2vlc11rx	139	12	mutational	mutational	JJ
cord-353749-2vlc11rx	139	13	events	event	NNS
cord-353749-2vlc11rx	139	14	in	in	IN
cord-353749-2vlc11rx	139	15	SARS	SARS	NNP
cord-353749-2vlc11rx	139	16	-	-	HYPH
cord-353749-2vlc11rx	139	17	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	139	18	virus	virus	NN
cord-353749-2vlc11rx	139	19	reveal	reveal	VBP
cord-353749-2vlc11rx	139	20	founder	founder	NN
cord-353749-2vlc11rx	139	21	effects	effect	NNS
cord-353749-2vlc11rx	139	22	across	across	IN
cord-353749-2vlc11rx	139	23	geographical	geographical	JJ
cord-353749-2vlc11rx	139	24	regions	region	NNS
cord-353749-2vlc11rx	139	25	Prevalence	prevalence	NN
cord-353749-2vlc11rx	139	26	of	of	IN
cord-353749-2vlc11rx	139	27	SARS	SARS	NNP
cord-353749-2vlc11rx	139	28	-	-	HYPH
cord-353749-2vlc11rx	139	29	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	139	30	in	in	IN
cord-353749-2vlc11rx	139	31	Spain	Spain	NNP
cord-353749-2vlc11rx	139	32	(	(	-LRB-
cord-353749-2vlc11rx	139	33	ENE	ENE	NNP
cord-353749-2vlc11rx	139	34	-	-	HYPH
cord-353749-2vlc11rx	139	35	COVID	COVID	NNP
cord-353749-2vlc11rx	139	36	)	)	-RRB-
cord-353749-2vlc11rx	139	37	:	:	:
cord-353749-2vlc11rx	140	1	a	a	DT
cord-353749-2vlc11rx	140	2	nationwide	nationwide	JJ
cord-353749-2vlc11rx	140	3	,	,	,
cord-353749-2vlc11rx	140	4	populationbased	populationbased	NNP
cord-353749-2vlc11rx	140	5	seroepidemiological	seroepidemiological	NNP
cord-353749-2vlc11rx	140	6	study	study	NN
cord-353749-2vlc11rx	140	7	Herd	Herd	NNP
cord-353749-2vlc11rx	140	8	immunityestimating	immunityestimate	VBG
cord-353749-2vlc11rx	140	9	the	the	DT
cord-353749-2vlc11rx	140	10	level	level	NN
cord-353749-2vlc11rx	140	11	required	require	VBN
cord-353749-2vlc11rx	140	12	to	to	TO
cord-353749-2vlc11rx	140	13	halt	halt	VB
cord-353749-2vlc11rx	140	14	the	the	DT
cord-353749-2vlc11rx	140	15	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	140	16	epidemics	epidemic	NNS
cord-353749-2vlc11rx	140	17	in	in	IN
cord-353749-2vlc11rx	140	18	affected	affected	JJ
cord-353749-2vlc11rx	140	19	countries	country	NNS
cord-353749-2vlc11rx	140	20	Pre	pre	JJ
cord-353749-2vlc11rx	140	21	-	-	JJ
cord-353749-2vlc11rx	140	22	exposure	exposure	JJ
cord-353749-2vlc11rx	140	23	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	140	24	(	(	-LRB-
cord-353749-2vlc11rx	140	25	PrEP	prep	NN
cord-353749-2vlc11rx	140	26	)	)	-RRB-
cord-353749-2vlc11rx	140	27	for	for	IN
cord-353749-2vlc11rx	140	28	HIV	HIV	NNP
cord-353749-2vlc11rx	140	29	prevention	prevention	NN
cord-353749-2vlc11rx	140	30	among	among	IN
cord-353749-2vlc11rx	140	31	men	man	NNS
cord-353749-2vlc11rx	140	32	who	who	WP
cord-353749-2vlc11rx	140	33	have	have	VBP
cord-353749-2vlc11rx	140	34	sex	sex	NN
cord-353749-2vlc11rx	140	35	with	with	IN
cord-353749-2vlc11rx	140	36	men	man	NNS
cord-353749-2vlc11rx	140	37	(	(	-LRB-
cord-353749-2vlc11rx	140	38	MSM	MSM	NNP
cord-353749-2vlc11rx	140	39	)	)	-RRB-
cord-353749-2vlc11rx	140	40	:	:	:
cord-353749-2vlc11rx	141	1	a	a	DT
cord-353749-2vlc11rx	141	2	scoping	scoping	NN
cord-353749-2vlc11rx	141	3	review	review	NN
cord-353749-2vlc11rx	141	4	on	on	IN
cord-353749-2vlc11rx	141	5	PrEP	prep	NN
cord-353749-2vlc11rx	141	6	service	service	NN
cord-353749-2vlc11rx	141	7	delivery	delivery	NN
cord-353749-2vlc11rx	141	8	and	and	CC
cord-353749-2vlc11rx	141	9	programming	program	VBG
cord-353749-2vlc11rx	141	10	SARS	SARS	NNP
cord-353749-2vlc11rx	141	11	-	-	HYPH
cord-353749-2vlc11rx	141	12	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	141	13	infection	infection	NN
cord-353749-2vlc11rx	141	14	in	in	IN
cord-353749-2vlc11rx	141	15	a	a	DT
cord-353749-2vlc11rx	141	16	patient	patient	NN
cord-353749-2vlc11rx	141	17	on	on	IN
cord-353749-2vlc11rx	141	18	chronic	chronic	JJ
cord-353749-2vlc11rx	141	19	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	141	20	therapy	therapy	NN
cord-353749-2vlc11rx	141	21	:	:	:
cord-353749-2vlc11rx	141	22	implications	implication	NNS
cord-353749-2vlc11rx	141	23	for	for	IN
cord-353749-2vlc11rx	141	24	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	142	1	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	142	2	and	and	CC
cord-353749-2vlc11rx	142	3	severe	severe	JJ
cord-353749-2vlc11rx	142	4	obesity	obesity	NN
cord-353749-2vlc11rx	142	5	:	:	:
cord-353749-2vlc11rx	142	6	a	a	DT
cord-353749-2vlc11rx	142	7	big	big	JJ
cord-353749-2vlc11rx	142	8	problem	problem	NN
cord-353749-2vlc11rx	142	9	Hospital	hospital	NN
cord-353749-2vlc11rx	142	10	-	-	HYPH
cord-353749-2vlc11rx	142	11	wide	wide	JJ
cord-353749-2vlc11rx	142	12	SARS	SARS	NNP
cord-353749-2vlc11rx	142	13	-	-	HYPH
cord-353749-2vlc11rx	142	14	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	142	15	antibody	antibody	NN
cord-353749-2vlc11rx	142	16	screening	screening	NN
cord-353749-2vlc11rx	142	17	in	in	IN
cord-353749-2vlc11rx	142	18	3056	3056	CD
cord-353749-2vlc11rx	142	19	staff	staff	NN
cord-353749-2vlc11rx	142	20	in	in	IN
cord-353749-2vlc11rx	142	21	a	a	DT
cord-353749-2vlc11rx	142	22	tertiary	tertiary	JJ
cord-353749-2vlc11rx	142	23	center	center	NN
cord-353749-2vlc11rx	142	24	in	in	IN
cord-353749-2vlc11rx	142	25	Belgium	Belgium	NNP
cord-353749-2vlc11rx	142	26	Risk	Risk	NNP
cord-353749-2vlc11rx	142	27	of	of	IN
cord-353749-2vlc11rx	142	28	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	142	29	among	among	IN
cord-353749-2vlc11rx	142	30	front	front	JJ
cord-353749-2vlc11rx	142	31	-	-	HYPH
cord-353749-2vlc11rx	142	32	line	line	NN
cord-353749-2vlc11rx	142	33	health	health	NN
cord-353749-2vlc11rx	142	34	-	-	HYPH
cord-353749-2vlc11rx	142	35	care	care	NN
cord-353749-2vlc11rx	142	36	workers	worker	NNS
cord-353749-2vlc11rx	142	37	and	and	CC
cord-353749-2vlc11rx	142	38	the	the	DT
cord-353749-2vlc11rx	142	39	general	general	JJ
cord-353749-2vlc11rx	142	40	community	community	NN
cord-353749-2vlc11rx	142	41	:	:	:
cord-353749-2vlc11rx	142	42	a	a	DT
cord-353749-2vlc11rx	142	43	prospective	prospective	JJ
cord-353749-2vlc11rx	142	44	cohort	cohort	NN
cord-353749-2vlc11rx	142	45	study	study	NN
cord-353749-2vlc11rx	142	46	Risk	Risk	NNP
cord-353749-2vlc11rx	142	47	for	for	IN
cord-353749-2vlc11rx	142	48	severe	severe	JJ
cord-353749-2vlc11rx	142	49	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	142	50	illness	illness	NN
cord-353749-2vlc11rx	142	51	among	among	IN
cord-353749-2vlc11rx	142	52	teachers	teacher	NNS
cord-353749-2vlc11rx	142	53	and	and	CC
cord-353749-2vlc11rx	142	54	adults	adult	NNS
cord-353749-2vlc11rx	142	55	living	live	VBG
cord-353749-2vlc11rx	142	56	with	with	IN
cord-353749-2vlc11rx	142	57	schoolaged	schoolaged	JJ
cord-353749-2vlc11rx	142	58	children	child	NNS
cord-353749-2vlc11rx	142	59	Prevalence	prevalence	NN
cord-353749-2vlc11rx	142	60	of	of	IN
cord-353749-2vlc11rx	142	61	asymptomatic	asymptomatic	JJ
cord-353749-2vlc11rx	142	62	SARS	SARS	NNP
cord-353749-2vlc11rx	142	63	-	-	HYPH
cord-353749-2vlc11rx	142	64	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	142	65	infection	infection	NN
cord-353749-2vlc11rx	142	66	.	.	.
cord-353749-2vlc11rx	143	1	A	a	DT
cord-353749-2vlc11rx	143	2	narrative	narrative	NN
cord-353749-2vlc11rx	143	3	review	review	NN
cord-353749-2vlc11rx	144	1	The	the	DT
cord-353749-2vlc11rx	144	2	major	major	JJ
cord-353749-2vlc11rx	144	3	genetic	genetic	JJ
cord-353749-2vlc11rx	144	4	risk	risk	NN
cord-353749-2vlc11rx	144	5	factor	factor	NN
cord-353749-2vlc11rx	144	6	for	for	IN
cord-353749-2vlc11rx	144	7	severe	severe	JJ
cord-353749-2vlc11rx	144	8	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	144	9	is	be	VBZ
cord-353749-2vlc11rx	144	10	inherited	inherit	VBN
cord-353749-2vlc11rx	144	11	from	from	IN
cord-353749-2vlc11rx	144	12	Neanderthals	Neanderthals	NNPS
cord-353749-2vlc11rx	144	13	Pharmacokinetics	Pharmacokinetics	NNP
cord-353749-2vlc11rx	144	14	of	of	IN
cord-353749-2vlc11rx	144	15	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	144	16	and	and	CC
cord-353749-2vlc11rx	144	17	its	-PRON-	PRP$
cord-353749-2vlc11rx	144	18	clinical	clinical	JJ
cord-353749-2vlc11rx	144	19	implications	implication	NNS
cord-353749-2vlc11rx	144	20	in	in	IN
cord-353749-2vlc11rx	144	21	chemoprophylaxis	chemoprophylaxis	NNP
cord-353749-2vlc11rx	144	22	against	against	IN
cord-353749-2vlc11rx	144	23	malaria	malaria	NN
cord-353749-2vlc11rx	144	24	caused	cause	VBN
cord-353749-2vlc11rx	144	25	by	by	IN
cord-353749-2vlc11rx	144	26	plasmodium	plasmodium	NN
cord-353749-2vlc11rx	144	27	vivax	vivax	NNP
cord-353749-2vlc11rx	144	28	Malaria	Malaria	NNP
cord-353749-2vlc11rx	144	29	control	control	NN
cord-353749-2vlc11rx	144	30	and	and	CC
cord-353749-2vlc11rx	144	31	chemoprophylaxis	chemoprophylaxis	JJ
cord-353749-2vlc11rx	144	32	policy	policy	NN
cord-353749-2vlc11rx	144	33	in	in	IN
cord-353749-2vlc11rx	144	34	the	the	DT
cord-353749-2vlc11rx	144	35	Republic	Republic	NNP
cord-353749-2vlc11rx	144	36	of	of	IN
cord-353749-2vlc11rx	144	37	Korea	Korea	NNP
cord-353749-2vlc11rx	144	38	Armed	Armed	NNP
cord-353749-2vlc11rx	144	39	Forces	Forces	NNPS
cord-353749-2vlc11rx	144	40	for	for	IN
cord-353749-2vlc11rx	144	41	the	the	DT
cord-353749-2vlc11rx	144	42	previous	previous	JJ
cord-353749-2vlc11rx	144	43	20	20	CD
cord-353749-2vlc11rx	144	44	years	year	NNS
cord-353749-2vlc11rx	144	45	(	(	-LRB-
cord-353749-2vlc11rx	144	46	1997	1997	CD
cord-353749-2vlc11rx	144	47	-	-	SYM
cord-353749-2vlc11rx	144	48	2016	2016	CD
cord-353749-2vlc11rx	144	49	)	)	-RRB-
cord-353749-2vlc11rx	145	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	145	2	:	:	:
cord-353749-2vlc11rx	145	3	an	an	DT
cord-353749-2vlc11rx	145	4	old	old	JJ
cord-353749-2vlc11rx	145	5	drug	drug	NN
cord-353749-2vlc11rx	145	6	with	with	IN
cord-353749-2vlc11rx	145	7	new	new	JJ
cord-353749-2vlc11rx	145	8	relevance	relevance	NN
cord-353749-2vlc11rx	146	1	In	in	IN
cord-353749-2vlc11rx	146	2	vitro	vitro	FW
cord-353749-2vlc11rx	146	3	antiviral	antiviral	JJ
cord-353749-2vlc11rx	146	4	activity	activity	NN
cord-353749-2vlc11rx	146	5	and	and	CC
cord-353749-2vlc11rx	146	6	projection	projection	NN
cord-353749-2vlc11rx	146	7	of	of	IN
cord-353749-2vlc11rx	146	8	optimized	optimize	VBN
cord-353749-2vlc11rx	146	9	dosing	dosing	NN
cord-353749-2vlc11rx	146	10	design	design	NN
cord-353749-2vlc11rx	146	11	of	of	IN
cord-353749-2vlc11rx	146	12	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	146	13	for	for	IN
cord-353749-2vlc11rx	146	14	the	the	DT
cord-353749-2vlc11rx	146	15	treatment	treatment	NN
cord-353749-2vlc11rx	146	16	of	of	IN
cord-353749-2vlc11rx	146	17	severe	severe	JJ
cord-353749-2vlc11rx	146	18	acute	acute	JJ
cord-353749-2vlc11rx	146	19	respiratory	respiratory	JJ
cord-353749-2vlc11rx	146	20	syndrome	syndrome	NN
cord-353749-2vlc11rx	146	21	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	146	22	To	to	TO
cord-353749-2vlc11rx	146	23	consider	consider	VB
cord-353749-2vlc11rx	146	24	or	or	CC
cord-353749-2vlc11rx	146	25	not	not	RB
cord-353749-2vlc11rx	146	26	antimalarials	antimalarial	NNS
cord-353749-2vlc11rx	146	27	as	as	IN
cord-353749-2vlc11rx	146	28	a	a	DT
cord-353749-2vlc11rx	146	29	prophylactic	prophylactic	JJ
cord-353749-2vlc11rx	146	30	intervention	intervention	NN
cord-353749-2vlc11rx	146	31	in	in	IN
cord-353749-2vlc11rx	146	32	the	the	DT
cord-353749-2vlc11rx	146	33	SARS	SARS	NNP
cord-353749-2vlc11rx	146	34	-	-	HYPH
cord-353749-2vlc11rx	146	35	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	146	36	(	(	-LRB-
cord-353749-2vlc11rx	146	37	Covid-19	covid-19	NN
cord-353749-2vlc11rx	146	38	)	)	-RRB-
cord-353749-2vlc11rx	146	39	pandemic	pandemic	NN
cord-353749-2vlc11rx	146	40	Early	early	JJ
cord-353749-2vlc11rx	146	41	transmission	transmission	NN
cord-353749-2vlc11rx	146	42	dynamics	dynamic	NNS
cord-353749-2vlc11rx	146	43	of	of	IN
cord-353749-2vlc11rx	146	44	novel	novel	JJ
cord-353749-2vlc11rx	146	45	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	146	46	(	(	-LRB-
cord-353749-2vlc11rx	146	47	COVID-19	covid-19	VB
cord-353749-2vlc11rx	146	48	)	)	-RRB-
cord-353749-2vlc11rx	146	49	in	in	IN
cord-353749-2vlc11rx	146	50	Nigeria	Nigeria	NNP
cord-353749-2vlc11rx	147	1	The	the	DT
cord-353749-2vlc11rx	147	2	prospects	prospect	NNS
cord-353749-2vlc11rx	147	3	for	for	IN
cord-353749-2vlc11rx	147	4	the	the	DT
cord-353749-2vlc11rx	147	5	SARS	SARS	NNP
cord-353749-2vlc11rx	147	6	-	-	HYPH
cord-353749-2vlc11rx	147	7	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	147	8	pandemic	pandemic	NN
cord-353749-2vlc11rx	147	9	in	in	IN
cord-353749-2vlc11rx	147	10	Africa	Africa	NNP
cord-353749-2vlc11rx	147	11	Safety	Safety	NNP
cord-353749-2vlc11rx	147	12	of	of	IN
cord-353749-2vlc11rx	147	13	hydroxychloroquine	hydroxychloroquine	NNP
cord-353749-2vlc11rx	147	14	among	among	IN
cord-353749-2vlc11rx	147	15	outpatient	outpatient	JJ
cord-353749-2vlc11rx	147	16	clinical	clinical	JJ
cord-353749-2vlc11rx	147	17	trial	trial	NN
cord-353749-2vlc11rx	147	18	participants	participant	NNS
cord-353749-2vlc11rx	147	19	for	for	IN
cord-353749-2vlc11rx	147	20	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	147	21	The	the	DT
cord-353749-2vlc11rx	147	22	impact	impact	NN
cord-353749-2vlc11rx	147	23	of	of	IN
cord-353749-2vlc11rx	147	24	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	147	25	treatment	treatment	NN
cord-353749-2vlc11rx	147	26	on	on	IN
cord-353749-2vlc11rx	147	27	pregnancy	pregnancy	NN
cord-353749-2vlc11rx	147	28	outcome	outcome	NN
cord-353749-2vlc11rx	147	29	in	in	IN
cord-353749-2vlc11rx	147	30	women	woman	NNS
cord-353749-2vlc11rx	147	31	with	with	IN
cord-353749-2vlc11rx	147	32	antiphospholipid	antiphospholipid	NNP
cord-353749-2vlc11rx	147	33	antibodies	antibodies	NNP
cord-353749-2vlc11rx	147	34	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	147	35	in	in	IN
cord-353749-2vlc11rx	147	36	children	child	NNS
cord-353749-2vlc11rx	147	37	with	with	IN
cord-353749-2vlc11rx	147	38	interstitial	interstitial	JJ
cord-353749-2vlc11rx	147	39	(	(	-LRB-
cord-353749-2vlc11rx	147	40	diffuse	diffuse	JJ
cord-353749-2vlc11rx	147	41	parenchymal	parenchymal	NN
cord-353749-2vlc11rx	147	42	)	)	-RRB-
cord-353749-2vlc11rx	147	43	lung	lung	NN
cord-353749-2vlc11rx	147	44	diseases	disease	NNS
cord-353749-2vlc11rx	147	45	Clinical	clinical	JJ
cord-353749-2vlc11rx	147	46	trials	trial	NNS
cord-353749-2vlc11rx	147	47	of	of	IN
cord-353749-2vlc11rx	147	48	disease	disease	NN
cord-353749-2vlc11rx	147	49	stages	stage	NNS
cord-353749-2vlc11rx	147	50	in	in	IN
cord-353749-2vlc11rx	147	51	COVID	COVID	NNP
cord-353749-2vlc11rx	147	52	19	19	CD
cord-353749-2vlc11rx	147	53	:	:	:
cord-353749-2vlc11rx	147	54	complicated	complicated	JJ
cord-353749-2vlc11rx	147	55	and	and	CC
cord-353749-2vlc11rx	147	56	often	often	RB
cord-353749-2vlc11rx	147	57	misinterpreted	misinterpret	VBD
cord-353749-2vlc11rx	147	58	Finding	find	VBG
cord-353749-2vlc11rx	147	59	the	the	DT
cord-353749-2vlc11rx	147	60	dose	dose	NN
cord-353749-2vlc11rx	147	61	for	for	IN
cord-353749-2vlc11rx	147	62	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	147	63	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	147	64	for	for	IN
cord-353749-2vlc11rx	147	65	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	147	66	;	;	:
cord-353749-2vlc11rx	147	67	the	the	DT
cord-353749-2vlc11rx	147	68	desperate	desperate	JJ
cord-353749-2vlc11rx	147	69	search	search	NN
cord-353749-2vlc11rx	147	70	for	for	IN
cord-353749-2vlc11rx	147	71	effectiveness	effectiveness	NN
cord-353749-2vlc11rx	147	72	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	147	73	disease	disease	NN
cord-353749-2vlc11rx	147	74	2019	2019	CD
cord-353749-2vlc11rx	147	75	,	,	,
cord-353749-2vlc11rx	147	76	and	and	CC
cord-353749-2vlc11rx	147	77	QT	QT	NNP
cord-353749-2vlc11rx	147	78	prolongation	prolongation	NN
cord-353749-2vlc11rx	147	79	Pre	pre	JJ
cord-353749-2vlc11rx	147	80	exposure	exposure	NN
cord-353749-2vlc11rx	147	81	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	147	82	use	use	NN
cord-353749-2vlc11rx	147	83	is	be	VBZ
cord-353749-2vlc11rx	147	84	associated	associate	VBN
cord-353749-2vlc11rx	147	85	with	with	IN
cord-353749-2vlc11rx	147	86	reduced	reduce	VBN
cord-353749-2vlc11rx	147	87	COVID19	COVID19	NNP
cord-353749-2vlc11rx	147	88	risk	risk	NN
cord-353749-2vlc11rx	147	89	in	in	IN
cord-353749-2vlc11rx	147	90	healthcare	healthcare	NN
cord-353749-2vlc11rx	147	91	workers	worker	NNS
cord-353749-2vlc11rx	147	92	Healthcare	Healthcare	NNP
cord-353749-2vlc11rx	147	93	workers	worker	NNS
cord-353749-2vlc11rx	147	94	and	and	CC
cord-353749-2vlc11rx	147	95	SARS	SARS	NNP
cord-353749-2vlc11rx	147	96	-	-	HYPH
cord-353749-2vlc11rx	147	97	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	147	98	infection	infection	NN
cord-353749-2vlc11rx	147	99	in	in	IN
cord-353749-2vlc11rx	147	100	India	India	NNP
cord-353749-2vlc11rx	147	101	:	:	:
cord-353749-2vlc11rx	147	102	a	a	DT
cord-353749-2vlc11rx	147	103	case	case	NN
cord-353749-2vlc11rx	147	104	-	-	HYPH
cord-353749-2vlc11rx	147	105	control	control	NN
cord-353749-2vlc11rx	147	106	investigation	investigation	NN
cord-353749-2vlc11rx	147	107	in	in	IN
cord-353749-2vlc11rx	147	108	the	the	DT
cord-353749-2vlc11rx	147	109	time	time	NN
cord-353749-2vlc11rx	147	110	of	of	IN
cord-353749-2vlc11rx	147	111	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	147	112	Prevalence	Prevalence	NNP
cord-353749-2vlc11rx	147	113	and	and	CC
cord-353749-2vlc11rx	147	114	clinical	clinical	JJ
cord-353749-2vlc11rx	147	115	correlates	correlate	NNS
cord-353749-2vlc11rx	147	116	of	of	IN
cord-353749-2vlc11rx	147	117	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	147	118	outbreak	outbreak	NN
cord-353749-2vlc11rx	147	119	among	among	IN
cord-353749-2vlc11rx	147	120	health	health	NN
cord-353749-2vlc11rx	147	121	care	care	NN
cord-353749-2vlc11rx	147	122	workers	worker	NNS
cord-353749-2vlc11rx	147	123	in	in	IN
cord-353749-2vlc11rx	147	124	a	a	DT
cord-353749-2vlc11rx	147	125	tertiary	tertiary	JJ
cord-353749-2vlc11rx	147	126	level	level	NN
cord-353749-2vlc11rx	147	127	hospital	hospital	NN
cord-353749-2vlc11rx	147	128	in	in	IN
cord-353749-2vlc11rx	147	129	Delhi	Delhi	NNP
cord-353749-2vlc11rx	147	130	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	147	131	in	in	IN
cord-353749-2vlc11rx	147	132	patients	patient	NNS
cord-353749-2vlc11rx	147	133	with	with	IN
cord-353749-2vlc11rx	147	134	rheumatic	rheumatic	JJ
cord-353749-2vlc11rx	147	135	disease	disease	NN
cord-353749-2vlc11rx	147	136	in	in	IN
cord-353749-2vlc11rx	147	137	Hubei	Hubei	NNP
cord-353749-2vlc11rx	147	138	province	province	NN
cord-353749-2vlc11rx	147	139	,	,	,
cord-353749-2vlc11rx	147	140	China	China	NNP
cord-353749-2vlc11rx	147	141	:	:	:
cord-353749-2vlc11rx	147	142	a	a	DT
cord-353749-2vlc11rx	147	143	multicentre	multicentre	NNP
cord-353749-2vlc11rx	147	144	retrospective	retrospective	JJ
cord-353749-2vlc11rx	147	145	observational	observational	JJ
cord-353749-2vlc11rx	147	146	study	study	NN
cord-353749-2vlc11rx	147	147	Chronic	Chronic	NNP
cord-353749-2vlc11rx	147	148	treatment	treatment	NN
cord-353749-2vlc11rx	147	149	with	with	IN
cord-353749-2vlc11rx	147	150	hydroxychloroquine	hydroxychloroquine	NNP
cord-353749-2vlc11rx	147	151	and	and	CC
cord-353749-2vlc11rx	147	152	SARS	SARS	NNP
cord-353749-2vlc11rx	147	153	-	-	HYPH
cord-353749-2vlc11rx	147	154	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	147	155	infection	infection	NN
cord-353749-2vlc11rx	147	156	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	147	157	in	in	IN
cord-353749-2vlc11rx	147	158	the	the	DT
cord-353749-2vlc11rx	147	159	treatment	treatment	NN
cord-353749-2vlc11rx	147	160	of	of	IN
cord-353749-2vlc11rx	147	161	outpatients	outpatient	NNS
cord-353749-2vlc11rx	147	162	with	with	IN
cord-353749-2vlc11rx	147	163	mildly	mildly	RB
cord-353749-2vlc11rx	147	164	symptomatic	symptomatic	JJ
cord-353749-2vlc11rx	147	165	COVID-19	covid-19	NN
cord-353749-2vlc11rx	147	166	:	:	:
cord-353749-2vlc11rx	147	167	a	a	DT
cord-353749-2vlc11rx	147	168	multi	multi	JJ
cord-353749-2vlc11rx	147	169	-	-	JJ
cord-353749-2vlc11rx	147	170	center	center	JJ
cord-353749-2vlc11rx	147	171	observational	observational	JJ
cord-353749-2vlc11rx	147	172	study	study	NN
cord-353749-2vlc11rx	147	173	Long	long	JJ
cord-353749-2vlc11rx	147	174	-	-	HYPH
cord-353749-2vlc11rx	147	175	term	term	NN
cord-353749-2vlc11rx	147	176	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	147	177	use	use	NN
cord-353749-2vlc11rx	147	178	in	in	IN
cord-353749-2vlc11rx	147	179	patients	patient	NNS
cord-353749-2vlc11rx	147	180	with	with	IN
cord-353749-2vlc11rx	147	181	rheumatic	rheumatic	JJ
cord-353749-2vlc11rx	147	182	conditions	condition	NNS
cord-353749-2vlc11rx	147	183	and	and	CC
cord-353749-2vlc11rx	147	184	development	development	NN
cord-353749-2vlc11rx	147	185	of	of	IN
cord-353749-2vlc11rx	147	186	SARS	SARS	NNP
cord-353749-2vlc11rx	147	187	-	-	HYPH
cord-353749-2vlc11rx	147	188	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	147	189	infection	infection	NN
cord-353749-2vlc11rx	148	1	:	:	:
cord-353749-2vlc11rx	148	2	a	a	DT
cord-353749-2vlc11rx	148	3	retrospective	retrospective	JJ
cord-353749-2vlc11rx	148	4	cohort	cohort	NN
cord-353749-2vlc11rx	148	5	study	study	NN
cord-353749-2vlc11rx	149	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	149	2	proves	prove	VBZ
cord-353749-2vlc11rx	149	3	ineffective	ineffective	JJ
cord-353749-2vlc11rx	149	4	in	in	IN
cord-353749-2vlc11rx	149	5	hamsters	hamster	NNS
cord-353749-2vlc11rx	149	6	and	and	CC
cord-353749-2vlc11rx	149	7	macaques	macaque	NNS
cord-353749-2vlc11rx	149	8	infected	infect	VBN
cord-353749-2vlc11rx	149	9	with	with	IN
cord-353749-2vlc11rx	149	10	SARS	SARS	NNP
cord-353749-2vlc11rx	149	11	-	-	HYPH
cord-353749-2vlc11rx	149	12	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	149	13	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	149	14	use	use	NN
cord-353749-2vlc11rx	149	15	against	against	IN
cord-353749-2vlc11rx	149	16	SARS	SARS	NNP
cord-353749-2vlc11rx	149	17	-	-	HYPH
cord-353749-2vlc11rx	149	18	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	149	19	infection	infection	NN
cord-353749-2vlc11rx	149	20	in	in	IN
cord-353749-2vlc11rx	149	21	non	non	JJ
cord-353749-2vlc11rx	149	22	-	-	JJ
cord-353749-2vlc11rx	149	23	human	human	JJ
cord-353749-2vlc11rx	149	24	primates	primate	NNS
cord-353749-2vlc11rx	149	25	Will	Will	MD
cord-353749-2vlc11rx	149	26	hydroxychloroquine	hydroxychloroquine	VB
cord-353749-2vlc11rx	149	27	impede	impede	VB
cord-353749-2vlc11rx	149	28	or	or	CC
cord-353749-2vlc11rx	149	29	prevent	prevent	VB
cord-353749-2vlc11rx	149	30	COVID-19	covid-19	CD
cord-353749-2vlc11rx	149	31	(	(	-LRB-
cord-353749-2vlc11rx	149	32	WHIP	WHIP	NNP
cord-353749-2vlc11rx	149	33	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	149	34	)	)	-RRB-
cord-353749-2vlc11rx	149	35	Protecting	protect	VBG
cord-353749-2vlc11rx	149	36	frontline	frontline	JJ
cord-353749-2vlc11rx	149	37	health	health	NN
cord-353749-2vlc11rx	149	38	care	care	NN
cord-353749-2vlc11rx	149	39	workers	worker	NNS
cord-353749-2vlc11rx	149	40	from	from	IN
cord-353749-2vlc11rx	149	41	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	149	42	with	with	IN
cord-353749-2vlc11rx	149	43	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	149	44	pre	pre	JJ
cord-353749-2vlc11rx	149	45	-	-	JJ
cord-353749-2vlc11rx	149	46	exposure	exposure	JJ
cord-353749-2vlc11rx	149	47	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	149	48	:	:	:
cord-353749-2vlc11rx	149	49	a	a	DT
cord-353749-2vlc11rx	149	50	structured	structured	JJ
cord-353749-2vlc11rx	149	51	summary	summary	NN
cord-353749-2vlc11rx	149	52	of	of	IN
cord-353749-2vlc11rx	149	53	a	a	DT
cord-353749-2vlc11rx	149	54	study	study	NN
cord-353749-2vlc11rx	149	55	protocol	protocol	NN
cord-353749-2vlc11rx	149	56	for	for	IN
cord-353749-2vlc11rx	149	57	a	a	DT
cord-353749-2vlc11rx	149	58	randomised	randomised	JJ
cord-353749-2vlc11rx	149	59	placebo	placebo	NN
cord-353749-2vlc11rx	149	60	-	-	HYPH
cord-353749-2vlc11rx	149	61	controlled	control	VBN
cord-353749-2vlc11rx	149	62	multisite	multisite	JJ
cord-353749-2vlc11rx	149	63	trial	trial	NN
cord-353749-2vlc11rx	149	64	in	in	IN
cord-353749-2vlc11rx	149	65	Toronto	Toronto	NNP
cord-353749-2vlc11rx	149	66	vitamin	vitamin	NN
cord-353749-2vlc11rx	149	67	C	c	NN
cord-353749-2vlc11rx	149	68	,	,	,
cord-353749-2vlc11rx	149	69	vitamin	vitamin	NN
cord-353749-2vlc11rx	149	70	D	d	NN
cord-353749-2vlc11rx	149	71	,	,	,
cord-353749-2vlc11rx	149	72	and	and	CC
cord-353749-2vlc11rx	149	73	zinc	zinc	NN
cord-353749-2vlc11rx	149	74	for	for	IN
cord-353749-2vlc11rx	149	75	the	the	DT
cord-353749-2vlc11rx	149	76	prevention	prevention	NN
cord-353749-2vlc11rx	149	77	of	of	IN
cord-353749-2vlc11rx	149	78	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	149	79	infection	infection	NN
cord-353749-2vlc11rx	149	80	(	(	-LRB-
cord-353749-2vlc11rx	149	81	HELPCOVID-19	HELPCOVID-19	NNP
cord-353749-2vlc11rx	149	82	)	)	-RRB-
cord-353749-2vlc11rx	149	83	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	149	84	in	in	IN
cord-353749-2vlc11rx	149	85	the	the	DT
cord-353749-2vlc11rx	149	86	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	149	87	pandemic	pandemic	NN
cord-353749-2vlc11rx	149	88	era	era	NN
cord-353749-2vlc11rx	149	89	:	:	:
cord-353749-2vlc11rx	149	90	in	in	IN
cord-353749-2vlc11rx	149	91	pursuit	pursuit	NN
cord-353749-2vlc11rx	149	92	of	of	IN
cord-353749-2vlc11rx	149	93	a	a	DT
cord-353749-2vlc11rx	149	94	rational	rational	JJ
cord-353749-2vlc11rx	149	95	use	use	NN
cord-353749-2vlc11rx	149	96	for	for	IN
cord-353749-2vlc11rx	149	97	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	149	98	of	of	IN
cord-353749-2vlc11rx	149	99	SARS	SARS	NNP
cord-353749-2vlc11rx	149	100	-	-	HYPH
cord-353749-2vlc11rx	149	101	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	149	102	infection	infection	NN
cord-353749-2vlc11rx	149	103	Efficacy	Efficacy	NNP
cord-353749-2vlc11rx	149	104	and	and	CC
cord-353749-2vlc11rx	149	105	safety	safety	NN
cord-353749-2vlc11rx	149	106	of	of	IN
cord-353749-2vlc11rx	149	107	hydroxychloroquine	hydroxychloroquine	NN
cord-353749-2vlc11rx	149	108	vs	vs	IN
cord-353749-2vlc11rx	149	109	placebo	placebo	NN
cord-353749-2vlc11rx	149	110	for	for	IN
cord-353749-2vlc11rx	149	111	preexposure	preexposure	NNP
cord-353749-2vlc11rx	149	112	SARS	SARS	NNP
cord-353749-2vlc11rx	149	113	-	-	HYPH
cord-353749-2vlc11rx	149	114	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	149	115	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	149	116	among	among	IN
cord-353749-2vlc11rx	149	117	health	health	NN
cord-353749-2vlc11rx	149	118	care	care	NN
cord-353749-2vlc11rx	149	119	workers	worker	NNS
cord-353749-2vlc11rx	149	120	:	:	:
cord-353749-2vlc11rx	150	1	A	a	DT
cord-353749-2vlc11rx	150	2	randomized	randomized	JJ
cord-353749-2vlc11rx	150	3	clinical	clinical	JJ
cord-353749-2vlc11rx	150	4	trial	trial	NN
cord-353749-2vlc11rx	150	5	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-353749-2vlc11rx	150	6	as	as	IN
cord-353749-2vlc11rx	150	7	pre	pre	JJ
cord-353749-2vlc11rx	150	8	-	-	JJ
cord-353749-2vlc11rx	150	9	exposure	exposure	JJ
cord-353749-2vlc11rx	150	10	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	150	11	for	for	IN
cord-353749-2vlc11rx	150	12	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	150	13	in	in	IN
cord-353749-2vlc11rx	150	14	healthcare	healthcare	NN
cord-353749-2vlc11rx	150	15	workers	worker	NNS
cord-353749-2vlc11rx	150	16	:	:	:
cord-353749-2vlc11rx	150	17	a	a	DT
cord-353749-2vlc11rx	150	18	randomized	randomized	JJ
cord-353749-2vlc11rx	150	19	trial	trial	NN
cord-353749-2vlc11rx	150	20	Beyond	beyond	IN
cord-353749-2vlc11rx	150	21	the	the	DT
cord-353749-2vlc11rx	150	22	randomized	randomized	JJ
cord-353749-2vlc11rx	150	23	controlled	control	VBN
cord-353749-2vlc11rx	150	24	trial	trial	NN
cord-353749-2vlc11rx	150	25	:	:	:
cord-353749-2vlc11rx	150	26	a	a	DT
cord-353749-2vlc11rx	150	27	review	review	NN
cord-353749-2vlc11rx	150	28	of	of	IN
cord-353749-2vlc11rx	150	29	alternatives	alternative	NNS
cord-353749-2vlc11rx	150	30	in	in	IN
cord-353749-2vlc11rx	150	31	mHealth	mHealth	NNP
cord-353749-2vlc11rx	150	32	clinical	clinical	JJ
cord-353749-2vlc11rx	150	33	trial	trial	NN
cord-353749-2vlc11rx	150	34	methods	method	NNS
cord-353749-2vlc11rx	150	35	Effect	effect	NN
cord-353749-2vlc11rx	150	36	of	of	IN
cord-353749-2vlc11rx	150	37	a	a	DT
cord-353749-2vlc11rx	150	38	US	US	NNP
cord-353749-2vlc11rx	150	39	National	National	NNP
cord-353749-2vlc11rx	150	40	Institutes	Institutes	NNPS
cord-353749-2vlc11rx	150	41	of	of	IN
cord-353749-2vlc11rx	150	42	Health	Health	NNP
cord-353749-2vlc11rx	150	43	programme	programme	NN
cord-353749-2vlc11rx	150	44	of	of	IN
cord-353749-2vlc11rx	150	45	clinical	clinical	JJ
cord-353749-2vlc11rx	150	46	trials	trial	NNS
cord-353749-2vlc11rx	150	47	on	on	IN
cord-353749-2vlc11rx	150	48	public	public	JJ
cord-353749-2vlc11rx	150	49	health	health	NN
cord-353749-2vlc11rx	150	50	and	and	CC
cord-353749-2vlc11rx	150	51	costs	cost	VBZ
cord-353749-2vlc11rx	150	52	Characteristics	characteristic	NNS
cord-353749-2vlc11rx	150	53	and	and	CC
cord-353749-2vlc11rx	150	54	strength	strength	NN
cord-353749-2vlc11rx	150	55	of	of	IN
cord-353749-2vlc11rx	150	56	evidence	evidence	NN
cord-353749-2vlc11rx	150	57	of	of	IN
cord-353749-2vlc11rx	150	58	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	150	59	studies	study	NNS
cord-353749-2vlc11rx	150	60	registered	register	VBN
cord-353749-2vlc11rx	150	61	on	on	IN
cord-353749-2vlc11rx	150	62	ClinicalTrials.gov	ClinicalTrials.gov	NNP
cord-353749-2vlc11rx	150	63	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	150	64	:	:	:
cord-353749-2vlc11rx	150	65	real	real	JJ
cord-353749-2vlc11rx	150	66	-	-	HYPH
cord-353749-2vlc11rx	150	67	time	time	NN
cord-353749-2vlc11rx	150	68	dissemination	dissemination	NN
cord-353749-2vlc11rx	150	69	of	of	IN
cord-353749-2vlc11rx	150	70	scientific	scientific	JJ
cord-353749-2vlc11rx	150	71	information	information	NN
cord-353749-2vlc11rx	150	72	to	to	TO
cord-353749-2vlc11rx	150	73	fight	fight	VB
cord-353749-2vlc11rx	150	74	a	a	DT
cord-353749-2vlc11rx	150	75	public	public	JJ
cord-353749-2vlc11rx	150	76	health	health	NN
cord-353749-2vlc11rx	150	77	emergency	emergency	NN
cord-353749-2vlc11rx	150	78	of	of	IN
cord-353749-2vlc11rx	150	79	international	international	JJ
cord-353749-2vlc11rx	150	80	concern	concern	NN
cord-353749-2vlc11rx	150	81	Mefloquine	Mefloquine	NNP
cord-353749-2vlc11rx	150	82	at	at	IN
cord-353749-2vlc11rx	150	83	the	the	DT
cord-353749-2vlc11rx	150	84	crossroads	crossroad	NNS
cord-353749-2vlc11rx	150	85	?	?	.
cord-353749-2vlc11rx	151	1	Implications	implication	NNS
cord-353749-2vlc11rx	151	2	for	for	IN
cord-353749-2vlc11rx	151	3	malaria	malaria	NN
cord-353749-2vlc11rx	151	4	chemoprophylaxis	chemoprophylaxis	NN
cord-353749-2vlc11rx	151	5	in	in	IN
cord-353749-2vlc11rx	151	6	Europe	Europe	NNP
cord-353749-2vlc11rx	151	7	Repurposing	Repurposing	NNP
cord-353749-2vlc11rx	151	8	of	of	IN
cord-353749-2vlc11rx	151	9	clinically	clinically	RB
cord-353749-2vlc11rx	151	10	approved	approve	VBN
cord-353749-2vlc11rx	151	11	drugs	drug	NNS
cord-353749-2vlc11rx	151	12	for	for	IN
cord-353749-2vlc11rx	151	13	treatment	treatment	NN
cord-353749-2vlc11rx	151	14	of	of	IN
cord-353749-2vlc11rx	151	15	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	151	16	disease	disease	NN
cord-353749-2vlc11rx	151	17	2019	2019	CD
cord-353749-2vlc11rx	151	18	in	in	IN
cord-353749-2vlc11rx	151	19	a	a	DT
cord-353749-2vlc11rx	151	20	2019-novel	2019-novel	CD
cord-353749-2vlc11rx	151	21	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	151	22	(	(	-LRB-
cord-353749-2vlc11rx	151	23	2019-nCoV	2019-ncov	CD
cord-353749-2vlc11rx	151	24	)	)	-RRB-
cord-353749-2vlc11rx	151	25	related	related	JJ
cord-353749-2vlc11rx	151	26	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	151	27	model	model	NN
cord-353749-2vlc11rx	152	1	The	the	DT
cord-353749-2vlc11rx	152	2	broad	broad	JJ
cord-353749-2vlc11rx	152	3	spectrum	spectrum	NN
cord-353749-2vlc11rx	152	4	antiviral	antiviral	JJ
cord-353749-2vlc11rx	152	5	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	152	6	targets	target	VBZ
cord-353749-2vlc11rx	152	7	the	the	DT
cord-353749-2vlc11rx	152	8	host	host	NN
cord-353749-2vlc11rx	152	9	nuclear	nuclear	JJ
cord-353749-2vlc11rx	152	10	transport	transport	NN
cord-353749-2vlc11rx	152	11	importin	importin	NNP
cord-353749-2vlc11rx	152	12	α	α	NNP
cord-353749-2vlc11rx	152	13	/	/	SYM
cord-353749-2vlc11rx	152	14	β1	β1	NNP
cord-353749-2vlc11rx	152	15	heterodimer	heterodimer	NN
cord-353749-2vlc11rx	153	1	The	the	DT
cord-353749-2vlc11rx	153	2	FDAapproved	fdaapproved	JJ
cord-353749-2vlc11rx	153	3	drug	drug	NN
cord-353749-2vlc11rx	154	1	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	154	2	inhibits	inhibit	VBZ
cord-353749-2vlc11rx	154	3	the	the	DT
cord-353749-2vlc11rx	154	4	replication	replication	NN
cord-353749-2vlc11rx	154	5	of	of	IN
cord-353749-2vlc11rx	154	6	SARS	SARS	NNP
cord-353749-2vlc11rx	154	7	-	-	HYPH
cord-353749-2vlc11rx	154	8	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	154	9	in	in	IN
cord-353749-2vlc11rx	154	10	vitro	vitro	FW
cord-353749-2vlc11rx	155	1	Ivermectin	Ivermectin	NNP
cord-353749-2vlc11rx	155	2	,	,	,
cord-353749-2vlc11rx	155	3	a	a	DT
cord-353749-2vlc11rx	155	4	new	new	JJ
cord-353749-2vlc11rx	155	5	candidate	candidate	NN
cord-353749-2vlc11rx	155	6	therapeutic	therapeutic	JJ
cord-353749-2vlc11rx	155	7	against	against	IN
cord-353749-2vlc11rx	155	8	SARS	SARS	NNP
cord-353749-2vlc11rx	155	9	-	-	HYPH
cord-353749-2vlc11rx	155	10	CoV-2/	CoV-2/	NNP
cord-353749-2vlc11rx	156	1	COVID-19	covid-19	JJ
cord-353749-2vlc11rx	156	2	ICON	icon	NN
cord-353749-2vlc11rx	156	3	(	(	-LRB-
cord-353749-2vlc11rx	156	4	Ivermectin	Ivermectin	NNP
cord-353749-2vlc11rx	156	5	in	in	IN
cord-353749-2vlc11rx	156	6	COvid	COvid	NNP
cord-353749-2vlc11rx	156	7	Nineteen	nineteen	CD
cord-353749-2vlc11rx	156	8	)	)	-RRB-
cord-353749-2vlc11rx	156	9	study	study	NN
cord-353749-2vlc11rx	156	10	:	:	:
cord-353749-2vlc11rx	156	11	use	use	NN
cord-353749-2vlc11rx	156	12	of	of	IN
cord-353749-2vlc11rx	156	13	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	156	14	is	be	VBZ
cord-353749-2vlc11rx	156	15	associated	associate	VBN
cord-353749-2vlc11rx	156	16	with	with	IN
cord-353749-2vlc11rx	156	17	lower	low	JJR
cord-353749-2vlc11rx	156	18	mortality	mortality	NN
cord-353749-2vlc11rx	156	19	in	in	IN
cord-353749-2vlc11rx	156	20	hospitalized	hospitalize	VBN
cord-353749-2vlc11rx	156	21	patients	patient	NNS
cord-353749-2vlc11rx	156	22	with	with	IN
cord-353749-2vlc11rx	156	23	COVID19	COVID19	NNP
cord-353749-2vlc11rx	156	24	Ivermectin	Ivermectin	NNP
cord-353749-2vlc11rx	156	25	and	and	CC
cord-353749-2vlc11rx	156	26	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	156	27	:	:	:
cord-353749-2vlc11rx	156	28	a	a	DT
cord-353749-2vlc11rx	156	29	report	report	NN
cord-353749-2vlc11rx	156	30	in	in	IN
cord-353749-2vlc11rx	156	31	Antiviral	Antiviral	NNP
cord-353749-2vlc11rx	156	32	Research	Research	NNP
cord-353749-2vlc11rx	156	33	,	,	,
cord-353749-2vlc11rx	156	34	widespread	widespread	JJ
cord-353749-2vlc11rx	156	35	interest	interest	NN
cord-353749-2vlc11rx	156	36	,	,	,
cord-353749-2vlc11rx	156	37	an	an	DT
cord-353749-2vlc11rx	156	38	FDA	FDA	NNP
cord-353749-2vlc11rx	156	39	warning	warn	VBG
cord-353749-2vlc11rx	156	40	Serious	serious	JJ
cord-353749-2vlc11rx	156	41	ivermectin	ivermectin	NNP
cord-353749-2vlc11rx	156	42	toxicity	toxicity	NN
cord-353749-2vlc11rx	156	43	and	and	CC
cord-353749-2vlc11rx	156	44	human	human	JJ
cord-353749-2vlc11rx	156	45	ABCB1	abcb1	NN
cord-353749-2vlc11rx	157	1	nonsense	nonsense	NN
cord-353749-2vlc11rx	157	2	mutations	mutation	NNS
cord-353749-2vlc11rx	158	1	A	a	DT
cord-353749-2vlc11rx	158	2	recommendation	recommendation	NN
cord-353749-2vlc11rx	158	3	for	for	IN
cord-353749-2vlc11rx	158	4	the	the	DT
cord-353749-2vlc11rx	158	5	use	use	NN
cord-353749-2vlc11rx	158	6	of	of	IN
cord-353749-2vlc11rx	158	7	chloroquine	chloroquine	NN
cord-353749-2vlc11rx	158	8	,	,	,
cord-353749-2vlc11rx	158	9	hydroxychloroquine	hydroxychloroquine	NNP
cord-353749-2vlc11rx	158	10	,	,	,
cord-353749-2vlc11rx	158	11	primaquine	primaquine	NNP
cord-353749-2vlc11rx	158	12	,	,	,
cord-353749-2vlc11rx	158	13	or	or	CC
cord-353749-2vlc11rx	158	14	tafenoquine	tafenoquine	NN
cord-353749-2vlc11rx	158	15	for	for	IN
cord-353749-2vlc11rx	158	16	prophylaxis	prophylaxis	NN
cord-353749-2vlc11rx	158	17	against	against	IN
cord-353749-2vlc11rx	158	18	the	the	DT
cord-353749-2vlc11rx	158	19	2019	2019	CD
cord-353749-2vlc11rx	158	20	novel	novel	NN
cord-353749-2vlc11rx	158	21	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	158	22	(	(	-LRB-
cord-353749-2vlc11rx	158	23	COVID-19	covid-19	VB
cord-353749-2vlc11rx	158	24	)	)	-RRB-
cord-353749-2vlc11rx	158	25	with	with	IN
cord-353749-2vlc11rx	158	26	note	note	NN
cord-353749-2vlc11rx	158	27	to	to	IN
cord-353749-2vlc11rx	158	28	the	the	DT
cord-353749-2vlc11rx	158	29	ophthalmic	ophthalmic	JJ
cord-353749-2vlc11rx	158	30	considerations	consideration	NNS
cord-353749-2vlc11rx	159	1	Tafenoquine	Tafenoquine	NNP
cord-353749-2vlc11rx	159	2	inhibits	inhibit	VBZ
cord-353749-2vlc11rx	159	3	replication	replication	NN
cord-353749-2vlc11rx	159	4	of	of	IN
cord-353749-2vlc11rx	159	5	SARS	SARS	NNP
cord-353749-2vlc11rx	159	6	-	-	HYPH
cord-353749-2vlc11rx	159	7	Cov-2	Cov-2	NNP
cord-353749-2vlc11rx	159	8	at	at	IN
cord-353749-2vlc11rx	159	9	pharmacologically	pharmacologically	RB
cord-353749-2vlc11rx	159	10	relevant	relevant	JJ
cord-353749-2vlc11rx	159	11	concentrations	concentration	NNS
cord-353749-2vlc11rx	159	12	in	in	IN
cord-353749-2vlc11rx	159	13	vitro	vitro	FW
cord-353749-2vlc11rx	159	14	Incidence	incidence	NN
cord-353749-2vlc11rx	159	15	and	and	CC
cord-353749-2vlc11rx	159	16	severity	severity	NN
cord-353749-2vlc11rx	159	17	of	of	IN
cord-353749-2vlc11rx	159	18	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	159	19	in	in	IN
cord-353749-2vlc11rx	159	20	HIV	HIV	NNP
cord-353749-2vlc11rx	159	21	-	-	HYPH
cord-353749-2vlc11rx	159	22	positive	positive	JJ
cord-353749-2vlc11rx	159	23	persons	person	NNS
cord-353749-2vlc11rx	159	24	receiving	receive	VBG
cord-353749-2vlc11rx	159	25	antiretroviral	antiretroviral	JJ
cord-353749-2vlc11rx	159	26	therapy	therapy	NN
cord-353749-2vlc11rx	160	1	-a	-a	:
cord-353749-2vlc11rx	160	2	cohort	cohort	NN
cord-353749-2vlc11rx	160	3	study	study	NN
cord-353749-2vlc11rx	160	4	The	the	DT
cord-353749-2vlc11rx	160	5	convalescent	convalescent	JJ
cord-353749-2vlc11rx	160	6	sera	sera	NN
cord-353749-2vlc11rx	160	7	option	option	NN
cord-353749-2vlc11rx	160	8	for	for	IN
cord-353749-2vlc11rx	160	9	containing	contain	VBG
cord-353749-2vlc11rx	160	10	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	160	11	Effect	Effect	NNP
cord-353749-2vlc11rx	160	12	of	of	IN
cord-353749-2vlc11rx	160	13	convalescent	convalescent	JJ
cord-353749-2vlc11rx	160	14	plasma	plasma	NN
cord-353749-2vlc11rx	160	15	therapy	therapy	NN
cord-353749-2vlc11rx	160	16	on	on	IN
cord-353749-2vlc11rx	160	17	time	time	NN
cord-353749-2vlc11rx	160	18	to	to	IN
cord-353749-2vlc11rx	160	19	clinical	clinical	JJ
cord-353749-2vlc11rx	160	20	improvement	improvement	NN
cord-353749-2vlc11rx	160	21	in	in	IN
cord-353749-2vlc11rx	160	22	patients	patient	NNS
cord-353749-2vlc11rx	160	23	with	with	IN
cord-353749-2vlc11rx	160	24	severe	severe	JJ
cord-353749-2vlc11rx	160	25	and	and	CC
cord-353749-2vlc11rx	160	26	life	life	NN
cord-353749-2vlc11rx	160	27	-	-	HYPH
cord-353749-2vlc11rx	160	28	threatening	threaten	VBG
cord-353749-2vlc11rx	160	29	COVID-19	covid-19	NN
cord-353749-2vlc11rx	160	30	.	.	.
cord-353749-2vlc11rx	161	1	A	a	DT
cord-353749-2vlc11rx	161	2	randomized	randomized	JJ
cord-353749-2vlc11rx	161	3	clinical	clinical	JJ
cord-353749-2vlc11rx	161	4	trial	trial	NN
cord-353749-2vlc11rx	161	5	Lessons	lesson	NNS
cord-353749-2vlc11rx	161	6	learned	learn	VBD
cord-353749-2vlc11rx	161	7	from	from	IN
cord-353749-2vlc11rx	161	8	early	early	JJ
cord-353749-2vlc11rx	161	9	compassionate	compassionate	JJ
cord-353749-2vlc11rx	161	10	use	use	NN
cord-353749-2vlc11rx	161	11	of	of	IN
cord-353749-2vlc11rx	161	12	convalescent	convalescent	JJ
cord-353749-2vlc11rx	161	13	plasma	plasma	NN
cord-353749-2vlc11rx	161	14	on	on	IN
cord-353749-2vlc11rx	161	15	critically	critically	RB
cord-353749-2vlc11rx	161	16	ill	ill	JJ
cord-353749-2vlc11rx	161	17	patients	patient	NNS
cord-353749-2vlc11rx	161	18	with	with	IN
cord-353749-2vlc11rx	161	19	Covid-19	Covid-19	NNP
cord-353749-2vlc11rx	161	20	Potent	potent	JJ
cord-353749-2vlc11rx	161	21	neutralizing	neutralize	VBG
cord-353749-2vlc11rx	161	22	antibodies	antibody	NNS
cord-353749-2vlc11rx	161	23	directed	direct	VBN
cord-353749-2vlc11rx	161	24	to	to	IN
cord-353749-2vlc11rx	161	25	multiple	multiple	JJ
cord-353749-2vlc11rx	161	26	epitopes	epitope	NNS
cord-353749-2vlc11rx	161	27	on	on	IN
cord-353749-2vlc11rx	161	28	SARS	SARS	NNP
cord-353749-2vlc11rx	161	29	-	-	HYPH
cord-353749-2vlc11rx	161	30	CoV-2	CoV-2	NNP
cord-353749-2vlc11rx	161	31	spike	spike	NN
cord-353749-2vlc11rx	161	32	Antibody	antibody	NN
cord-353749-2vlc11rx	161	33	therapies	therapy	NNS
cord-353749-2vlc11rx	161	34	could	could	MD
cord-353749-2vlc11rx	161	35	be	be	VB
cord-353749-2vlc11rx	161	36	a	a	DT
cord-353749-2vlc11rx	161	37	bridge	bridge	NN
cord-353749-2vlc11rx	161	38	to	to	IN
cord-353749-2vlc11rx	161	39	a	a	DT
cord-353749-2vlc11rx	161	40	coronavirus	coronavirus	NN
cord-353749-2vlc11rx	161	41	vaccine	vaccine	NN
cord-353749-2vlc11rx	161	42	-but	-but	:
cord-353749-2vlc11rx	161	43	will	will	MD
cord-353749-2vlc11rx	161	44	the	the	DT
cord-353749-2vlc11rx	161	45	world	world	NN
cord-353749-2vlc11rx	161	46	benefit	benefit	VB
cord-353749-2vlc11rx	161	47	?	?	.
cord-353749-2vlc11rx	162	1	Universal	universal	JJ
cord-353749-2vlc11rx	162	2	use	use	NN
cord-353749-2vlc11rx	162	3	of	of	IN
cord-353749-2vlc11rx	162	4	face	face	NN
cord-353749-2vlc11rx	162	5	masks	mask	NNS
cord-353749-2vlc11rx	162	6	for	for	IN
cord-353749-2vlc11rx	162	7	success	success	NN
cord-353749-2vlc11rx	162	8	against	against	IN
cord-353749-2vlc11rx	162	9	COVID-19	covid-19	VB
cord-353749-2vlc11rx	162	10	:	:	:
cord-353749-2vlc11rx	162	11	evidence	evidence	NN
cord-353749-2vlc11rx	162	12	and	and	CC
cord-353749-2vlc11rx	162	13	implications	implication	NNS
cord-353749-2vlc11rx	162	14	for	for	IN
cord-353749-2vlc11rx	162	15	prevention	prevention	NN
cord-353749-2vlc11rx	162	16	policies	policy	NNS
cord-353749-2vlc11rx	162	17	Use	Use	NNP
cord-353749-2vlc11rx	162	18	of	of	IN
cord-353749-2vlc11rx	162	19	facemasks	facemask	NNS
cord-353749-2vlc11rx	162	20	during	during	IN
cord-353749-2vlc11rx	162	21	the	the	DT
cord-353749-2vlc11rx	162	22	COVID-19	COVID-19	NNP
cord-353749-2vlc11rx	162	23	pandemic	pandemic	NN
cord-353749-2vlc11rx	162	24	2020	2020	CD
cord-353749-2vlc11rx	162	25	.	.	.
cord-353749-2vlc11rx	163	1	doi:10.1056/	doi:10.1056/	NNP
cord-353749-2vlc11rx	164	1	NEJMp2026913	NEJMp2026913	NNP
cord-353749-2vlc11rx	164	2	and	and	CC
cord-353749-2vlc11rx	164	3	the	the	DT
cord-353749-2vlc11rx	164	4	mechanisms	mechanism	NNS
cord-353749-2vlc11rx	164	5	of	of	IN
cord-353749-2vlc11rx	164	6	resistance	resistance	NN
cord-353749-2vlc11rx	164	7	development	development	NN
cord-353749-2vlc11rx	164	8	and	and	CC
cord-353749-2vlc11rx	164	9	diffusion	diffusion	NN
cord-353749-2vlc11rx	164	10	in	in	IN
cord-353749-2vlc11rx	164	11	both	both	DT
cord-353749-2vlc11rx	164	12	hospitals	hospital	NNS
cord-353749-2vlc11rx	164	13	and	and	CC
cord-353749-2vlc11rx	164	14	the	the	DT
cord-353749-2vlc11rx	164	15	community	community	NN
cord-353749-2vlc11rx	164	16	.	.	.
cord-353749-2vlc11rx	165	1	The	the	DT
cord-353749-2vlc11rx	165	2	manuscript	manuscript	NN
cord-353749-2vlc11rx	165	3	management	management	NN
cord-353749-2vlc11rx	165	4	system	system	NN
cord-353749-2vlc11rx	165	5	is	be	VBZ
cord-353749-2vlc11rx	165	6	completely	completely	RB
cord-353749-2vlc11rx	165	7	online	online	JJ
cord-353749-2vlc11rx	165	8	and	and	CC
cord-353749-2vlc11rx	165	9	includes	include	VBZ
cord-353749-2vlc11rx	165	10	a	a	DT
cord-353749-2vlc11rx	165	11	very	very	RB
cord-353749-2vlc11rx	165	12	quick	quick	JJ
cord-353749-2vlc11rx	165	13	and	and	CC
cord-353749-2vlc11rx	165	14	fair	fair	JJ
cord-353749-2vlc11rx	165	15	peerreview	peerreview	NN
cord-353749-2vlc11rx	165	16	system	system	NN
cord-353749-2vlc11rx	165	17	,	,	,
cord-353749-2vlc11rx	165	18	which	which	WDT
cord-353749-2vlc11rx	165	19	is	be	VBZ
cord-353749-2vlc11rx	165	20	all	all	RB
cord-353749-2vlc11rx	165	21	easy	easy	JJ
cord-353749-2vlc11rx	165	22	to	to	TO
cord-353749-2vlc11rx	165	23	use	use	VB